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Abstract 
Exercise training promotes a beneficial endothelial cell (EC) phenotype and results in conduit 
vessel adaptation. The specific underlying mechanisms have been proposed (shear stress, 
circumferential stress, hypoxia, metabolic) but are yet to be fully elucidated. This thesis 
investigated the predominant stimuli responsible for conduit vessel adaptation with training. 
Further, it developed a method of in situ EC extraction to allow for determination of the cellular 
and molecular mechanisms underpinning these adaptations. The methodology utilised two-
dimensional (2D) Doppler ultrasound, strain gauge plethysmography, immunocytochemistry 
and RT-qPCR to provide insight in to vascular characteristics, predominantly of the brachial 
artery and peripheral EC. Long-term repeated isometric forearm muscle contractions as 
performed by well-trained rock climbers promoted greater resting, peak (in response to 5 min 
ischaemia) and maximal (in response to ischaemic exercise) brachial artery diameters 
compared with controls. This structural response is dependent upon confounders associated 
with exercise additional to shear stress as evidenced by the lack of brachial artery remodelling 
in response to 8 weeks of ischaemic preconditioning (IPC). A transient increase in flow-
mediated dilation (FMD)% was observed following 6 weeks exposure to IPC, which became 
significant when controlled for baseline artery diameter, despite an absence of augmentation 
following long-term (≥ 8 weeks) exposure to a shear stimulus. This is in line with the suggested 
timeline of conduit vessel adaptation to exercise training of a transient increase in function at 
2-4 weeks. Underpinning molecular mechanisms responsible were not determined but may be 
further investigated given that the endovascular biopsy technique was developed and improved 
in this thesis. The endovascular biopsy successfully yields approximately 2100 ± 1700 EC per 
sample, providing sufficient material for determination of expression of both mRNA (RT-
qPCR) and protein (immunocytochemistry). Specifically, type 2 diabetics (T2DM) with 
symptomatic cardiac abnormalities exhibited augmented eNOS mRNA and protein in brachial 
artery EC as compared with non-diabetic controls with symptomatic cardiac abnormalities. In 
conclusion, this thesis demonstrates that although shear stress promotes a transient trend for 
enhancement in function of the peripheral conduit arteries, additional factors are required for 
long-term structural adaptations. Further, the endovascular biopsy technique offers a novel 
method of extracting and analysing EC for genes and proteins of interest to vascular health. 
The use of this technique to decipher the underlying cellular and molecular mechanisms 
involved in vascular adaptations with exercise requires further investigation. 
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Chapter 1 – Introduction 
Much prospective epidemiological research has been conducted in to the benefits of exercise 
on health, documenting specifically the reduction in risk of cardiovascular disease (CVD) in 
healthy individuals and in those with predetermined CVD or exhibiting risk factors for such 
pathological conditions (Nelson et al., 2007). However, only approximately 50% of the 
reduction in risk of coronary heart disease witnessed with exercise can be attributed to 
modification of traditional cardiovascular risk factors such as blood pressure, lipids, body mass 
index (BMI) and inflammatory/haemostatic biomarkers, the latter being the greatest 
contributor to lowered risk (Mora, Cook, Buring, Ridker and Lee, 2007). Although the 
mechanisms accounting for the remaining reduction in risk have not yet been elucidated, they 
may be attributed to adaptations within the vasculature itself, specifically endothelial function 
and changes in blood flow. 
 Studies on the effects of exercise on the vasculature, specifically of the large conduit 
and smaller resistance arteries have been extensively conducted, with varying conclusions 
regarding the effects of both aerobic and resistance exercise on arterial function and structure 
(Sinoway, Musch, Minotti and Zelis, 1986; Dinenno et al., 2001; Rakobowchuk, Tanguay, 
Burgomaster, Howarth, Gibala and MacDonald, 2008). However, it is now generally accepted 
that well-trained individuals exhibit an enhanced vascular phenotype, recently termed the 
‘athletes artery’ (Green, Spence, Rowley, Thijssen and Naylor, 2012), and that adaptations 
occur in a time-dependent manner (Laughlin, 1995; Tinken, Thijssen, Black, Cable and Green, 
2008; Green et al., 2012; Hunt, Walton and Ferguson, 2012).  
 Despite the recognised vascular adaptations with training, the specific mechanisms 
underlying such adaptations have not yet been fully elucidated. Several factors have been 
proposed as potential contributors, namely shear stress (Laughlin, Newcomer and Bender, 2008; 
Tinken, Thijssen, Hopkins, Dawson, Cable and Green, 2010; Newcomer, Thijssen and Green, 
2011), circumferential stress (Awolesi, Widmann, Sessa and Sumpio, 1994), ischaemia 
(Credeur, Hollis and Welsch, 2010; Hunt et al., 2012) and metabolic perturbations (Cacicedo, 
Gauthier, Lebrasseur, Jasuja, Ruderman and Ido, 2011). As yet, in vivo studies of the effects of 
acute and chronic exercise have provided limited mechanistic insight in to the specific factors 
involved in these adaptive processes. 
What is clear is that the endothelium plays a vital role in regulation of basic vessel 
function (Furchgott and Zawadzki, 1980) as well as vascular adaptations (Rudic, Shesely, 
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Maedo, Smithies, Segal and Sessa, 1998). Consequently, understanding the cellular responses 
in endothelial cells (EC) in response to exercise and exercise training will offer a unique insight 
in to mechanisms of vascular adaptation. Animal studies allow for straightforward extraction 
of relevant tissue for subsequent study whilst in vitro cell culture work provides additional 
insight in to the contributing molecular physiology. However, obtaining endothelial tissue from 
humans is relatively more complex. The endovascular biopsy technique, as originally proposed 
in the early 1990’s (Feng, Stern and Pile-Spellman, 1999) allows for the safe and reproducible 
harvesting of viable vascular EC for analysis of expression of genes and proteins of interest to 
vascular health and adaptation. As yet, this method is rarely adopted, with limited research 
having been conducted in clinical populations and minimal use in relation to exercise and 
vascular adaptation. 
This thesis aimed to manipulate and investigate the contributing factors to vascular 
adaptations observed with exercise. Climbers were utilised as an example of a chronically 
trained cohort, frequently subjecting the forearm vasculature to intermittent ischaemia resulting 
from repeated isometric contractions. Following which, IPC was implemented to longitudinally 
simulate similar intermittent ischaemic conditions. In order to elucidate the specific molecular 
signals implemented with these stimuli, a further aim was to develop a method of EC extraction 
from intact arteries for the purpose of EC analysis and quantification and to utilise the technique 
in a patient population to provide proof of concept observations. 
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1.1 Vascular structure 
The human vascular system has developed such that a branching structure has evolved, 
whereby large elastic and muscular conduit arteries feed to the microcirculation via the 
resistance arteries before entering the single cell capillaries for gas and solute exchange.  Blood 
vessels branch off from the aorta originating from the heart to provide specialised networks to 
distinct organs or localities of the body. Large elastic arteries, upon reaching the target organ 
then continue to branch in to smaller arteries, becoming resistance arteries when reaching a 
diameter of less than 200 µm (Smith and Fernhall, 2011). Following a further decrease in size 
and smooth muscle content, innumerable capillaries of 5-6µm diameter (Levick, 1991) are 
present, consisting of one to three flattened EC and a basement membrane, which constitute 
the site of solute exchange between blood and tissue. These capillaries subsequently converge 
to become venules and ultimately veins before feeding back to the heart via the vena cava. 
With the exception of capillaries, which are composed of a single layer of  
EC at approximately 0.5µm thick (Levick, 1991), blood vessels are composed of three discrete 
layers. A monolayer of vascular EC forms the endothelium, which not only acts as a barrier 
between the lumen and blood vessel wall, but plays a major role in controlling vascular function 
and integrity. This single layer of EC forms the tunica intima, which is followed outwardly by 
the elastic basal lamina on which it sits. The tunica media contains predominantly vascular 
smooth muscle (VSM) cells and provides mechanical strength for the relatively week intima, 
with spindle like smooth muscle cells largely interconnected within an elastin and collagen-
based matrix (Levick, 1991). The tunica adventitia forms the outermost layer, providing loose 
support for the vessel via its predominant composition of connective tissue (Fig. 1.1). 
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Figure 1.1. Micrograph of an elastic artery. Image adapted from (Young, Lowe, Stevens and 
Heath, 2006); I tunica intima; M tunica media; A tunica adventitia. 
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1.2 The endothelial cell 
The endothelial lining provides a semi-permeable membrane between the lumen blood flow 
and the local tissue and is comprised of a single layer of EC covering a surface area of 
approximately 1 to 7 m2 (Augustin, Kozian and Johnson, 1994). The EC play a key role in 
regulating blood flow, metabolic and immunologic functions (Fishman, 1982) as well as 
playing a fundamental role in vasculogenesis and angiogenesis. 
 Endothelial dysfunction i.e. pathological changes in the normal structure and function 
of the endothelium (Smith and Fernhall, 2011) is recognised as a primary step in the 
development of atherosclerosis (Schächinger et al., 2000). EC perturbations in functional 
homeostasis are well-recognised as potential contributors to vascular dysfunction in a number 
of pathophysiological disease states, most notably cardiovascular disease, hypertension and 
diabetes. Given the importance of EC in the processes of both vascular adaptation and 
dysfunction, continuing research at the molecular level of these cells is crucial in understanding 
the development of such disease states and further, in elucidating possible biomarker targets 
for the improvement and prevention of vascular dysfunction. 
 
1.2.1 EC structure 
EC originate from bipotential haemangioblast precursors which give rise to angioblasts or 
endothelial progenitor cells (EPC) which then migrate, proliferate and differentiate during 
vasculogenesis to form the rudiments of blood vessels (Alberts, Johnson, Lewis, Raff, Roberts 
and Walter, 2008). EC are thin, slightly elongated cells measuring approximately 50 – 70 µm 
long, 10 – 30 µm wide and 0.1 – 10 µm thick (Rafael, 2011) and exhibit phenotypic and 
morphological heterogeneity throughout the vascular tree (Aird, 2007). The vascular 
endothelial lining is classified as simple squamous epithelium (Fig. 1.2) whilst structural 
heterogeneity classes are categorised according to variations in intercellular junctions. These 
include continuous endothelium, fenestrated endothelium and discontinuous endothelium 
(Bennett et al., 1959) with continuous endothelium, coupled by tight junctions, being present 
in most vascular tissue (Fẻlẻtou, 2011). Cells can also vary according to shape and structural 
composition. Phenotypic variation is evident in differential expression of surface antigens and 
receptors which transcend to produce different responses despite an equivocal stimulus (Galley 
and Webster, 2004). Thus, EC originating from differing localisations may respond differently 
to the same stimulus, whilst EC obtained from the same portion of the vascular tree from 
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different individuals may also vary in their expression and responses to stimuli (Sumpio,  Riley 
and Dardik, 2002). 
 
Figure 1.2 Photo-micrograph of a small blood vessel illustrating the simple squamous 
epithelium; E endothelium. Image adapted from (Wheater, Burkitt and Daniels, 1993). 
 
1.2.2 Physiological roles of EC 
EC regulate blood vessel function and calibre, whilst they also play a role in vascular 
remodelling in response to perturbations in the surrounding environment. Given that the 
endothelial lining is constantly exposed to the vascular lumen, the EC are primary sensors of 
the predominant mechanical stresses on the vasculature, namely shear stress (the stress 
resulting from laminar blood flow) and circumferential stress (the distension of vessels due to 
blood pressure variation which is transferred to all layers of the vessel wall). Under basal 
physiological conditions the level of shear stress stimulates the relatively quiescent EC to 
release antithrombotic and vasoactive factors and maintain a relatively low proliferation rate. 
Since EC act as the mechanoreceptors of the vasculature, they align according to flow exposure 
and the mechanical response of the EC depends on the type of stress applied (Paszkowiak and 
Dardik, 2003). 
The obligatory role of EC in the dilation of isolated arteries was identified originally in 
vitro by Furchgott and Zawadzki (1980). The authors attributed this to the release of a factor 
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(endothelium-derived relaxant factor [EDRF]) in response to stimulation of the muscarinic 
receptors of these cells by acetylcholine (ACh) and the subsequent diffusion into the underlying 
vascular smooth muscle. EDRF has since been identified as nitric oxide (NO) (Moncada, 
Radomski and Palmer, 1988; Palmer, Ferrige and Moncada, 1987). Following the discovery of 
NO, the role of the endothelium in the release of contracting substances, specifically the 
endothelin peptides, was discovered (Furchgott and Vanhoutee, 1989) and subsequently, 
prostacyclin and other relatively minor vasodilatory factors (carbon monoxide, C-type 
natriuretic peptide and parathyroid hormone-related peptide) have been identified. Under 
physiological conditions, these vasoactive relaxing and contracting factors are maintained at 
equilibrium, ensuring an adequate blood supply to the target organ. This balance is disrupted 
under physiological and pathological conditions such as exercise and cardiovascular disease, 
respectively.  
NO is the most well-recognised and likely important vasoactive substance that is 
released by EC and its availability is commonly referenced as an index of endothelial function 
(Maiorana, O’Driscoll, Taylor and Green, 2003). This pleiotropic factor is released primarily 
in response to shear stress but also to a number of chemical stimuli such as ACh, bradykinin 
(BK), adenosine diphosphate (ADP) and substance P (SP). Endothelial nitric oxide synthase 
(eNOS), a reduced nicotinamide adenine dinucleotide phosphate (NAD(P)H)-dependent 
oxygenase and the enzyme responsible for the production of NO from L-arginine, is targeted to 
plasmalemmal caveolae (Boulanger and Vanhoutte, 1998). eNOS is tightly controlled through 
the presence of multiple phosphorylation sites, protein-protein interaction and translational 
lipid modifications (Fulton, Gratton and Sessa, 2001; Sessa, 2004) and additional to the 
requirement for L-arginine, the production of NO via eNOS depends on the presence of co-
factors, specifically tetrahydrobiopterin (H4B) and flavins (flavin mononucleotide [FMN] and 
flavin adenine dinucleotide [FAD]). Regulated via the phosphorylation and expression of 
eNOS, diffusion of NO in to the smooth muscle lining of the vessel initiates relaxation via a 
rise in the second messenger cyclic guanosine monophosphate (cGMP). This reduces in Ca2+ 
within the VSM cell, resulting in a reduction in phosphorylation and activation of myosin light 
chain kinase (MLCK) (which can also be inhibited by an increase in cyclic adenosine 
monophosphate [cAMP]) leading to smooth muscle relaxation (Levick, 1991). (Fig. 1.3).  
Additionally, the endothelium releases vasoconstrictors such as endothelin-1 (ET-1), 
which act on the smooth muscle to constrict the vessel both in response to transient increases 
in laminar (Yoshizumi et al., 1989) and asynchronous shear stress (Dancu, Berardi, Vanden 
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Heuvel and Tarbell., 2004). Complex interactions between vasoactive substances contribute to 
maintenance of vascular tone. For example, the binding of ET-1 to its receptor acts as a stimulus 
to increase eNOS production, whilst NO inhibits ET-1 activity (Smith and Fernhall, 2011). 
Vascular EC produce only ET-1 (Inoue et al., 1989) which acts through the stimulation of ETA 
receptors in smooth muscle to constrict the vessel, but also through ETB receptors in EC to 
vasodilate (Galley and Webster, 2004). The expression of collagenase, prostaglandin 
endoperoxidase synthase and platelet-derived growth factor genes is increased in response to 
ET-1 stimulated cell proliferation (Galley and Webster, 2004).  
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Figure 1.3 Endothelial nitric oxide production and it actions in the vascular smooth muscle 
cell. ACh= acetylcholine; BK= bradykinin; ATP= adenosine triphosphate; ADP= adenosine 
diphosphate; SP= substance P; SOCa2+= store-operated calcium (Ca2+) channel; ER= 
endoplasmic reticulum; NO= nitric oxide; sGC= soluble guanylyl cyclase; cGMP= cyclic 
guanosine-3’, 5 monophosphate; MLCK= myosin light chain kinase. *When Ca2+ stores of the 
endoplasmic reticulum are depleted a signal is sent to SOCa2+ channel which allows 
extracellular Ca2+ into the endothelial cell. Diagram adapted from (Sandoo, Veldhuijzen van 
Zanten, Metsios, Carroll and Kitas, 2010). 
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1.2.3 Factors that influence EC 
1.2.3.1 Shear stress  
Due to their luminal location, EC are primarily subjected to shear stress. This mechanical stress 
is thought to be the predominant regulator of eNOS and hence NO bioavailability via its 
detection by the negatively charged, carbohydrate-rich glycocalyx that lines the luminal surface 
of the endothelium (Fisslthaler, Dimmeler, Hermann, Busse and Fleming, 2000). Shear stress 
can be calculated from the following equation: τ = 4η Q̇ / πr3, where τ is the shear stress, η is 
the viscosity of blood, Q̇ is the rate of blood flow and r is the radius of the vessel. This notion 
is important given the key role of shear in the vasodilatory response of vessels in response to 
stressors and it is evident that it is dependent not only on vessel morphology but also on rate 
of blood flow. Either through the direct detection of mechanical stressors, or through the 
detection of alterations in local concentrations of bioactive substances, EC biology is crucial 
in mechanotransduction within the vasculature. ECs play a vital role in the transduction of 
signals to the desired biochemical response whilst presenting a challenge to researchers to 
decipher the specific mechanisms stimulated by flow- and metabolic-induced stressors. 
Laminar shear stress effects on EC 
Shear stress induces signal transduction via phosphatidylinositol 3-kinase (PI3K)/Akt and 
adenylate cyclase (AC)/protein kinase A (PKA) pathways and subsequent phosphorylation and 
activation of eNOS on serine residues (Ser617 and Ser1179, Ser635 and Ser1179, respectively). 
Elevations in shear stress also directly activate AMP-activated protein kinase (AMPK) (Zhang 
et al., 2006) which phosphorylates eNOS at Ser1177 (Chen et al., 1999). The mRNA levels of 
type III eNOS, the constitutive isoform, may also be up-regulated by vascular endothelial 
growth factor (VEGF), oestrogens and oxidised low density lipoprotein (LDL) whilst tumour 
necrosis factor α (TNF-α) may shorten the half-life (Boulanger and Vanhoutte, 1998). Further, 
VEGF has been reported to induce the Ca2+-independent activation of eNOS via the induction 
of vascular endothelial growth factor receptor-2 (VEGFR-2) in a reciprocal cycle (Egginton, 
2009), whilst laminar shear activates VEGFR-2 and subsequently eNOS in cultured EC (Jin, 
Ueba, Tanimoto, Lungu, Frame and Berk, 2003). 
Following activation, eNOS orchestrates the mobilisation, recruitment, migration and 
differentiation of vascular progenitor cells (Balligand, Feron and Dessy, 2009). NO can induce 
matrix metalloproteinases (MMPs) (Sasaki, Hattori, Fujisawa, Takahashi, Inoue and Takigawa, 
1998) which facilitate extracellular matrix degradation (Galis and Khatri, 2002) and 
reorganisation, a process required for the remodelling process. Additionally, genes implicated 
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in the angiogenic response (tyrosine kinase receptors Tie2, Flk-1) and vascular remodelling 
(matrix metalloproteinase-1 [MMP-1]) are upregulated in response to shear stress in cultured 
human umbilical vein endothelial cells (HUVEC) (Chen et al., 2001; Chien, 2007).  
Oscillatory shear stress effects on EC 
The nature of shear stress to which EC are exposed produces diverse results in cell activity. 
Additional to the laminar shear stress, oscillatory shear, characterised by high levels of 
retrograde shear (Thijssen et al., 2009b) may also be experienced by the vasculature, 
particularly during exercise, and likely opposes some of the positive molecular signals 
stimulated by laminar flow. Oscillatory flow induces expression of atherogenic genes e.g. 
monocyte chemotactic protein-1 (MCP-1), relatively greater expression of ET-1 mRNA and 
activity of pro-oxidant NADH oxidase but lower expression of eNOS mRNA (De Keulenaer, 
Chappell, Ishizaka, Nerem, Alexander and Griendling, 1998; Ziegler, Bouzouréne, Harrison, 
Brunner and Hayox, 1998; Chiu and Chien. 2011). The upregulation of various atherogenic 
and proinflammatory genes in response to low or oscillatory flow is absent or minimal in cells 
exposed to laminar shear (Chiu and Chien, 2011).  Further, an augmentation in oscillatory flow 
is thought to produce an atherosclerotic EC phenotype, with a decrease in eNOS expression 
(Ziegler et al., 1998) and therefore a likely successive reduction in NO bioavailability. 
Conversely, an increase in both eNOS and NO has been identified with oscillatory shear stress 
(Harrison, Widder, Grumbach, Chen, Weber and Searles, 2006). Finally, oscillatory shear 
induces the production of reactive oxygen species (ROS) (Laughlin et al., 2008), which act to 
catabolise NO to peroxynitrite forming nitrotyrosine, reducing NO bioavailability (Schiffrin, 
2008). All of these factors may contribute to the observed impairment in endothelial function 
with retrograde flow (Thijssen et al., 2009b).  
Shear stress-induced mechanoreceptors 
Two models of mechanotransduction within the vasculature have been demonstrated: 
the localised model and the decentralised model (Stoner, Young, Fryer and Sabatier, 2012). 
The former describes the localisation of the mechanoreceptor in the cellular membrane 
analogous to other channel-bound membranes. The decentralised model describes an internal 
localisation of mechanoreceptors, whereby the transmission through to the cytoskeleton of 
shear stress stimulates the appropriate biological response. The exact mechanisms of how stress 
is transmitted remain incompletely elucidated and although these models have been 
demonstrated in HUVEC exposed to mechanical pertubations in culture (Paszkowiak and 
Dardik, 2003), EC in vivo may respond differently, especially given the variations in EC 
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properties between arteries and veins and between vessels of varying hierarchical levels. Cell 
culture and environment manipulation techniques cells have led researchers to believe that 
shear stress and its effects on proliferation and gene expression play a major role in adaptation 
although this cannot be definitively stated through in vitro work alone.   
As the suggested predominant stimulus for vascular adaptation, shear stress can be 
manipulated in vitro using flow chambers which have been extensively employed in an effort 
to decipher the specific responses of HUVEC to shear stress. By exposure to a pressure 
difference applied through the inlet and the outlet of the chamber, confluent cells are subjected 
to steady and disturbed shear (Chien, 2007). At a relatively low level of shear application (0.5 
dyn/cm2) HUVECs are maintained with a nutrient supply without the induction of shear-
induced responses (Chien, 2007). However, when the magnitude of shear stress is manipulated 
in culture, EC become uniformly oriented with flow and undergo a conformational change to 
ellipsoidal from polygonal in a time-dependent manner (Dewey, Bussolari, Gimbrone and 
Davies, 1981), with their long axis aligned in the direction of blood flow. Additionally, elevated 
shear stress alters the EC microfilament network via the induction of actin stress fibres (Malek 
and Izumo, 1996). When EC are cultured in a flow chamber and subjected to shear levels 
matched to those expected in vivo, i.e. 5-20 dyn/cm2, they exhibit similar morphological 
responses as those witnessed within the vessel wall with regards to cell elongation and 
orientation (Darsch and Betz, 1989), suggesting EC in culture respond similarly to those in 
intact vessels. The down-regulation of genes related to EC proliferation and inflammation 
following 24 hours of steady shear is also evident (Chen et al., 2001). Laminar shear stress 
stimulates a dose-dependent attenuation of EC proliferation, evidencing the protective effect 
of laminar shear by reducing EC turnover (Li et al., 2005). 
Shear stress can activate a number of mechanoreceptors on EC i.e. integrins, receptor 
tyrosine kinases e.g. Flk-1, the VEGF receptor, Ca2+ channels, G proteins and G-protein 
coupled receptors (GPCR) and intercellular junction proteins (Chien, 2007). These receptors 
are additional to the roles likely played by the EC glycocalyx and membrane lipids. The 
detection of stresses by these EC mechanoreceptors stimulates the signalling cascades 
responsible for the modulation of gene expression witnessed with shear stress, most notably 
via protein kinase C (PKC), PI3K and mitogen-activated protein kinase (MAPK).  
The anchoring of EC to their matrix is essential for successful transduction in response 
to shear stress (Takahashi and Berk, 1996). Integrins are transmembrane glycoproteins 
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containing an extracellular domain which binds to specific extracellular matrix ligands, whilst 
the cytoplasmic domain interacts with signalling molecules in the focal adhesion sites (Li, Haga 
and Chien, 2005).  Stimuli acting extracellularly activate numerous intracellular signalling 
cascades via integrin activation, including but not limited to that involved in the cytoskeletal 
proteins (Li et al., 2005). Conformational activation of integrins in response to shear results in 
an increase in binding to extracellular matrix proteins, causing a transient inactivation of the 
small GTPase Rho (Tzima, del Pozo, Shattil, Chien and Schwartz, 2001), a mediator of 
mechanical signalling. This allows for cytoskeletal alignment in the direction of flow, 
highlighting the requirement of integrins and Rho in the mechanotransduction of shear to EC 
adaptation. The activation of integrins in response to shear stress occurs almost immediately 
(within 1 minute) and is maintained for more than 6 hours (Li et al., 2005; Wang et al., 2002).  
GPCR are additional mechanosensors present in EC which undergo conformational 
change upon sensing fluid shear stress (Chachisvillis, Zhang and Frangos, 2006). Initial 
evidence of this was provided when G proteins were activated within 1 second of flow onset 
in HUVECs, proposing GPCR activation as one of the earliest flow-induced signalling 
responses following shear stress (Gudi, Clark and Frangos, 1996). Further, inhibition of G 
proteins in EC exposed to shear stress inhibits the initial augmentation in NO without affecting 
sustained NO production, indicating the initial but not prolonged dependence on G proteins for 
mechanotransduction in response to shear stress (Kuchan, Jo and Frangos, 1994). 
Oscillatory shear stress can be simulated in vitro by imposing a rectangular obstacle 
within the flow chamber or with the use of a reciprocating flow pump (Chiu and Chien, 2011). 
Morphological elongation changes are less apparent when EC are exposed to low-level reverse 
flow with different levels of mean and oscillatory components and exhibit a slower rate of 
remodeling compared with steady flow. However, following exposure to high-level pure 
oscillatory flow they remain polygonal (as in static culture) and lack actin fibres (Helmlinger, 
Geiger, Schreck and Nerem, 1991). Additionally, oscillatory flow enhances EC proliferation 
and turnover rate (Li, Haga and Chien., 2005) but does not induce Ca2+ influx (Helmlinger, 
Berk and Nerem, 1995). This suggests the ability of EC to ‘recognise’ the flow stimulus in the 
surrounding vessel which will impact on the response of the cell and subsequent vascular 
properties. 
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1.2.3.2 Circumferential stress 
Circumferential stress occurs as a result of the pulse pressure variation within the vessel, 
specifically from arterial pressure waveforms acting on the compliance of the wall; usually 
subjecting EC in vivo to increases in approximately 10% strain (Moore et al., 1994). This has 
been simulated in culture by seeding EC on to a stretch chamber and applying uniaxial or 
biaxial stretch (Chien, 2007) utilising ‘hoop’ stretching or a vacuum where the latter results in 
deformation of the silastic membrane on which cells are cultured. 
 As witnessed with shear stress, circumferential stress results in elongation and 
alignment of EC, although in this case cells become aligned perpendicular to the direction of 
stretching (Ives, Eskin and McIntire, 1986). Circumferential stress has been shown to increase 
EC proliferation (Sumpio, Banes, Levin and Johnson, 1987) and morphological alignment (Iba 
and Sumpio, 1991; Califano and Reinhart-King, 2010). Exposing EC to cyclic stretch results 
in a time-dependent increase in basal and stimulated AC expression, suggesting the presence 
of an AC-coupled stretch receptor which modulates EC function (Letsou et al., 1990). This 
may act as a mechanoreceptor in response to circumferential stress which likely subsequently 
increases the vasodilatory effects of cAMP. Additionally, stretch appears to work in synergy 
with shear whereby exposure to both stimuli enhances EC alignment, indicating that the former 
may modulate the sensitivity of EC towards to shear stress (Moore et al., 1994; Zhao et al., 
1995). Both the independent and synergistic effects of these mechanical stressors promote 
predominantly positive effects on EC. 
An increase in eNOS gene and protein expression with cyclic strain-induced cultured 
EC is evident after 24 hours of exposure (Awolesi, Sessa and Sumpio, 1995), whilst others 
have witnessed no change in the gene expression of eNOS (Ziegler et al., 1998). It has therefore 
been proposed that increased expression of eNOS occurs with distension of arteries (Laughlin 
et al., 2008) which aids in providing an antiatherogenic EC phenotype. An increase in the 
activation of PKC is also evident with cyclic stretch (Rosales and Sumpio, 1992). Although 
not basally altered, cyclic strain may also increase prostacyclin synthetic capacity (Sumpio and 
Banes, 1988) despite an opposing increase in adhesion factors (ET-1, intracellular adhesion 
molecule-1 [ICAM-1]) and ROS (Sumpio and Widmann, 1990; Laughlin et al., 2008). Despite 
reducing NO bioavailability, ROS may indirectly increase eNOS expression (Barton, Ni and 
Vaziri, 2001). It is likely that circumferential stress predominantly results in a proatherogenic 
phenotype given the increases in ROS and adhesion molecules which override the effects of 
increases in eNOS expression (Laughlin et al., 2008). 
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The response of the multiple sensing mechanisms is dependent on the type of 
mechanical stress applied, leading to the activation of various signalling pathways and gene 
expression important to vascular function and structure. The interplay between these 
mechanoreceptors and protein-protein interactions in vivo ultimately affect the resultant 
biochemical signals, interactions which are as yet not fully elucidated from in vitro 
investigation.  
 
1.2.3.3 Additional factors 
Hypoxia 
It has previously been proposed that variations in tissue hypoxia and metabolic demand may 
influence EC properties leading to enhancements in blood vessel function and / or structure. 
Due to the difficulty in elucidating these specific stimuli and their confounding signalling 
pathways with mechanical factors in vivo, the potential magnitude of influence of these factors 
on EC physiology has not yet been established and research has focussed predominantly on in 
vitro models of investigation. 
Cells can be exposed to variations in oxygen tension to simulate the cell environment 
experienced in physiological or pathological conditions. These intermittent oscillations in 
oxygen tension can be simulated in culture through placing cells in to an air-tight incubator 
infused with a low oxygen air mixture, usually at 1% to 2% O2/5% CO2. Transduction of the 
hypoxic stimuli is hypothesised to occur through a specific oxygen sensor consisting of a haem-
binding protein (Faller, 1999), although this mechanism is not yet fully elucidated. Subsequent 
signal transduction occurs through second messengers, protein kinases and transcription factors, 
hypoxia-inducible transcription factor-1 (HIF-1) being the most well-defined. HIF-1 is 
expressed in most tissues including vascular endothelial and smooth muscle cells and exits as 
a heterodimeric complex of an α- and β-subunit. HIF-1 activates the transcription of genes 
involved in the angiogenic response (Manalo et al., 2005) where HIF-1α expression increases 
exponentially with reductions in oxygen concentration (Jiang, Semenza, Bauer and Marti, 1996) 
and its continuous synthesis and degradation is the predominant sensor in the response to 
varying oxygen concentrations. 
 Under conditions of low oxygen saturation, pro-proliferative mechanisms are up-
regulated whilst factors known to inhibit mitogenesis of EC are diminished (Faller, 1999), thus 
promoting proliferation and synthesis. Prolonged exposure of endothelial cells to hypoxia 
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attenuates the ability of cells to rearrange, reducing the ability to form tube-like structures by 
50%, likely as a result of a modulation of the cytoskeletal functions (Baffert et al., 2001), 
further decreasing to approximately 80% with continued exposure.  
Alterations in the metabolic demand of surrounding tissue initiate fluctuations in 
oxygen concentration. Simulating a hypoxic environment via the cessation of flow in 
previously flow-adapted bovine pulmonary artery endothelial cells (BPAEC) results in the 
activation of Ca2+/calmodulin (CaM)-dependent NO synthase and hence NO expression 
following immediate depolarization and subsequent increase in intracellular Ca2+ (Manevich, 
Al-Mehdi, Muzykantov and Fisher, 2001). Hypoxia also leads to the release of VEGF protein 
(Shweiki, Itin, Soffer and Keshet, 1992) and an increase in VEGF mRNA expression in a time 
dependent manner (Namiki et al., 1995). Additionally, the mobilisation of EPCs from bone 
marrow occurs in response to hypoxia (Urbich and Dimmeler, 2004), primarily in response to 
upregulation of VEGF via an MMP-9 dependent pathway (Urbich and Dimmeler, 2004). 
Indeed, there is a clear relationship between endothelial function and EPCs (Hill et al., 2003). 
However, despite the observed increases in these artereo- and angiogenic factors with 
hypoxia in vitro and somewhat in contrast to this hypothesis, the predominance of which is 
dependent on single condition manipulation, the role of hypoxia in the collateral growth of 
blood vessels has been refuted. Following occlusion of the femoral artery using the rabbit 
ischaemic hind limb model, an absence of augmentation of HIF-1α or VEGF mRNA was 
observed (Heil and Schaper, 2007). When considered in conjunction with these authors’ 
observation that during collateral growth the site of arterial occlusion is typically proximal to 
the hypoxic site, hypoxia was deemed unnecessary for arteriogenesis, at least in the peripheral 
vasculature. This perhaps highlights the necessity of in vivo EC investigation given the 
previous failings to identify any patho-physiologically relevant advantageous effects of 
reductions in oxygen saturation and the respective growth factors on arteriogenesis. 
Metabolism 
During exercise, there are dramatic perturbations in energy requirements and consequent 
changes in the concentrations of metabolites, which are released by contracting muscle in to 
the surrounding area. Under such conditions 5’ AMP-activated protein kinase (AMPK), a 
serine-threonine kinase described as a master regulator of cellular metabolism (Hardie, 2007), 
is activated via direct allosteric binding of AMP (Jørgensen, Richter and Wojtaszewski, 2006). 
Whilst the suppression of AMPK attenuates the migration of HUVECs (Nagata, Mogi and 
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Walsh, 2003), the phosphorylation of AMPK in EC under metabolic stress leads to the 
activation of eNOS, both in vitro and under ischaemic conditions (Chen et al., 1999). This 
occurs via phosphorylation at eNOS Ser1177 and is associated with a concomitant increase in 
NO production (Morrow, Foufelle, Connell, Petrie, Gould and Salt, 2003). 5-aminoimidazole-
4-carboxamide ribonucleoside (AICAR), an artificial AMPK activator, has been shown to 
lower blood pressure in rats (Buhl et al., 2002) and it is thus plausible but not conclusive that 
the positive effects of AICAR on vascular function may be through the effects of AMPK and 
NO, highlighting the importance of AMPK to vascular control. AMPK also acts to upregulate 
VEGF via the activation of peroxisome proliferator-activated receptor gamma coactivator 1-
alpha (PCG-1α) (Leick et al., 2009).  
Previous observations in cultured EC have since been observed in mice exposed to an 
acute bout of exercise. Both AMPK and eNOS were activated in the EC of the aortas of mice 
following exhaustive treadmill running, the magnitude of which was correlated with the AMPK 
regulatory proteins silent information regulator-1 (SIRT1)-LKB-1 and calmodulin-dependent 
protein kinase kinase-β (CaMKKβ) (Cacicedo et al., 2011). Interestingly and perhaps more 
importantly, no augmentation in Akt, PKA, protein kinase G (PKG) and Src were observed. 
However, the researchers recorded a 10 minute rest period following exercise before animals 
were sedated, euthanized and aortas excised and it may be that these additional enzymes 
followed alternative time-courses of expression. However, PI3K activation occurs within 15s 
of shear stress exposure (Go et al., 1998), with the downstream Akt pathway being active for 
at least 6 hours (Boo et al., 2002) at least in vivo, thus suggesting time course of expression 
cannot fully explain the absence of expression augmentation of these proteins. Conversely, 
further research observed that Akt is activated following 50 minutes of treadmill running in the 
femoral and iliac arteries of mice, upon which eNOS Ser1177 phosphorylation was 
approximately 50% dependent (Zhang, McMillin, Tanner, Palionyte, Abel and Symons, 2009). 
Although animal studies suggest the presence of complex interactions that are yet to be fully 
elucidated, research nonetheless suggests that AMPK and its subsequent phosphorylation of 
eNOS at Ser1177 may play a primary role in EC physiology and endothelial function, 
specifically during times of physiological perturbations, whilst the likely multiple upstream 
signalling pathways remain partially understood (Fig 1.4).  
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Figure 1.4 Possible role of AMP-activated protein kinase (AMPK) in the control of vascular 
tone in response to metabolic perturbations. 
 
Additional to the effects on AMPK from the increase in AMP/ATP ratio, it has been 
shown through its addition to culture medium that adenosine; the breakdown product of ATP 
not only stimulates the proliferation of HUVEC (Ethier, Chander and Dobson, 1993), but also 
enhances NO production by porcine EC via adenosine receptor activation (Li, Fenton, Cutler 
and Dobson, 1995). Surplus to the role of adenosine in inducing AMPK phosphorylation and 
activation via its metabolism by AC (da Silva et al., 2006), it may also play a role in 
angiogenesis (Adair, Gay and Montani, 1990) and has been previously been shown to be 
stimulated by hypoxia (Katori and Berne, 1966). Further, exposure of EC to hypoxia with the 
addition of adenosine and adenosine receptor agonists and antagonists identified the mediatory 
role played by adenosine in the induction of VEGF when cells are exposed to low oxygen 
environments (Takagi, King, Robinson, Ferrara and Aiello, 1996). Ultimately, all metabolic 
vasodilatory stimuli converge on the activation of KATP channels, leading to VSM cell 
hyperpolarisation and attenuation of voltage-gated Ca2+ activation (Gielen, Schuler and Adams, 
2010). 
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Although the manipulation of HUVEC in culture provides some evidence of the role 
played by variations in haemodynamic and humoral conditions on vascular properties within 
the body, a clear caveat is present in that these cells are rarely of a primary nature, and have 
been further cultured within an artificial environment. One must consider the physiological 
conditions experienced by EC within the vasculature, and the differences in cell characteristics 
and expression compared with those in culture. The effects of alterations in the haemodynamic 
stressors have been investigated both in vivo and in vitro through various molecular biology 
techniques (Fisslthaler et al., 2000; Hambrecht et al., 2003). However, the interactions between 
multiple stressors cannot be accounted for in culture (Newcomer et al., 2011), but are indeed 
suggested to be influenced by physiological conditions (Dancu et al., 2004; Dancu, Berardi, 
Vanden Heubel and Tarbell, 2007). Further, there is evident heterogeneity of haemodynamic 
stimuli throughout the vasculature (Newcomer et al., 2011), which is unlikely to be comparable 
between EC throughout the intact vessels and within a cultured environment. 
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1.3 Vascular adaptation to exercise training 
Acute exercise manipulates the haemodynamic and humoral factors that regulate endothelial 
control and vascular tone, thus adaptations to the vasculature as a result of chronic exercise 
training are not only anticipated, but are also of interest when deciphering the mechanisms 
behind such adaptations. 
 
1.3.1  Functional adaptation 
Original work in animals by Laughlin and colleagues suggested an early enhancement in 
conduit artery endothelial function with exercise training (Laughlin, 1995). Short-term training 
of 7 days in pigs provided additional support that endothelial function of the conduit arteries is 
improved following the onset of exercise training (Laughlin, Rubin, Rush, Price, Schrage and 
Woodman, 2003).  
Subsequent work in humans has attempted to determine the presence of functional 
adaptations in conduit arteries in vivo. Originally reported in 1992, a noninvasive method for 
the assessment of endothelial function involves the use of high-resolution ultrasound to 
measure the diameter of conduit arteries (Celermajer et al., 1992). Flow mediated dilation 
(FMD) is considered the ‘gold-standard’ method of assessing conduit artery function in vivo, 
identifying the change in artery diameter in response to a shear stress stimulus evoked by 
complete occlusion and subsequent reactive hyperaemia. FMD is an endothelium-dependent 
response and in an attempt to account for variability in artery size, is expressed as a ratio of 
peak to baseline diameter. The response of conduit arteries to the FMD stimulus is recognised 
as a test for the NO pathway given the abolishment of dilation in the presence of the NO 
synthase inhibitor NG – monomethyl-L-arginine (L-NMMA) (Joannides et al., 1995).  
 Endothelial function in humans is suggested to be unaltered with chronic training 
stimuli (Tinken et al., 2008), i.e. in training lasting over ~4 weeks (Hunt, Galea, Tufft, Bunce 
and Ferguson, 2013). The initial short-term augmentation in function of untrained or coronary 
disease groups (Hambrecht et al., 2003) is not evident in athletic populations (Green et al., 
2012) or in those trained for greater time periods. The body of literature initially suggested 
short term training improved vascular function in dog coronary arterioles (Sessa, Pritchard, 
Seyedi, Wang and Hintze, 1994) and in rat skeletal muscle arterioles (Sun, Huang, Koller and 
Kaley, 1994), but these improvements were not evident in training studies of longer duration 
of greater than 16 weeks (Kingwell, Sherrard, Jennings and Dart, 1997).  
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Following Laughlin’s original proposition that function is enhanced early in the 
exercise-adaptive process (Laughlin, 1995); researchers have aimed to replicate this in humans 
exposed to exercise training. The first study to demonstrate this identified an increase in FMD 
at weeks 2 and 4 of endurance exercise training, which had returned to baseline by week 8 
(Tinken et al., 2008). Further support for early increases in function have also been 
demonstrated in different modes of exercise i.e. cycling (Birk et al., 2012), and blood flow-
restricted (BFR) handgrip exercise (Hunt et al., 2013). As such it is now generally accepted 
that arteries undergo a time-dependent adaptation to training, whereby functional 
improvements occur transiently following approximately 2-4 weeks of training before 
returning to baseline (Laughlin, 1995; Tinken et al., 2008; Green et al., 2012; Hunt et al., 2012). 
 
1.3.2 Structural adaptation 
Structural adaptation involving arterial remodeling (arteriogenesis) can be described as the 
change in cross-sectional area of pre-existing functional arteries. Initial observations in animals 
suggested structural remodelling of the arteries with physical training e.g. an increase in 
coronary arteries diameter of rats after 10 weeks (Leon and Bloor, 1968), circumflex artery 
diameter of dogs after 12 weeks (Wyatt and Mitchell, 1978) and the coronary arteries of 
monkeys following 42 months of training (Kramsch, Aspen, Abramowitz, Kremendahl and 
Hood, 1981). In humans, assessment of arterial structure can be achieved in response to 
ischaemic exercise as measured using 2D Doppler ultrasound. This methodology provides a 
reliable surrogate marker of conduit vessel structure as opposed to resting diameter, the latter 
of which may be influenced by various confounding factors (sympathetic tone, circulating 
hormones and local paracrine effects) (Naylor, Weisbrod, O’Driscoll and Green, 2005). 
Dilatory capacity (DC) is used to describe the response of the artery to ischaemic exercise (Birk 
et al., 2012; Rowley et al., 2011a) which promotes a similar maximal response to the 
application of sublingual pharmacological vasodilators (glyceryl trinitrate (GTN) or 
nitroglycerine) (Naylor et al., 2005). The enforcement of maximal artery diameter in this 
manner removes the influence of the confounding functional factors and is largely NO-
independent (Green, 2005; Mullen et al., 2001), despite being endothelium dependent.  
Cross-sectional studies have demonstrated remodelling in the femoral artery of 
chronically trained endurance athletes (Schmidt-Truckäss et al., 2000; Rowley et al., 2011b) 
and locally in the brachial artery of the dominant arm and subclavian artery of elite racket 
athletes (Rowley et al., 2011b; Huonker, Schmid, Schmid-Truckass, Grathwohl and Keul, 
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2003). Further evidence of arterial remodelling has been observed in the upper limbs of 
wheelchair athletes (Zeppilli et al., 1995) and in cyclists compared to healthy controls and 
paraplegic or below-knee amputees (Huonker et al., 2003).  Although predominantly cross-
sectional research, longitudinal studies of exercise training have observed enlargement of local 
conduit arteries (Dinenno et al., 2001; Miyachi, Tanaka, Yamamoto, Yoshioka, Takahashi and 
Onodera, 2001) and a progressive increase in brachial artery DC throughout 8 weeks of training 
(Tinken et al., 2008). Thus, evidence suggests that well-trained individuals exhibit structurally 
larger peripheral conduit arteries than control participants, supported by studies identifying an 
improvement in DC with exercise training. 
This research conducted in humans exposed to exercise training emulates Laughlin’s 
original proposition that structural changes may supersede functional adaptation (Laughlin, 
1995). Remodelling of the arteries appears to be a homeostatic response which occurs to return 
shear stress and hence arterial function to pre-adaptive levels. This offers explanation as to the 
transient nature of functional adaptations with exercise training, whilst subsequent structural 
changes may obviate the requirement for functional improvements (Green et al., 2012) (Fig. 
1.5). Indeed, artery lumen dimension correlates highly with the magnitude of functional 
responses (Thijssen, Dawson, Black, Hopman, Cable and Green, 2008), a concept which may 
have implications for the measurement of arterial function in well-trained groups. Originally 
reported in 2012 (Green et al., 2012), the ‘athlete’s artery’ phenomenon elaborates upon this 
time course and describes the occurrence of the conduit arteries of athletes exhibiting an 
enhancement in structure (Tinken et al., 2008; Dinneno et al., 2011; Rowley et al., 2011b), 
despite no evident improvement in function with chronic training (Tinken et al., 2008) (Fig. 
1.6).  
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Figure 1.5 Diagram depicting the suggested timescale of a rapid change in conduit artery 
function (dashed line) and subsequent change in artery structure which supersedes this 
functional change (solid line) in response to exercise training. Taken from Green (2009). 
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Figure 1.6 Diagram of a typical artery from a non-athletic control (left) versus a typical artery 
from an athletic counterpart. Athlete artery exhibits a larger luminal diameter and possibly a 
decreased wall thickness compared to non-athletic artery. Diagram adapted from (Green et al., 
2012); I tunica intima; M tunica media; A tunica adventitia. 
 
1.3.3 Physiological signals for adaptation with exercise 
Adaptation of the vasculature is multifactorial and is proposed to occur as a result of stimulation 
by physical stressors such as shear and circumferential stress whilst hypoxia and metabolic 
factors may also contribute. Exercise modifies the magnitude and pattern of these stimuli and 
they therefore present as potential physiological signals for vascular adaptations with chronic 
training.  
It is well established that exercise results in alterations in the level of shear stress 
witnessed by the endothelium (Thijssen, Dawson, Black, Hopman, Cable and Green, 2009a). 
Initial evidence of the requirement of shear to exercise induced vascular adaptation was 
provided from ligation in animals where a reduction in arterial size resulted from a removal of 
shear (Langille and O’Donnell, 1986), the effect of which was endothelium dependent. Shear 
stress has since been proposed to be the main physiological factor contributing to the 
adaptations observed with exercise training (Laughlin et al., 2008; Tinken et al., 2010; 
Newcomer et al., 2011). Studies in humans have assessed this hypothesis by using limb 
occlusion with the use of a pneumatic cuff to manipulate the magnitude of shear stress borne 
by the vasculature. Specifically, partial occlusion (60 mmHg) applied to the distal forearm 
results in attenuation of the shear rate increase which occurs with exercise at the brachial artery 
(i.e. proximal to the cuff) (Tinken et al., 2009; Tinken et al., 2010). In response to 8 weeks of 
bilateral handgrip training brachial artery function and structure are enhanced (in the time 
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dependent manner previously described; Tinken et al., 2008), in only the uncuffed limb (where 
shear is maintained), suggesting that alterations in shear with exercise provide the principle 
stimulus for both functional and structural vascular adaptation with exercise training (Tinken 
et al., 2010). Further evidence has been provided by exposing limbs to heating to stimulate 
blood flow and hence increase shear rate whilst simultaneously excluding metabolic 
confounders associated with muscle contraction. Forearm heating in this manner for 8 weeks 
also resulted in brachial artery adaptation, again a response which is not evident when shear 
stress is reduced by partial distal limb occlusion (Green, Carter, Fitzsimons, Cable, Thijssen 
and Naylor, 2010; Naylor, FitzSimons, Cable, Thijssen and Green, 2011). Moreover, 8 weeks 
of lower limb exercise has since been found to induce functional adaptation in untrained upper 
limbs, which is in part attributable to the systemic effects of exercise on shear stress given the 
lack of adaptation when the forearm is occluded (Birk et al., 2012).  
 Additional to laminar shear stress, the vasculature is exposed to oscillatory shear 
patterns which may conversely adversely affect arterial function, at least acutely. Indeed, cuff-
induced blood flow restriction in the absence of exercise reduces FMD due to greater retrograde 
flow and shear rate in a dose-dependent manner (Thijssen et al., 2009b). Different modalities 
of exercise likely produce diverse shear patterns. Exercise involving large muscle groups 
results in incremental increases in both antero- and retrograde flow compared with a lack of 
induction of retrograde flow in localised training (Green, 2009). It is plausible that antegrade 
blood flow and shear stimulate acute enhancements in endothelial function and that this may 
act to counteract the impairments witnessed with the retrograde patterns produced with exercise 
(Green, 2009).  
 Although in vivo research predominantly surrounds the effects of shear stress on 
vascular adaptation, circumferential stress, hypoxia and various metabolic factors are 
additional potential contributors on account of the vascular responses observed in animal and 
cell culture models. Given the role of hypoxia and AMPK in EC metabolism as investigated in 
vitro, there may be a suggestion of their role in physiological adaptation. 
Numerous methods have been employed in an attempt to elucidate the specific 
mechanisms responsible for vascular adaptations to exercise training. However, researchers 
still face challenges in separating and removing confounding factors to allow for definitive 
elucidation. One such method involves the restriction of blood flow to the working limb whilst 
performing a localised exercise stimulus. In its original purpose, BFR training was used as an 
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alternative method of high intensity resistance training, from which similar strength and 
hypertrophic gains can be achieved whilst using a low load and concurrent occlusion of the 
limb (Takarada, Takazawa, Sato, Takebayashi, Tanaka and Ishii, 2000). Typically, a pressure 
cuff is applied proximal to the conduit artery i.e. to the upper thigh or upper arm at 120 mmHg 
or 80 mmHg for unilateral plantar flexion and handgrip training, respectively. Training load is 
set at 30% - 40% 1RM and unilateral contraction is performed to concentric failure, ensuring 
completion within <10 minutes and allowing 1 minute recovery between sets but maintenance 
of occlusion (Hunt et al., 2012; Hunt et al., 2013). BFR is likely to manipulate the local oxygen 
content and dependent on the cuff position also the shear response.  It will also produce a large 
reactive hyperaemic stimulus following the removal of occlusion. It was recently observed that 
brachial artery diameter at rest, in response to ischaemia (peak diameter) and ischaemic 
exercise (maximal dilation) increased to a greater extent after low-load BFR training of the 
forearm than low load training alone (Hunt et al., 2012). As such the relatively long period of 
ischaemia (~10 min) may provide the stimulus for the observed adaptations despite a relatively 
lower load. In accordance with the aforementioned time course of vascular adaptation (Tinken 
et al., 2008; Tinken et al., 2010), this type of training also induced an initial transient change 
in arterial function that was superseded by arterial remodelling (Hunt et al., 2013).  
Due to the substantial variations in mechanical and chemical stimuli induced with BFR, 
there are multiple potential signalling pathways for adaptation that have been investigated and 
partially elucidated. For example, after only one acute bout of low-load BFR exercise, an 
increase in VEGF, VEGFR-2, HIF-1α and inducible nitric oxide synthase (iNOS) transcript 
expression in muscle was observed (Larkin, MacNeil, Dirain, Sandesara, Manini and Buford, 
2012). The upregulation of these angiogenic and potentially arteriogenic factors has been 
reiterated whilst increases in expression of PGC-1α and eNOS mRNA were also observed 
(Hunt et al, 2014). A signalling cascade generated from the inactivation of shear stress-sensitive 
K+ channels with a subsequent membrane depolarisation may also contribute to the vascular 
adaptations witnessed in vivo, the generation of ROS and Ca2+ release additionally contributing 
(Fisher, Chien, Barakat and Nerem, 2001). These observations offer insight in to the 
supplementary role of hypoxia and shear in the vascular response to training. 
Despite the potential of the BFR protocol for stimuli manipulation, it is limited in that 
it does not allow the specific investigation in to the role of metabolism in isolation from 
exercise itself. A further method of stimuli manipulation involves occlusion in the absence of 
an exercise stimulus, removing any confounding factors resulting from muscle contraction with 
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exercise. Ischaemic preconditioning (IPC), where a vessel is exposed to a transient ischaemic 
period followed by episodes of reperfusion, is suggested to enhance protection against further 
ischaemic damage through improved endothelial function and augmented endothelium-
dependent vasodilation (Kimura et al., 2007).  The mechanisms through which this occurs 
appear to be multi-factorial, but it is proposed that the periodic exposure to high shear stress 
from repeated bouts of reactive hyperaemia (de Haro, Acin, Florez, Bleda and Fernandez, 2010) 
acts on mechanosensors subsiding on the EC membranes, stimulating an increase in eNOS 
activity. Moreover, an increase in maximal forearm blood flow in response to ACh injection is 
evident after IPC, an increase which correlates with an increase in EPCs (Kimura et al., 2007). 
Despite the lack of functional measures of endothelial function this study highlights the 
possibility that repetitive IPC in itself may be sufficient to improve endothelial function. 
Functional outcomes have since been investigated, with IPC treatment preventing the expected 
reduction in FMD following an acute bout of exercise (Bailey et al., 2012). Further, when this 
IPC stimulus is continued for a period of 7 days, an improvement in brachial artery function 
can be observed (Jones, Hopkins, Bailey, Green, Cable and Thijssen, 2014a).  
The implementation of BFR and IPC has proven useful in deciphering the contributing 
stimuli for vascular adaptation with exercise, proposing shear stress and / or hypoxia as key 
physiological determinants. Elucidation of the mechanisms of adaptation with training and of 
the specific stimuli which result in a healthy or adapted EC phenotype is of clinical significance 
as these cells offer the potential to be exploited in order to maximise vascular health and 
performance. 
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1.4 EC biopsy 
Whilst much is known about the factors involved in vascular adaptation in vitro and from the 
use of animals, there is an obvious lack of data regarding the specific molecular modifications 
within the vasculature that occur in humans. Moreover, translational data is yet to be observed, 
whereby relationships are deciphered between the cell signalling pathways and the adaptations 
observed at a whole body level. Correlating molecular measurements from humans with 
previously established functional and structural measures will provide a true understanding of 
the molecular mechanisms underlying the observed vascular adaptations with exercise and the 
dysfunction evident in diseased states and offer a novel perspective on potential therapeutic 
implications. Research surrounding vascular adaptation to exercise, specifically in the conduit 
arteries, has focussed predominantly on surrogate markers of function or in vivo measurements. 
The lack of available data regarding the specific cellular mechanisms underpinning the 
adaptations witnessed in vivo highlights the necessity of contributing research from cellular 
and molecular work. Although some research has identified genes and proteins of interest, these 
have been identified from either skeletal muscle (which is more relevant to angiogenesis) or 
blood samples, with no direct vascular cell samples being quantified from humans. Such work 
allows for the targeted manipulation of the cell environment and measurement of outcomes of 
interest, in an attempt to provide an insight in to the conditions and pathways that occur within 
the body.  
In an attempt to bridge this gap between cell culture techniques and non-invasive 
indirect human measurements, a relatively novel method, originally reported in 1992 involved 
the harvesting of viable EC from large elastic and conduit arteries (Feng et al., 1999). The 
endovascular biopsy technique allowed for in situ cell extraction via the detachment of EC 
from the vascular endothelium and subsequent analysis of cell characteristics. With specific 
reference to the paper, the biopsy was conducted using a coaxial curved stainless steel wire 
with a 0.038-inch diameter, 3-mm curve radius and heparin coating (J-wire; Cook, 
Bloomington, Ind.). The wire was inserted through the iliac artery through a Potts needle and 
a femoral sheath advanced over the wire (Fig. 1.7). It was then pulled back through the femoral 
sheath, and the tip of the wire was cut 3-inches from the tip and transferred to a test tube 
containing dissociation buffer. Cells were then incubated and further washed with buffer before 
being processed and subsequently stored at -80ºC pending immunocytochemical analysis. The 
authors concluded that viable EC could be obtained using the endovascular biopsy technique, 
given their morphology and positive identification through dual-fluorescence of the endothelial 
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markers angiotensin-converting enzyme (ACE), thrombomodulin and von Willebrand factor 
(vWF). 
 
Figure 1.7 Schematic diagram of the initial stage of the endovascular biopsy technique (Feng 
et al., 1999). A) The J-shaped wire is inserted through a cannula into the vessel of interest. B) 
The wire is advanced roughly 10 cm through the vessel and retracted to obtain EC collected 
under the J-shaped tip. C) The wire is cut at approximately 3 cm and placed in a test tube 
containing 25 mL of EC dissociation buffer. 
 
Although the initial biopsy technique harvested only a few hundred cells, of which only 
20-30% proved to be viable, further work conducted by this group, whilst validating 
immunofluorescence against immunoblotting in cultured EC, improved the available cell yield, 
collecting up to 1000 cells per wire (Colombo et al., 2002). Improvement of the initial 
technique involved the use of immunomagnetic isolation of CD146+ (a cell adhesion molecule 
evident in cells of endothelial lineage) but the methodology suffered the same limitations as 
previous studies i.e. the invasive sampling technique, small sample size and semi-quantitative 
nature of quantitative-polymerase chain reaction (qPCR) (Onat, Brillon, Colombo and Schmidt, 
2011). As the authors suggested, the superiority of using qPCR rather than 
immunocytochemistry is explained by the ability to investigate an unlimited number of genes 
using the amplified cDNAs, especially useful when cell numbers may be limited as a result of 
endovascular biopsy.  
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1.4.1 Clinical Applications of the Endovascular Biopsy 
Combining these techniques with the in vivo vascular measures previously discussed would 
allow for the measurement of the alterations in EC and surrounding vasculature in response to 
both acute and chronic interventions and would offer insight in to the mechanisms instigating 
and contributing to such adaptations. As such the technique has largely been used in 
populations exhibiting endothelial dysfunction for the obvious reason of attempting to ascertain 
the cellular and molecular underpinnings of this dysfunction.  
 
Ageing 
The pioneering work that emerged from New York and Colorado presented the endovascular 
biopsy technique as a valid and safe method of harvesting viable EC. Additionally, it provided 
the first evidence of differential protein expression in ageing patients. Interestingly, brachial 
artery eNOS protein is not reduced with ageing and in fact a trend for increased expression is 
observed in older healthy men (Donato et al., 2009) suggesting a minor role, if any, of eNOS 
in vascular endothelial dysfunction with ageing. These findings were further enhanced by 
observations of an increase in brachial artery expression of ET-1 with age and concomitant 
reduction in function of the brachial artery (Donato et al., 2009). Inversely related to FMD, 
older men also exhibit greater brachial artery EC nitrotyrosine abundance, additional to greater 
arterial and venous EC nuclear factor kappa-light-chain-enhancer of activated B cells (NF-KB) 
and venous TNF-α and MCP-1 expression (Donato et al., 2007; Donato, Black, Jablonski, Gano 
and Seals, 2008), suggesting an increase in oxidative stress with ageing that is related to 
reduced endothelial function. These initial studies provided the first evidence of the link 
between the molecular mechanisms evident in the vascular system and the endothelial 
dysfunction that occurs with ageing. Moreover, these studies identified the link from the 
underpinning molecular mechanisms to the functional measurements of vascular heath and 
provided a gateway for future research to make similar associations. 
 
Disease 
Endothelial dysfunction is a well-recognised precursor of CVD (Quyyumi, 1998), thus it is of 
interest to utilise the endovascular biopsy technique to aid in deciphering the underlying 
mechanisms of this dysfunction. The original paper validating quantitative 
immunofluorescence against immunoblotting of cultured EC concurrently investigated 
differential protein expression in EC isolated from patients with severe coronary heart failure 
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(CHF) and healthy males, and identified an 8-fold greater expression of venous 
cyclooxygenase-2 (COX-2) in CHF patients compared to healthy controls (Colombo et al., 
2002). Furthermore, eNOS expression was significantly greater in the arteries of patients than 
in peripheral veins, although this was not different from control venous samples. Greater 
quantitative information has been obtained using qPCR to analyse venous EC obtained from a 
small number of patients with history of cardiovascular events and the group also identified an 
association between vascular disease and both the induction of early growth response gene 
product-1 (Erg-1) and MCP-1, both genes being implicated in atherosclerosis (Onat et al., 
2007).  
 The clinical application of this technique has been furthered with research into type 2 
diabetes mellitus (T2DM) (Feng, Matsumoto, Schwartz, Schmidt, Stern and Pile-Spellman, 
2005) and obesity (Silver et al., 2007; Jelic et al., 2010). qPCR of EC biopsy samples revealed 
strong associations between the induction of receptor for advanced glycation end product 
(RAGE) mRNA and diabetes and also between RAGE (an inflammatory marker) and MCP-1 
(Feng et al., 2005). Diabetics are a population with previously established endothelial 
dysfunction (Schalkwijk and Stehouwer, 2005) within which CVD is the main cause of death 
(Rydén et al., 2007). This group offer an additional clinical population with whom the 
endovascular biopsy technique may offer a unique insight i.e. in to the role of vascular 
inflammation and the contributing molecular signals to T2DM, subsequently providing novel 
therapeutic potential. 
The development of this technique has led to further clinical insight, specifically in to 
the relationships between obesity and adiposity with vascular dysfunction. Obese individuals 
exhibit an upregulation of antioxidant enzymes and Ser1177-phosphorylated eNOS, likely 
compensating for the increases in endothelial oxidative stress, as demonstrated by increased 
expression of NAD(P)H oxidase-p47phox (Silver et al., 2007). Although augmentation of 
additional factors such as ET-1 and NF-KB has also been observed (Silver et al., 2007), it has 
been suggested that further factors such as obstructive sleep apnoea, rather than obesity itself 
that is a major determinant of endothelial dysfunction in overweight and obese individuals 
(Jelic et al., 2010). Nonetheless, the initial determination of the molecular cardiovascular 
events in these populations highlights the benefits of such a technique in clinical groups. The 
previous research emphasises the role of endothelial dysfunction at a cellular level in the 
progression of disease. Molecular work in this field may ultimately aid in the development of 
32 
 
interventions targeting vascular disease, with the identification of biomarkers indicative of 
incidence and severity. 
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1.5 Aims of thesis 
There is no doubt that vascular adaptation occurs with exercise training. Multiple factors have 
been implicated in the adaptive process, yet few studies have manipulated these conditions in 
vivo to decipher the specific stimuli responsible. Further, although cell culture techniques have 
alluded to the mechanisms which may be responsible, the in vitro nature of these studies does 
not allow for direct comparison and conclusions to be made regarding the specific molecular 
signalling processes within the whole body. In light of previous success in identifying the 
potential mechanistic basis of changes evident with varying cardiovascular health status, it 
seems logical that the endovascular biopsy be used to identify the mechanisms and hence 
specific stimuli underpinning the conduit vessel adaptations seen with exercise. Therefore, the 
main objective of this thesis was to address the mechanistic basis for vascular adaptation with 
exercise via manipulation of potential stimuli and to develop an EC biopsy technique which 
would allow for the elucidation of the cellular and molecular signals affected by these stimuli. 
This was addressed through the following specific research aims: 
1. To determine if conduit vessel functional and structural adaptation occurs in response 
to repeated exposure to intermittent shear stress in both the presence (Chapter 3) and 
absence (Chapter 4) of muscle contraction.  
2. To determine if functional and structural adaptations of the conduit artery occur in a 
time-dependent manner in response an IPC stimulus (Chapter 4). 
3. To develop a method of extracting EC from the intact vasculature (Chapter 5) and 
determine its applicability in providing cellular and molecular information in a 
population with expected variations in endothelial function in a proof of concept study 
(Chapter 6). 
Rock climbers were utilised as a model of a chronically trained cohort, the forearms of whom 
are frequently subjected to intermittent ischaemic conditions as a result of repeated isometric 
muscle contractions. Subsequently, a longitudinal study utilising IPC, a method of 
implementing intermittent ischaemic conditions, was conducted to determine if time-dependent 
vascular adaptations are observed with intermittent ischaemia whereby, as opposed to rock 
climbing, there is an absence of muscle contraction.  
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Chapter 2 – General methods 
2.1 In vivo methods 
2.1.1 Participant recruitment 
In vivo study participants 
Participants for all exercise / training studies (males aged 18-35 years) completed a health 
screening questionnaire and were fully informed of the purposes, risks and discomforts 
associated with the experiment before providing written, informed consent. Participants with 
known cardiovascular, respiratory, haematological or metabolic disease and those currently 
taking any medication were excluded from the study. All studies conformed to local guidelines 
and the Declaration of Helsinki and were approved by Loughborough University Ethics 
Advisory Committee. 
 
Endovascular biopsy study participants 
All participants were patients undergoing a percutaneous coronary intervention (PCI) and had 
previously provided written consent as a patient of the Biomedical Research Informatics Centre 
for Cardiovascular Science (BRICCS) database in collaboration with The University Hospitals 
of Leicester NHS Trust Cardiovascular Biomedical Research Unit. The specific removal of EC 
had been further approved by the review board. Participants were excluded if vasodilators were 
extensively utilised during the PCI procedure. 
 
2.1.2 Vascular measures 
After an overnight fast, participants reported to the laboratory (at approximately 6am - 8am) 
having refrained from strenuous physical activity for 24 hours and abstaining from the 
consumption of alcohol, caffeine, tobacco and vitamin supplementation for 12 hours. The 
participant rested for a minimum of 20 minutes in a supine position in a quiet temperature-
controlled (24 ± 1ºC) room before vascular measures were taken (Thijssen et al., 2011). 
 
2.1.2.1 2D Doppler ultrasound 
The participant remained resting in a supine position with the arm comfortably extended and 
immobilised at an angle approximately 80° from the torso. Two-dimensional (2D) Doppler 
ultrasound imaging was performed by the same sonographer using a Toshiba Powervision 6000 
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with a multi-frequency linear array transducer (7-11 MHz). A 90° B-mode image of the 
brachial artery at 3 cm depth was obtained >3 cm proximal to the olecranon process in the 
longitudinal plane (Fig. 2.1). An image was selected and deemed suitable when a clear anterior 
and posterior intimal interface between the arterial lumen and vessel was evident (Corretti et 
al., 2002). Image clarity was optimised by adjusting receiver gain, pulse repetition frequency 
and dynamic range whilst simultaneously correcting the degree of angulation of the probe. 
In duplex mode the sample volume was centralised within the artery and the ultrasound 
beam aligned with direction of flow (insonation angle ≤69°) (Fig. 2.1). Once a satisfactory 
image was obtained, the probe was held in a constant position for the duration of the test. A 
vascular ECG gating module (Medical Imaging Applications, LLC, Coralville, Iowa, USA) 
triggered acquisition of the ultrasound images on the R-wave pulse of an ECG signal. 
Sequential end-diastolic images were stored from on-line image digitisation. Ensuring 
measurements were taken at the same stage of each cardiac cycle eliminated the possible effects 
of non-endothelium-dependent factors which result from arterial distension during systole 
(Kizhakekuttu et al., 2010). 
 
 
 
 
 
 
 
 
36 
 
 
Figure 2.1  B-mode image of the brachial artery at 3 cm depth in the longitudinal plane with 
centralised sample volume. Pink lines represent detection of intima media from which 
measurement of diameter are obtained. 
 
Flow-Mediated Dilation (FMD) 
For resting measurements, brachial diameter and blood flow were recorded at rest for 30 
cardiac cycles. For the ischaemic FMD stimulus a pneumatic cuff (E20 Rapid cuff inflator and 
AG101 Cuff Inflator Air Source, Hokanson, WA, USA) was placed immediately distal to the 
olecranon process and inflated to 200 mmHg (Fig. 2.2). Occlusion was maintained for 5 
minutes before rapid cuff deflation. Recording of real-time duplex imaging was resumed 15 
seconds before deflation and continued for ~3 minutes post-deflation, capturing the transient 
changes in flow and diameter over approximately 200 cardiac cycles.  
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Figure 2.2 Ultrasound probe and pneumatic cuff placement for measurement of FMD 
 
Maximal Dilatory Capacity (DC) 
For maximal DC measurements, brachial diameter and flow were re-measured and a return to 
baseline values ensured before commencing the DC protocol. For the ischaemic exercise DC 
stimulus, the pneumatic cuff was positioned on the upper arm proximal to the ultrasound probe 
(Fig. 2.3). The cuff was inflated to 200 mmHg with occlusion maintained for 5 minutes. During 
the middle 3 minutes, rhythmic isometric handgrip exercise was performed with a handgrip 
dynamometer (approximately 20 contractions per minute performed at a duty cycle of 1.5s 
concentric and 1.5s eccentric muscle actions). Real-time duplex imaging was performed as 
described for FMD. 
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Figure 2.3 Ultrasound probe and pneumatic cuff placement for measurements of DC 
 
Ultrasound data analysis 
Brachial artery diameter and flow velocity were analysed with a commercially available, edge 
detection and wall tracking software (Vascular Research Tools 5, Medical Imaging 
Applications, LLC, Coralville, Iowa, USA). Media-to-media diastolic diameter was measured 
within a specified region of interest on B-mode images. The 2D Doppler flow velocity 
spectrum was traced and time average mean velocity (TAMV) (cm/s) computed. Synchronised 
diameter and velocity data, sampled at 20 Hz, enabled calculation of blood flow and shear rate. 
Resting diastolic diameter (mm) was averaged over 30 cardiac cycles. The dilatory response to 
FMD and DC protocols was determined from smoothed data (moving average across 3 cardiac 
cycles) as variability of the diameter measurement is least when an average is derived from 
multiple measurements (Corretti et al., 2002) and peak and maximal diameter defined, 
respectively. FMD and DC are repeatedly presented as the absolute (mm) and relative (%) 
change in post-stimulus diameter; (maximum post stimulus diameter – baseline 
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diameter)/baseline diameter. Time to peak diameter (s) was calculated from the point of cuff 
deflation to the maximum post-deflation diameter. Blood flow (ml/min) was calculated as 
(TAMV x πr2) x 60, where r is the radius of the brachial artery lumen. Resting blood flow was 
averaged over 30 cardiac cycles. Peak blood flow was recorded as the highest value (across a 
single cardiac cycle) following cuff deflation. Shear rate was derived from Poiseuillie’s law 
and calculated accordingly as (4 x TAMV) / diameter. The accumulated shear stimulus 
contributing to the FMD response was defined as the area under the shear rate curve (SRAUC) 
calculated for data up to the point of peak dilation for each individual, as this is suggested as 
the most accurate normalisation (Black, Cable, Thijssen and Green, 2008). FMD to shear rate 
area SRAUC has been suggested to minimise the effects of the large inter-subject variability in 
shear stress resulting from the reactive hyperaemic stimulus (Padilla et al., 2008). 
 
2.1.2.2 Reproducibility and repeatability of 2D Doppler ultrasound measures 
Eight recreationally active participants volunteered to undertake brachial artery assessments on 
2 occasions separated by a maximum of 7 days (Table 2.1). Participants followed the standard 
experimental protocol as described above and were tested under matched conditions on each 
occasion. Mean values for each outcome measure were compared and the Pearson correlation 
coefficient determined. The coefficient of variation (CV%) was calculated from the division of 
the standard deviation for each variable by the mean value of each respective measure x 100 
and the mean for the group was determined. Paired student t-tests were used to determine 
differences between measurements for each variable. Mean bias was determined from the 
average of the 95% limits of agreement for each measure and the mean for the group was 
determined.  
 
 
 
 
  
Table 2.1 Reproducibility of brachial artery 2D Doppler ultrasound measures 
Measurement is mean ± SD; Significant correlation * P < 0.05, † P < 0.01, ‡ P < 0.001. BF, blood flow; SR, shear rate; FMD, flow mediated 
dilation; SRAUC, shear rate area under curve; DC, dilatory capacity 
 Measurement 1 Measurement 2 Correlation coefficient (r) CV Bias 
Resting 
Diameter (mm) 4.24 ± 0.49 4.23 ± 0.48 0.998‡ 0.3% 0.01 ± 0.03 
BF (ml/min) 203 ± 45 191 ± 42 0.808* 8.2% 12.21 ± 27.25 
Velocity (cm/s) 24.6 ± 6.3 23.0 ± 5.5 0.794* 9.2% 1.57 ± 3.83 
SR (s-1) 239 ± 78 221 ± 81 0.901† 8.7% 17.79 ± 35.46 
Response to 5-min ischaemia 
Peak diameter (mm) 4.61 ± 0.47 4.57 ± 0.47 0.982‡ 0.8% 0.04 ± 0.09 
FMD (%) 8.4 ± 2.5 8.3 ± 2.9 0.940‡ 7.3% 0.00 ± 0.01 
FMD (mm) 0.35 ± 0.07 0.34 ± 0.09 0.887† 7.7% 0.01 ± 0.04 
FMD normalised (10-5) 2.54 ± 1.28 3.22 ± 1.93 0.545 10.9% 0.00 ± 0.00 
Peak BF (ml/min) 1076 ± 228 979 ± 231 0.852† 10.8% 118.99 ± 147.04 
Peak velocity (cm/s) 129.6 ± 18.3 112.5 ± 13.2 0.157 11.7% 14.98 ± 21.25 
Peak SR (s-1) 1253 ± 294 1171 ± 180 0.886† 8.5% 54.01 ± 169.09 
SRAUC 3120 ± 985 2833 ± 631 0.807* 10.2% 168.44 ± 635.37 
Response to 5-min ischaemic exercise 
Max diameter (mm) 5.00 ± 0.41 4.94 ± 0.38 0.939‡ 1.2% 0.06 ± 0.14 
DC (%) 18.4 ± 6.1 16.9 ± 6.0 0.957‡ 5.8% 0.02 ± 0.02 
DC (mm) 0.76 ±0.21 0.70 ± 0.21 0.928‡ 5.7% 0.06 ± 0.08 
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Significant correlations were evident for diameter (rest, peak, maximum) between 
measurements 1 and 2 (P < 0.001), with inter-session CV% comparable or somewhat lower 
than those previously reported (1.1% - 5.2%) (Hijmering et al., 2001; De Roos et al., 2003). 
The CV% of FMD% was relatively greater than diameter changes which although may be 
explained by operator or equipment errors, is likely due to physiological influences given the 
low variability in diameter and the comparatively lower DC% CV% after the maximal 
dilatory stimulus, despite the difference between measurements (P < 0.05). Recent evidence 
of largely equivocal variation between inter- and intra-session FMD% outcomes across 
multiple testing centres adds further weight to the notion of intrinsic FMD variability 
(Ghiadoni et al., 2012). Nonetheless, variability was substantially lower than previously 
reported (De Roos et al., 2003; Ghiadoni et al., 2012), although the former study performed 
assessments on 6 occasions rather than 2 which may have contributed to the comparatively 
higher value. No differences in any other variable were observed between measurement 
sessions. Relatively greater within-subject variability was evident in measures of blood flow, 
velocity and SRAUC. Further, there was no correlation within measures of FMD normalised 
for shear rate or peak velocity. The high variability of the former was likely due to the 
relatively large CV% of SRAUC. Peak velocity variability was comparable to previous 
research. 
 
2.1.2.3 Strain gauge plethysmography 
In Chapter 3, venous occlusion strain-gauge plethysmography (Hokanson, Bellvue, WA, USA) 
was used to determine forearm resting blood flow and capillary filtration capacity. With the 
forearm supported above the level of the heart and the subject lying supine, pneumatic cuffs 
(E20 Rapid cuff inflator and AG101 Cuff Inflator Air Source, Hokanson, WA, USA) were 
positioned proximal to the olecranon process and around the wrist. A mercury strain gauge was 
placed around the widest portion of the forearm and attached to a dual channel plethysmograph 
(EC6 Plethysmograph, Hokanson, Bellvue, WA, USA). Strain gauge signals were sampled on 
line at 100Hz (Powerlab, ADInstruments, NSA, Australia) and measured using Chart version 
5 software (ADInstruments, NSW, Australia). 
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Resting forearm blood flow 
The wrist cuff was inflated to 300 mmHg 30 seconds before commencing flow measurements 
to exclude arterial blood flow to the hand. After 45 seconds, the upper cuff was inflated to 50 
mmHg for ~8 seconds, equivalent to 5 cardiac cycles and subsequently deflated. This was 
repeated 3 times, with a 60 second break between each inflation-deflation cycle, after which 
the wrist cuff was immediately deflated. Blood flow was calculated from the slope of the 
volume change over the first cardiac cycle (Tschakovsky et al., 1995) following cuff inflation 
and expressed in ml/min/100ml of tissue. 
 
Capillary filtration capacity 
After 20 minutes supine rest, 4-minute cumulative pressure increments of 8 mmHg (not 
exceeding diastolic pressure) were applied to the cuff, lasting a total of 32 minutes after which 
point the cuff pressure was released and strain gauge removed. Increments beyond 
isovolumetric venous pressure induced a two-phase forearm volume response comprising of; 
1) an initial rapid phase attributed to venous filling and 2) a subsequent slower phase attributed 
to fluid filtration (Gamble, Gartside and Christ, 1993). The fluid filtration rate (Jv) was 
measured from the slope of volume change during the 2-4th min of each pressure step. This 
filtration rate was plotted against cuff pressure and the slope of the linear relationship defined 
the filtration capacity (Kf; 10-3 x ml.min
-1.mmHg-1.100ml tissue-1).   
 
2.1.3 Muscle strength measures 
In chapter 3, a handgrip dynamometer (Jamar, Sammons Preston Rolyan, Bolingbrook, IL, 
USA) was used to determine maximum isometric handgrip strength in the right arm. Three 
maximal contractions performed for a duration of approximately 3 sec with the elbow flexed 
at 90º. A minimum of 3 minutes rest was taken between each contraction. The highest value 
obtained was recorded as maximum isometric strength. 
 
2.1.4 Anthropometric measures 
In chapter 3, the widest point of forearm girth was recorded as a measure of forearm muscle 
hypertrophy. 
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2.2 In vitro methods 
2.2.1 Standard solutions for cell culture 
The standard solutions and equipment used during cell culture techniques can be seen in Table 
2.2 and Table 2.3, respectively. 
 
Table 2.2 Standard solutions for cell culture 
Supplier Materials 
Sigma, Poole, England, UK  
 Trypsin 
Haemocytometer 
Trypan blue 
75 cm2 cell culture flasks 
Glass coverslips 
6 well plates 
Gelatin 
Phosphate buffered saline (PBS) 
Methanol acetone 
 Glutamine 
HEPES 
Sodium bicarbonate 
 Syringe 
100µm filter 
DAPI stain 
Goat serum 
TRIS buffered saline (TBS) 
Triton-x-100  
Mowiol 
Poly-L-lysine 
Bovine serum albumin (BSA) 
Rabbit serum 
Sodium chloride (NaCl) 
Cell strainers (100 µm / 40 µm) 
Paraformaldehyde 
Wright stain 
Invitrogen, Paisley, UK Fetal calf serum (FCS) 
 Penicillin / streptomycin 
Promocell, Heidelberg, Germany Endothelial cell medium – C22010 
Life Technologies, UK M199 stock solution 
 
44 
 
Table 2.3 List of equipment and suppliers for cell culture 
Supplier Equipment 
ThermoScientific, Leicestershire,  HERAsafe KS incubation hood 
England HERAcell 240i CO2 incubator 
 HERAeus Megafuge 11R centrifuge 
 Nanodrop 2000 Spectrophotometer 
Leica Microsystems Ltd,  DMIL LED Phase contrast microscope 
Switzerland DM2500 Bright field microscope 
Qiagen, Crawley, UK RNeasy micro kit 
 Quantifast SYBR green 1 step RT-PCR kit 
Stratgene, Agilent Technologies Mx3005P Stratagene multiplex quantitative PCR 
system 
Scientific lab supplies, 
Nottingham, England, UK 
Vortex Genie 2 
Jencons Scientific Limited, 
Bedfordshire, England 
Liquid nitrogen tank 
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2.3 Statistical analysis 
All statistical tests were conducted using IBM SPSS Statistics for Windows, Version 21.0 
(Armonk, NY: IBM Corp). The level of significance for all statistical analysis was accepted at 
P < 0.05. 
 
2.3.1 General statistical methods 
Data in all investigations was subjected to a Shapiro-Wilk test to confirm normal distribution 
and a Mauchley’s test of sphericity to verify homogeneity of variance. In chapter 3, 
independent t-tests were conducted to compare the differences between groups (climbers, 
control). In chapter 4, initially a three-way ANOVA with repeated measures for time was 
performed to determine the within-subject effect of intervention conditions and cuff location. 
This was followed by a two-way ANOVA for collapsed data and a one-way ANOVA to 
determine change over time in each arm separately. LSD post hoc tests were undertaken to 
locate significant differences. In chapter 5, a one-way ANOVA was performed to determine 
differences in cell yield between extraction sits (coronary artery, coronary balloon, brachial 
artery) and the effect of cell lysis on cell yield. In chapter 6, independent t-tests were conducted 
to compare the differences between groups (diabetics, control). This was followed by 
determination of effect sizes for each measure (mRNA, protein). 
 
2.3.2 Allometric Modelling 
Although the measurement of FMD is frequently cited as the primary in vivo method of 
measuring endothelial function, having been used in over 2700 published research papers 
(Atkinson and Batterham, 2013a), the use of percentages with the aim of scaling for body size 
between individuals has long been criticised by physiologists (Packard and Boardman, 1999). 
Recent research has focussed this caveat on the validity of FMD%. It is becoming increasingly 
apparent that this method may in fact violate a number of statistical assumptions required in 
order to make valid conclusions surrounding endothelial function.  In order for FMD% to 
represent an unbiased measure, it must work on the assumption that the change in diameter is 
directly and consistently proportional to resting baseline diameter (Atkinson and Batterham, 
2013b.). Given that FMD% is mathematically equivalent to the ratio of peak diameter divided 
by baseline diameter, the assumption is apparent that the bigger the baseline diameter, the 
greater the change in diameter in a proportional manner (Atkinson and Batterham, 2013b). 
46 
 
However, the established negative correlation between FMD% and baseline diameter 
(Celermajer et al., 1992) suggests that this assumption is somewhat violated when comparing 
groups of differing baseline artery diameters. Apropos to this suggestion, up to 64% of the 
variability in FMD% can be explained by variations in baseline diameter when referring to 
previously cited correlation coefficients (Atkinson and Batterham, 2013a). 
A novel method of statistical analysis whereby absolute FMD values are scaled 
according to baseline diameter appears to minimise the potential bias and provide functional 
data which may be of greater validity. In chapter 3, allometric scaling was performed in 
accordance with the protocol originally suggested by Atkinson (Atkinson and Batterham, 
2013b). Baseline and peak diameters were log transformed and a one-way analysis of 
covariance (ANCOVA) performed. The difference between transformed baseline and peak 
diameters was selected as the dependent variable and the transformed baseline diameter the 
covariate. This accounted for the effect of differences in baseline artery diameter between 
groups on FMD%. Group mean values were subsequently anti-logged and interpreted as 
FMD%. This was also conducted for maximum diameters to scale DC% values in a similar 
manner, as although this has not previously been conducted, DC% is also a ratio based on 
change from baseline diameter. In chapter 4, log transformed differences were selected as the 
dependent variable within a linear mixed model approach, dependent variables selected as 
factors and logged baseline diameter inserted as a covariate. Output values were again back 
transformed to provide FMD% values. In this manner, DC% values were also scaled. LSD 
post-hoc tests were used to locate significance in all allometrically scaled measures. 
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Chapter 3 - Brachial artery characteristics and micro-vascular filtration 
capacity in rock climbers  
Previously published as: Thompson EB, Farrow L, Hunt JE, Lewis MP & Ferguson RA (2014). 
Brachial artery characteristics and micro-vascular filtration capacity in rock climbers. Eur J 
Sport Sci, (ahead-of-print), 1-9. 
3.1 Introduction 
It is now evident that well-trained athletes undergo significant adaptations to the peripheral 
vasculature. Structural adaptations, including a relatively greater diameter of the conduit 
arteries have been observed (Huonker et al., 2003; Rowley et al., 2011a; Rowley et al., 2011b) 
despite a lack of a functional improvement or in some cases a functional decrease (Petersen et 
al., 2006; Rowley et al., 2011b). This phenomenon has recently been called the ‘athletes 
paradox’ (Green et al, 2012). 
Rock climbers typically exhibit small statures and low body fatness with high strength 
to weight ratios (Watts, Martin, & Durtschi, 1993). Despite previous anthropometric profiling 
of this group of athletes, the specific characteristics of the peripheral vasculature remain 
relatively poorly understood. Ferguson and Brown (1997) identified a higher peak vascular 
conductance and forearm vasodilatory capacity in climbers allowing for greater functional 
hyperaemia compared with non-climbers, suggesting adaptation of the resistance vessels. Rock 
climbing requires continuous work at approximately 50% of maximal aerobic capacity which 
increases with levels of climbing difficulty (Sheel, 2004). It involves repeated isometric 
forearm muscle contractions (Macleod et al., 2007), and while the precise level of forces 
produced during ascents are unknown, the percentage of forearm maximal voluntary 
contraction at which climbers must work vary considerably, especially given the occasional 
dependence on lower limbs for upward propulsion (Sheel, Seddon, Knight, McKenzie, & 
Warburton, 2003), where approximately 57% of vertical forces are applied to the feet in the 
standard vertical position (Noé, Quaine, & Martin, 2001). Although intramuscular pressure 
may vary between muscle groups and individuals, blood flow is insufficient to maintain 
homeostasis at intensities greater than 10% maximal voluntary contraction (MVC) (Sjøgaard, 
Savard, & Juel, 1988). Thus, although no specific data exists surrounding the proportion of 
MVC utilised during climb, it is fair to speculate that the exercising muscle and related 
vasculature is subjected to regular periods of ischaemia (Sadamoto, Bonde-Petersen, & Suzuki, 
1983). 
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Although shear stress is suggested to be the predominant stimulus for conduit artery 
adaptation with training (Laughlin et al., 2008; Newcomer et al., 2011; Tinken et al., 2010), 
the episodic reductions in oxygen availability as a result of muscle ischaemia may also play a 
role via AMPK mediated (Chen et al., 2009) eNOS activation (Rudic et al., 1998), as well as 
the role played by VEGF and HIF-1α in angiogenesis (Egginton, 2009). One model of exercise 
that has allowed examination of such vascular adaptations and in some respect may reflect the 
conditions encountered in the active muscles and vasculature during rock climbing, is training 
under BFR conditions which has been shown to increase conduit artery diameter (Hunt et al., 
2013; Hunt et al., 2012). Adaptations are also evident through the vascular tree and peripheral 
resistance vessels also exhibit remodelling with training (Ferguson & Brown, 1997; Martin et 
al., 1987; Sinoway et al., 1986; Snell, Martin, Buckey, & Bloomqvist, 1987). Further 
downstream, adaptation of the microvasculature has been observed with short-term training in 
a blood flow restricted state, providing a stimulus for a greater micro-vascular filtration 
capacity in calf muscles (Evans, Vance, & Brown, 2010). 
Given the paucity of data in this athletic population the aim of this study was to 
determine vascular adaptations in rock climbers, from the level of large conduit arteries to the 
micro-vascular capillary network. In accordance with the ‘athletes paradox’ theory (Green et 
al., 2012) it was hypothesised that rock climbers would exhibit an enlarged artery diameter, 
suggestive of arterial remodelling, but there would be an absence of any functional adaptations. 
It was also hypothesised that rock climbers would exhibit an enhanced capillary filtration 
capacity, reflective of a greater capillary density (Brown, Jeal, Bryant, & Gamble, 2001). 
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3.2 Methods 
3.2.1 Participants 
A total of 16 healthy males volunteered to take part in the study; 8 were rock climbers (CLIMB) 
recruited via advertisement at local climbing centres, and 8 age-matched individuals recruited 
from the local university population as control participants (CON) (Table 3.1). Post-hoc power 
analysis revealed a minimum of 96% statistical power (at an α level of 0.05) for all brachial 
artery measurements. Climbers had a minimum of 3 years climbing experience and were able 
to climb at a grade of F6a (5.10a Yosemite Decimal System or equivalent) or above. This level 
equates to the minimum in the ‘extremely severe’ category of climbs and one that some degree 
of expertise/training is required. Control participants were habitually physically active but none 
performed resistance exercise training or racket sports. All participants completed a health 
screening questionnaire and were fully informed of the purposes, risks and discomforts 
associated with the experiment before providing written, informed consent. Participants with 
known cardiovascular, respiratory, haematological or metabolic disease and those currently 
taking any medication were excluded from the study. This study conformed to local guidelines 
and the Declaration of Helsinki and was approved by Loughborough University Ethics 
Advisory Committee. 
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Table 3.1 Anthropometric data of participants 
 CON CLIMB t-test 
Age (years) 23 ± 2 24 ± 3 0.571 
Height (cm) 175 ± 7 180 ± 11 0.260 
Body mass (kg) 73 ± 12 72 ± 8 0.794 
BMI (kg.m2) 23.8 ± 2.6 22.2 ± 2.0 0.197 
Systolic blood pressure (mmHg) 129 ± 15 125 ± 6 0.548 
Diastolic blood pressure (mmHg) 71 ± 11 67 ± 2 0.309 
Resting heart rate (bpm) 60 ± 10 59 ± 10 0.844 
Forearm circumference (cm) 25.6 ± 2.1 27.4 ± 1.8 0.082 
MVC (kg) 37 ± 9 46 ± 8 0.055 
Strength / Body mass 0.50 ± 0.11 0.64 ± 0.12 0.032 
Values are mean ± SD. BMI indicates body mass index; bpm, beats per minute; MVC, maximal 
voluntary contraction.  
 
3.2.2 Experimental protocol 
After an overnight fast, participants reported to the laboratory (at approximately 8 am) having 
refrained from strenuous physical activity for 24 hours, and abstaining from the consumption 
of alcohol, caffeine, tobacco and vitamin supplementation for 12 hours. Following an initial 
familiarisation to the protocol and equipment the participant rested for a minimum of 20 
minutes in a supine position in a quiet temperature-controlled (24, ± 1°C) room. Initially, 2D 
Doppler ultrasound was used to assess brachial artery function (FMD), structure (maximum 
dilatory capacity; DC) and blood flow. All measures were taken on the right arm, which was 
the dominant arm in all participants. After a 40-minute break from testing, the participant 
returned to a supine position for a further 20 min before resting forearm blood flow and 
capillary filtration capacity was determined using venous occlusion plethysmography on the 
same arm. Following vascular measures, forearm strength and anthropometry measures were 
obtained. 
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3.2.3 Brachial artery assessments 
Two-dimensional Doppler ultrasound imaging was performed by the same sonographer using 
a Toshiba Powervision 6000 with a multifrequency linear array transducer (7–11 MHz). 
Participants lay supine with the imaged arm extended and immobilised at an angle 
approximately 80° from the torso. A 90° B-mode image of the brachial artery at 3 cm depth 
was obtained >3 cm proximal to the olecranon process. In duplex mode, the sample volume 
was centralised within the artery and the ultrasound beam aligned with direction of flow 
(insonation angle ≤ 69°). Once a satisfactory image was obtained, the probe was held in a 
constant position for the duration of the test. A vascular ECG gating module (Medical Imaging 
Applications, LLC, Coralville, Iowa, USA) triggered acquisition of the ultrasound images on 
the R-wave pulse of an ECG signal. Sequential end-diastolic images were stored from on-line 
image digitisation. 
 
Flow mediated dilation (FMD) 
Resting brachial diameter and blood flow were recorded for 30 cardiac cycles. For the 
ischaemic FMD stimulus a pneumatic cuff (E20 Rapid cuff inflator and AG101 Cuff Inflator 
Air Source, Hokanson, WA, USA) was placed immediately distal to the olecranon process and 
inflated to 200 mmHg. Occlusion was maintained for 5 min before rapid cuff deflation. 
Recording of real-time duplex imaging was resumed 10 sec before deflation and continued for 
∼3 min post-deflation, capturing the transient changes in flow and diameter over a total of 200 
cardiac cycles. 
 
Dilatory capacity (DC) 
Following a minimum of 10 minutes supine rest, resting brachial diameter and blood flow were 
re-measured before commencing the DC protocol. Subsequent analysis confirmed the resting 
status of these values (i.e. 0.5% and 1.2% of initial resting values for diameter and blood flow, 
respectively). For the ischaemic exercise DC stimulus, the pneumatic cuff was positioned on 
the upper arm proximal to the ultrasound probe. The cuff was inflated to 200 mmHg with 
occlusion maintained for 5 min. During the middle three minutes, rhythmic isometric handgrip 
exercise was performed with a handgrip dynamometer. Real-time duplex imaging was 
performed as described for FMD. 
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Ultrasound data analysis 
Brachial artery diameter and flow velocity were analysed with a custom-designed, edge 
detection and wall tracking software (Vascular Research Tools 5, Medical Imaging 
Applications, LLC, Coralville, Iowa, USA). Media-to-media diastolic diameter was measured 
within a specified region of interest on B-mode images. The 2D Doppler flow velocity 
spectrum was traced and TAMV (cm/s) computed. Synchronised diameter and velocity data, 
sampled at 20 Hz, enabled calculation of blood flow and shear rate. Resting diastolic diameter 
(mm) was averaged over 30 cardiac cycles. The dilatory response to FMD and DC protocols 
was determined from smoothed data (moving average across three cardiac cycles) and peak 
and maximal diameter defined, respectively. FMD and DC are presented as the absolute (mm) 
and relative (%) change in post-stimulus diameter; (maximum post-stimulus diameter – 
baseline diameter)/baseline diameter. Time to peak diameter (s) was calculated from the point 
of cuff deflation to the maximum post-deflation diameter. Blood flow (ml/min) was calculated 
as (TAMV × πr2) × 60, where r is the radius of the brachial artery lumen. Resting blood flow 
was averaged over 30 cardiac cycles. Peak blood flow was recorded as the highest value (across 
a single cardiac cycle) following cuff deflation. Shear rate was derived from Poiseuillies law 
and calculated accordingly as (4 × TAMV)/diameter. The accumulated shear stimulus 
contributing to the FMD response was defined as SRAUC calculated for data from the time of 
cuff deflation to the point of peak dilation for each individual. The day-to-day reproducibility 
of brachial artery measurements was: diameter (0.7%), blood flow (9.1%), FMD% (7.0%) and 
DC% (3.8%) respectively. 
 
3.2.4 Capillary filtration capacity 
Venous occlusion strain-gauge plethysmography (Hokanson, Bellvue, WA, USA) was used to 
determine forearm capillary filtration capacity. With the forearm supported above the level of 
the heart and the subject lying supine, a pneumatic cuff (E20 Rapid cuff inflator and AG101 
Cuff Inflator Air Source, Hokanson, WA, USA) was positioned proximal to the olecranon 
process. A mercury strain gauge was placed around the widest portion of the forearm and 
attached to a dual channel plethysmograph (EC6 Plethysmograph, Hokanson, Bellvue, WA, 
USA). After 20 minutes supine rest, 4-min cumulative pressure increments of 8 mmHg (not 
exceeding diastolic pressure) were applied to the cuff, lasting a total of 32 minutes after which 
point, the cuff pressure was released and strain gauge removed. Change in forearm volume was 
detected throughout through strain gauge signals sampled on line at 100 Hz (Powerlab, 
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ADInstruments, NSA, Australia) and measured using Chart version 5 software (ADInstruments, 
NSW, Australia). Increments beyond isovolumetric venous pressure induced a two-phase calf 
volume response comprising of; (1) an initial rapid phase attributed to venous filling and (2) a 
subsequent slower phase attributed to fluid filtration (Gamble, Gartside, & Christ, 1993). The 
fluid filtration rate (Jv) was measured from the slope of volume change during the 2–4th min 
of each pressure step. This filtration rate was plotted against cuff pressure, and the slope of the 
linear relationship defined the filtration capacity (Kf; 10–3 × ml.min−1.mmHg−1.100 ml tissue−1). 
 
3.2.5 Forearm strength and anthropometry 
Maximum isometric handgrip strength was determined in the right arm using a handgrip 
dynamometer (Jamar, Sammons Preston Rolyan, Bolingbrook, IL, USA). The participants 
stood with the elbow flexed at 90°. Three maximal contractions were performed for ∼3 seconds, 
with a rest interval of three minutes between each contraction. The maximum value obtained 
from the three contractions was recorded as the maximum isometric strength. Maximum 
forearm circumference was measured in supination and determined as the widest point between 
the olecranon process and ulnar styloid. 
 
3.2.6 Statistical analysis 
A Shapiro-Wilk test was used to confirm normal distribution and a Mauchley test of sphericity 
to verify homogeneity of variance. Independent t-tests were conducted to compare the 
differences between the two groups. Baseline and peak diameters were log transformed and a 
one-way analysis of covariance (ANCOVA) performed with the difference between 
transformed baseline and peak diameters used as the dependent variable and transformed 
baseline diameter the covariate. This accounted for the effect of differences in baseline artery 
diameter between groups on FMD% (Atkinson & Batterham, 2013a). Means were 
subsequently anti logged and interpreted as FMD%. This was also conducted for maximum 
diameters to scale DC% values. All data are presented as mean ± standard deviation and 
significance was accepted at P < 0.05. 
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3.3 Results 
There were no differences in anthropometrical measures between CLIMB and CON, and 
despite no significant difference in forearm circumference or maximum isometric handgrip 
strength, after correcting for body mass CLIMB exhibited a greater strength to body mass ratio 
compared to CON (Table 3.1). 
 
3.3.1 Brachial artery measures 
All data are shown in Table 3.2. Resting diameter was 11.8% greater in CLIMB than CON. 
Blood flow and shear rate at rest were not different between groups. Peak diameter in response 
to the ischaemic stimulus was 11.7% greater in CLIMB than CON; however, there was no 
difference in time to peak diameter. There were no differences in both relative (%) and absolute 
(mm) FMD or shear stimulus (SRAUC) between groups. This lack of difference was still present 
following normalisation of FMD for shear. Following allometric scaling to account for baseline 
diameter, FMD% was 8.2 ± 3.2% and 9.0 ± 3.2% in CLIMB and CON, respectively with no 
difference between groups (P = 0.663). 
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Table 3.2 Brachial artery characteristics in rock climbers and control participants 
 CON CLIMB t-test 
 Resting 
Diameter (mm) 3.79 ± 0.39 4.30 ± 0.26 0.006 
BF (ml/min) 143 ± 52 168 ± 36 0.141 
SR (s-1) 225 ± 78 179 ± 47 0.168 
 Response to 5-min ischaemia 
Peak diameter (mm) 4.12 ± 0.45 4.67 ± 0.31 0.011 
FMD (%) 8.7 ± 2.9 9.2 ± 2.6 0.765 
Time to peak diameter (s) 53 ± 24 42 ± 13 0.143 
SRAUC 37380 ± 28748 32087 ± 14446 0.383 
 Response to 5-min ischaemic exercise 
Max diameter (mm) 4.35 ± 0.47 5.14 ± 0.42 0.003 
DC (%) 13.6 ± 3.0 19.0 ± 4.4 0.019 
Peak RHBF (ml/min) 651 ± 221 1136 ± 504 0.013 
Values are mean ± SD. BF indicates blood flow; SR, shear rate; FMD, flow mediated dilation; 
SRAUC, shear rate area under the curve; DC, dilatory capacity; RHBF, reactive hyperaemia blood 
flow.  
 
Maximal diameter was 15.3% greater and DC 25.5% greater in CLIMB than CON, respectively 
(Table 3.2). Following allometric scaling, DC% was 19.8 ± 4.9% and 13.7 ± 5.5% in CLIMB 
and CON, respectively with no difference between groups (P = 0.085). 
 
3.3.2 Capillary filtration capacity 
There was no difference in resting forearm blood flow. Capillary filtration capacity was 
27.4% greater in CLIMB compared to CON (Table 3.3). 
 
 
56 
 
Table 3.3 Micro-vascular filtration capacity in rock climbers and control participants 
 CON CLIMB t-test 
Resting BF (ml.100ml-1.min-1) 3.7 ± 1.1 3.6 ± 1.8 0.858 
Kf (ml.min-1.mmHg-1.100ml tissue-1 x10-3) 3.8 ± 0.9 5.2 ± 0.7 0.010 
Values are mean ± SD. BF indicates blood flow; Kf, capillary filtration.  
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3.4 Discussion 
The present study has demonstrated that rock climbers exhibit greater arterial diameters 
compared to untrained control participants. However, there was no difference in FMD between 
groups. Rock climbers also exhibited an enhanced capillary filtration capacity, suggestive of a 
greater capillary density. Taken together with the observations of resistance vessel adaptation 
(Ferguson & Brown, 1997), rock climbers evidently possess an enhanced vasculature at all 
levels of the arterial tree and microcirculation and offer a unique insight into the vascular 
adaptations with chronic training in repeated isometric ischaemic conditions. 
The present observation of an enhanced brachial artery diameter in rock climbers 
supports the large body of evidence of a greater peripheral conduit artery size in well-trained 
populations. For example, chronically trained endurance athletes exhibit an overall increase in 
arterial size, specifically in the common femoral arteries of endurance athletes which are both 
structurally and functionally adapted compared with inactive individuals (Schmidt-Trucksäss 
et al., 2000). Rowley et al. (2011b) observed larger femoral artery diameters in runners and 
cyclists and in the playing arm of elite squash players. Larger vessels are also a feature in the 
upper-body of wheelchair athletes (Zeppilli et al., 1995). An enlargement of the arteries in 
trained individuals may contribute to an improvement in performance through an enhanced 
blood flow and oxygen delivery (Green et al., 2012; Welsch, Blalock, Credeur, & Parish, 2013). 
Although it is appreciated that local blood flow is regulated by the resistance vessels it was 
previously demonstrated that resistance vessel adaptation results in an enhanced limb blood 
flow capacity and functional hyperaemia in climbers (Ferguson & Brown, 1997). Moreover, 
there is a greater potential for enhanced oxygen extraction as demonstrated by the enhanced 
capillary filtration capacity. 
The higher basal diameter observed in rock climbers may be due to altered sympathetic 
vasomotor tone, circulating hormones and local paracrine effects. A reduction in sympathetic 
activity in trained individuals (Lehmann, Schmid, & Keul, 1984) may extrinsically alter basal 
vascular tone and stimulate vasodilation. Further, chronic exercise training may lower plasma 
concentrations of the vasoconstrictor hormones ET-1 (Maeda et al., 2009) and angiotensin II 
(Braith, Welsch, Feigenbaum, Kluess, & Pepine, 1999), although a relationship between ET-1 
and basal vascular tone is disputed (Thijssen et al., 2007). Additionally, the bioactivity of NO, 
a potent stimulus for enlargement of vessels (Rudic et al., 1998) is greater with training (Green, 
Maiorana, O'Driscoll, & Taylor, 2004; Kingwell, Sherrard, Jennings, & Dart, 1997) and may 
present as a larger conduit vessel diameter due to its contribution to basal arterial tone (Vallance, 
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Collier, & Moncada, 1989). Despite this, the greater maximal diameter (stimulated by 
ischaemic exercise) in the present study suggests the presence of vascular remodelling (Naylor 
et al., 2005). 
The key physiological stimulus proposed to be responsible for the remodelling of the 
conduit arteries is the repetitive shear stress produced during exercise (Langille & O'Donnell, 
1986; Tinken et al., 2010; Green et al., 2012) which activates a number of signalling cascades 
within the endothelial cells resulting in an altered endothelial cell phenotype (Chien, 2007) and 
consequent remodelling. Independent of, or indeed in addition to the effects of shear stress, 
there may be contributions from other stimuli, for example, hypoxic/metabolic conditions via 
AMPK mediated (Chen et al., 2009) eNOS activation which has been shown to be obligatory 
for arterial remodelling (Rudic et al., 1998). Additionally, lactate released by contracting 
muscle may up-regulate VEGF and its receptor VEGFR2 (Kumar, Viji, Kiran, & Sudhakaran, 
2007). Indeed, a strong correlation exists between lactate and exercise induced changes in 
VEGF protein (Takano et al., 2005). However, although VEGF leads to the up-regulation of 
eNOS, the direct effect on arteriogenesis is currently undetermined (Prior, Yang, & Terjung, 
2004). 
The absence of any enhancement in FMD in climbers is perhaps not surprising and 
corresponds to the mounting evidence regarding the impact of exercise training on artery 
function. Although improved function has been observed with exercise training in patients with 
cardiovascular disease (Hambrecht et al., 2003), the same has not been observed in healthy 
athletic populations (Tinken et al., 2008; Rowley et al., 2011b). It is now apparent that an 
‘athlete paradox’ exists, whereby despite the expectation of greater vascular function in highly 
trained individuals, this group exhibits functionally ‘normal’ arteries (Green et al., 2012). This 
lack of functional adaptation can be also explained by appreciating the time-course of artery 
adaptation to exercise training. Although the cross-sectional nature of the present and other 
studies does not allow us to elucidate this, previous work using aerobic type exercise training 
has demonstrated that functional changes occur rapidly and are then superseded by structural 
changes with artery function returning to baseline (Tinken et al., 2008). A similar time-course 
of adaptation has also been observed in response to BFR exercise (Hunt et al., 2012, 2013), a 
model of exercise that may reflect the conditions encountered in the active muscles and 
vasculature during rock climbing. Our results, therefore, appear to be in accordance with the 
‘athlete artery’ paradigm, and suggest repeated isometric contractions results in structural 
adaptation of the conduit arteries, although we do appreciate that longitudinal data on the effect 
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of this type of specific training is lacking and the impact of distinct forms of exercise, such as 
in weight- or power-trained individuals have not been specifically investigated (Green et al., 
2012). 
Given that artery function may be overestimated in those with smaller baseline diameter 
and conversely be underestimated in those with a larger baseline diameter (Atkinson & 
Batterham, 2013a), we employed a relatively novel allometric scaling approach to our data 
(Atkinson & Batterham, 2013b) to minimise the potential bias of FMD% values. Due to the 
inverse relationship between baseline diameter and FMD% (Celermajer et al., 1992) and the 
observed greater baseline diameter in climbers than controls in the present study, it was of 
interest to determine whether differences between groups, or lack thereof, were still apparent 
following allometric adjustments and hence removal of statistical bias. Although no difference 
was observed between groups following FMD%, the differences between groups in DC% lost 
significance after baseline diameter bias was removed. Structural differences in diameter 
between groups were nonetheless confirmed given the observed differences in resting, peak 
and maximal diameter. 
Despite our observations of enhanced brachial artery diameters in rock climbers, the 
influence of body mass and forearm size must be taken into consideration (Hopkins et al., 2009). 
First, whole body mass was not different between CLIMB and CON (Table 3.1). Importantly 
there were no initial correlations between whole body mass and artery diameters (Table 3.4). 
Subsequent scaling of artery diameters with body mass did reveal significant correlations 
(Table 3.4) and suggest that appropriate allometric scaling should be performed which, as 
predicted, produced size independent normalised data (Table 3.4). Hopkins et al (2009) also 
observed that anthropometrical segmental measures had an influence on artery diameter similar 
to whole body mass. Unfortunately, direct measures of forearm muscle mass were not taken in 
the present study. However, forearm circumference has previously been shown to correlate 
with muscle mass (Kallman, Plato, & Tobin, 1990). Like whole body mass, forearm 
circumference was not different between CLIMB and CON (Table 3.1), although there was a 
tendency for a larger circumference in CLIMB. Subsequent analysis revealed no correlations 
between forearm circumference and artery diameters and neither when artery diameters were 
scaled for forearm circumference (Table 3.4). Therefore, our data does not necessarily support 
the notion of scaling or normalisation for brachial artery diameters in the present subject cohort, 
since segmental measures (albeit not completely optimal) did not reveal any size dependence. 
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Table 3.4 Correlations used to check size independence of brachial artery diameter 
BM indicates body mass; FC, forearm circumference 
 
Adaptation of resistance vessels (peak reactive hyperaemia) was also observed in 
climbers compared with untrained control participants and is in line with previous observations 
of an enhanced post-occlusion reactive hyperaemic blood flow in rock climbers (Ferguson & 
Brown, 1997) and other athletic populations (Martin et al., 1987; Sinoway et al., 1986; Snell et 
al., 1987). The magnitude of post-occlusion blood flow is governed by resistance vessel cross-
sectional area (Naylor et al., 2011), and therefore influenced by vessel function and structure. 
It is possible that there is a greater responsiveness to metabolic and endothelial vasodilators 
during periods of ischaemia. It is also plausible that rock climbers exhibit a greater number of 
resistance vessels, allowing for augmented blood flow into the forearm in conjunction with 
attenuated outflow by virtue of decreased venous congestion. This could be brought about by 
an increased number of capillaries and/or venules in parallel (Egaña, Reilly, & Green, 2010). 
Indeed, we have observed a greater capillary filtration capacity in climbers suggesting an 
increase in the muscle capillary density of these individuals (Brown et al., 2001). Exercise 
training has long been recognised as a potent stimulus for increasing muscle capillarity 
(Egginton, 2009). The addition of a hypoxic stimulus may stimulate capillary growth via the 
up-regulation of various growth factors, the likely principal mediator being VEGF (Egginton, 
2009). As previously discussed, intermittent ischaemic training in rock climbers may up-
regulate the expression of HIF-1α, which itself leads to an increase in VEGF expression and 
capillary growth (Hoppeler, 1999). Indeed, micro-vascular filtration capacity has previously 
been shown to be enhanced with short-term low-intensity exercise training with blood flow 
restriction (Evans et al., 2010). 
 Resting 
diameter 
 Peak diameter  Max diameter 
 r value P value  r value P value  r value P value 
Diameter/BM -0.062 0.819  -0.089 0.743  -0.152 0.587 
Diameter/BM:BM -0.802 <0.001  -0.803 <0.001  -0.755 0.001 
Diameter/BMᵇ:BM -0.422 0.103  -0.451 0.079  -0.466 0.080 
Diameter/FC 0.374 0.153  0.347 0.188  0.351 0.200 
Diameter/FC:FC -0.387 0.138  -0.386 0.140  -0.229 0.412 
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In conclusion, this study has identified an enhanced peripheral vasculature in rock 
climbers compared to untrained control participants. Rock climbers exhibit greater arterial 
diameters compared to sedentary control participants despite no difference in FMD between 
groups. These results are in accordance with the ‘athlete's artery’ paradigm (Green et al., 2012) 
of an enlarged arterial lumen despite being functionally ‘normal’. Additionally, rock climbers 
exhibit an enhanced capillary filtration capacity. The present data, together with the 
observations of resistance vessel adaptations (Ferguson & Brown, 1997) clearly demonstrate 
an enhanced peripheral vasculature in rock climbers. An enhancement in resistance vessel 
and/or micro-vascular function and structure would subsequently enhance functional blood 
flow, hence substrate exchange and metabolite removal, critical in individual performance and 
longevity of the climb. These observations also offer a unique insight into vascular adaptation 
with chronic training in intermittent blood flow restricted conditions. Future studies are 
required to investigate the mechanisms responsible for such adaptations throughout the 
vascular tree, and the cellular and molecular mechanisms underpinning these changes. Future 
studies should also examine the acute haemodynamic responses to climbing specific exercise 
to fully establish whether the adaptations observed translate to functional changes in blood 
flow. 
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Chapter 4 – The effect of 8 weeks of ischaemic preconditioning on local and 
systemic brachial artery characteristics 
4.1 Introduction 
Cardiovascular disease is responsible for 4.1 million deaths every year in Europe alone 
(Nichols, Townsend, Scarborough and Rayner, 2013). Modifications to the vascular system in 
response to exercise interventions may directly reduce the risk of CVD, given the major role 
of endothelial dysfunction in the development of atherosclerosis (Laughlin et al., 2008). The 
coronary and peripheral arteries are therefore targets for interventions that may reduce the risk 
of developing CVD, improve pre-existing diagnosis and enhance recovery rates from 
associated surgical interventions. 
 The effects of exercise training on vascular health potentially contribute to up to 50% 
of the reduction in risk of CVD that is induced with exercise (Mora et al., 2007). Indeed, the 
vasculature is subjected to multiple mechanical and metabolic stimuli during exercise. 
Primarily, shear stress has been proposed as the predominant stimulus for conduit artery 
adaptation (Laughlin et al., 2008; Tinken et al., 2010; Newcomer et al., 2011), where an initial 
increase in function (after approximately 2 weeks) is subsequently superseded by structural 
enlargement (Green et al., 2012: Laughlin, 1995; Rowley et al., 2011b). Other means of 
increasing the shear stress stimulus to the conduit artery in the absence of an actual exercise 
stimulus, such as via local heating can also evoke a similar augmentation in arterial function 
as is observed with exercise training (Naylor et al., 2011). 
Repeated bouts of ischaemia and the subsequent reactive hyperaemic blood flow 
response, as occurs in the forearms of rock climbers when performing repeated isometric 
contractions (chapter 3), can be induced externally by application of mechanical compressions, 
providing an IPC stimulus.  IPC is well established as an acute means of cardioprotection and 
has previously been shown to prevent arterial endothelial damage after a prolonged ischaemic 
stimulus (Loukogeorgakis, Panagiotidou, Broadhead, Deanfield and MacAllister, 2005). 
Evidence of both the local (Kharbanda et al., 2001; Kimura et al., 2007) and remote (Enko et 
al., 2011) effects of IPC advocate it as a technique which could be implemented to improve 
vascular health. Indeed, when implemented daily, 7 days of an IPC stimulus results in an 
improvement in brachial artery endothelial function, observed in both the artery to which IPC 
is applied and additionally in the contralateral limb (Jones et al., 2014a.).  This remote effect 
is also observed when a similar stimulus is applied prior to acute exercise which prevents the 
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expected reduction in brachial arterial function, as measured by FMD following strenuous 
lower limb exercise (Bailey et al., 2012). 
Despite these acute positive effects of IPC, limited research exists surrounding the 
possible long-term effects on the vasculature. Although longitudinal data is lacking, initial 
research suggests that 4 weeks of IPC results in minimal adaptations to forearm blood flow 
capacity despite a trend for an increase in peak blood flow (Roseguini et al., 2011). Moreover, 
when IPC is extended to 8 weeks, an improvement in brachial artery function is observed after 
2 weeks and maintained by 8 weeks compared with controls, although function is no greater 
than the increase following 7 days IPC (Jones et al., 2014a; Jones et al., 2014b). As yet, no 
studies have applied a chronic IPC stimulus greater than 4 weeks and observed the response of 
both the local and remote conduit arteries. Further, the location of the occlusion stimulus 
applied throughout the intervention has varied amongst researchers. Specifically, the relevance 
of location of occlusion application and indeed, the potential optimal position in respect to the 
hypoxic stimulus experienced by the conduit artery and the subsequent vascular adaptation is 
yet to be investigated. This study therefore, aimed to determine both the local and systemic 
effects of 8 weeks of an IPC intervention on brachial artery and forearm resistance vessel 
function and structure. Additionally, the effect of occlusion location on the modulation of 
potential vascular adaptations was investigated. 
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4.2 Methods 
4.2.1 Participants 
A total of 12 recreationally active healthy males (age; 23 ± 3 yrs, height; 181.0 ± 6.4 cm, body 
mass; 78.6 ± 10.9 kg, resting systolic blood pressure: 125 ± 11 mmHg, resting diastolic blood 
pressure: 73 ± 7 mmHg) volunteered to take part in the study. All were habitually physically 
active but none were partaking in resistance exercise training. All participants were fully 
informed of the purpose and possible risks of the study before completing a health screening 
questionnaire and written informed consent. Participants taking any medication or supplements 
or with known cardiovascular, respiratory, haematological or metabolic disease were excluded 
from the study. This study conformed to local guidelines and the Declaration of Helsinki and 
was approved by Loughborough University Ethics Advisory Committee. 
 
4.2.2 Experimental protocol 
Participants were familiarised to the testing and training procedures during one preliminary 
visit. Participants then commenced an 8 week unilateral IPC intervention. Participants were 
randomly assigned to groups differentiated by cuff placement on the intervention arm, either 
proximal (PROX) or distal (DIST) to the olecranon process, in a counterbalanced manner for 
dominant and non-dominant arms, with the contralateral arm serving as a control (CON). 
Baseline measures were conducted on the brachial artery of both arms using 2D Doppler 
ultrasound and at 2-week intervals throughout the 8 week intervention.  
 
4.2.3 Brachial artery assessments 
Two-dimensional Doppler ultrasound imaging was performed by the same sonographer using 
a Toshiba Powervision 6000 with a multi-frequency linear array transducer (7-11 MHz). 
Participants lay supine with the imaged arm extended and immobilised at an angle 
approximately 80° from the torso. A 90° B-mode image of the brachial artery at 3 cm depth 
was obtained >3 cm proximal of the olecranon process. In duplex mode the sample volume 
was centralised within the artery and the ultrasound beam aligned with direction of flow 
(insonation angle ≤69°). Once a satisfactory image was obtained, the probe was held in a 
constant position for the duration of the test. A vascular ECG gating module (Medical Imaging 
Applications, LLC, Coralville, Iowa, USA) triggered acquisition of the ultrasound images on 
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the R-wave pulse of an ECG signal. Sequential end-diastolic images were stored from on-line 
image digitization.  
Flow mediated dilation (FMD) 
Resting brachial diameter and blood flow were recorded for 30 cardiac cycles following a 20 
min rest period. For the ischemic FMD stimulus a pneumatic cuff (E20 Rapid cuff inflator and 
AG101 Cuff Inflator Air Source, Hokanson, WA, USA) was placed immediately distal to the 
olecranon process and inflated to 200 mmHg. Occlusion was maintained for 5 minutes before 
rapid cuff deflation. Recording of real-time duplex imaging was resumed 10 seconds before 
deflation and continued for ~3 minutes post-deflation, capturing the transient changes in flow 
and diameter over a total of 200 cardiac cycles.  
 
Dilatory capacity (DC)  
Following a minimum of 10 minutes supine rest, resting brachial diameter and blood flow were 
re-measured before commencing the DC protocol. Subsequent analysis confirmed the resting 
status of these values (i.e. 0.6% and 5.3% of initial resting values for diameter and blood flow, 
respectively). For the ischaemic exercise DC stimulus, the pneumatic cuff was positioned on 
the upper arm proximal to the ultrasound probe. The cuff was inflated to 200 mmHg with 
occlusion maintained for 5 minutes. During the middle 3 minutes, rhythmic isometric handgrip 
exercise was performed with a handgrip dynamometer. Real-time duplex imaging was 
performed as described for FMD. 
 
Ultrasound Data Analysis  
Brachial artery diameter and flow velocity were analysed with a custom-designed, edge 
detection and wall tracking software (Vascular Research Tools 5, Medical Imaging 
Applications, LLC, Coralville, Iowa). Media-to-media diastolic diameter was measured within 
a specified region of interest on B-mode images. The 2D Doppler flow velocity spectrum was 
traced and TAMV (cm/s) computed. Synchronised diameter and velocity data, sampled at 20 
Hz, enabled calculation of blood flow and shear rate. Resting diastolic diameter (mm) was 
averaged over 30 cardiac cycles. The dilatory response to FMD and DC protocols was 
determined from smoothed data (moving average across 3 cardiac cycles) and peak and 
maximal diameter defined, respectively. FMD and DC are presented as the absolute (mm) and 
relative (%) change in post-stimulus diameter; (maximum post stimulus diameter – baseline 
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diameter)/baseline diameter. Time to peak diameter (s) was calculated from the point of cuff 
deflation to the maximum post-deflation diameter. Blood flow (ml/min) was calculated as 
(TAMV x πr2) x 60, where r is the radius of the brachial artery lumen. Resting blood flow was 
averaged over 30 cardiac cycles. Peak blood flow was recorded as the highest value (across a 
single cardiac cycle) following cuff deflation. Shear rate was derived from Poiseuillies law and 
calculated accordingly as (4 x TAMV) / diameter. The accumulated shear stimulus contributing 
to the FMD response was defined as SRAUC calculated for data up to the point of peak dilation 
for each individual. The day-to-day reproducibility of brachial artery measurements was; 
diameter (0.7%), blood flow (9.1%), FMD% (7.0%) and DC% (3.8%) respectively.  
 
4.2.4 IPC intervention 
The 8 week intervention comprised of 3 sessions / week with each session involving 3 periods 
of limb occlusion via a pneumatic cuff (E20 Rapid cuff inflator and AG101 Cuff Inflator Air 
Source, Hokanson, WA, USA) at 200 mmHg whilst the subject lay in a supine position. On 
one arm IPC was applied either PROX or DIST to the olecranon process with the contralateral 
arm serving as CON. Each set of occlusion was initially maintained for 5 minutes, interspersed 
with 5 minutes rest. Both set and rest periods were increased by 1 minute every 2 weeks until 
a final occlusion time of 8 minutes per set with an equivocal rest period was reached.  
 
4.2.5 Statistical analysis 
A Shapiro-Wilk test was used to confirm normal distribution and Mauchley test of sphericity 
to verify homogeneity of variance. Initially, a three-way (2x2x5) ANOVA with repeated 
measures for time (weeks 0, 2, 4, 6, 8) was conducted to analyse the within subject effect of 
training condition (IPC, CON) and cuff location (PROX, DIST). This was followed by a two-
way ANOVA for collapsed data (IPC, CON and PROX, DIST) over time. One-way repeated 
measures ANOVA was used to confirm change over time in each arm separately.  Post-hoc 
LSD tests were conducted to locate significance between locations. FMD and DC data were 
additionally presented as covariate controlled for baseline artery diameter and analysed using 
a 3-factor general linear model with repeated measures of IPC (4 levels: IPC arm and CON 
arm; PROX arm and DIST arm) and time (5 levels: 0, 2, 4, 6 and 8 weeks). Significant main 
effects were analysed using the LSD method for pairwise multiple comparisons. All data are 
presented as mean ± SD unless otherwise stated. Significance was accepted at P < 0.05. 
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4.3 Results 
All participants successfully completed the 24 training sessions with 100% compliance. Due 
to illness, values from one subject from the PROX group at week 2 were excluded from analysis.  
 
4.3.1 Resting diameter, blood flow and shear rate 
No differences were observed in resting blood flow, resting diameter and shear rate between 
conditions (three-way ANOVA time x arm x location interaction, P = 0.719, P = 0.948 and P 
= 0.549). Subsequent two-way ANOVA revealed resting blood flow was greater in PROX 
compared to DIST after 4 weeks and 8 weeks of IPC (P = 0.025 and P = 0.015, respectively; 
main effect of location (P = 0.032)) (Table 4.1). There were no differences in resting diameter 
and shear rate between PROX and DIST (Table 4.1).  
To better understand the effects of cuff location the PROX and DIST groups were subsequently 
collapsed (IPC) and compared with CON arm. However, there were no differences in resting 
diameter, blood flow or shear rate between IPC and CON or over time (Table 4.2). 
 
4.3.2 Response to 5-min ischaemia 
No differences were observed in peak diameter, peak blood flow and FMD (absolute or relative) 
between conditions (three-way ANOVA time x arm x location interaction, P = 0.527, P = 0.223, 
P = 0.439 and P = 0.384). Subsequent two-way ANOVA revealed there was a main effect for 
time (P = 0.020) for peak diameter (Table 4.1). Successive one-way ANOVA on each arm 
revealed no main effect of time in PROX whereas in DIST there was a main effect of time (P 
= 0.003) and differences at 4, 6 and 8 weeks compared to 0 weeks (P = 0.012, 0.005, 0.040, 
respectively; Table 4.1). Peak blood flow was greater (main effect of location P = 0.030) in 
PROX than DIST after 2, 4 and 6 weeks of IPC (P = 0.019, P = 0.004 and P = 0.044, 
respectively) (Table 4.1; Fig. 4.1). There was also a main effect for time (P = 0.018) for peak 
blood flow, however subsequent one-way ANOVA did not detect any further effect in PROX 
or DIST. There were no differences in FMD (absolute, relative or corrected) and SRAUC 
between PROX and DIS (Table 4.1).  
To better understand the effects of cuff location the PROX and DIST groups were subsequently 
collapsed (IPC) and compared with CON arm. There was a main effect for time (P = 0.014) 
for peak diameter. Subsequent one-way ANOVA on each arm revealed no main effect of time 
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in CON whereas in IPC there was a main effect of time (P = 0.038) and differences between 0 
weeks and 6 weeks (P = 0.020).  
There was also a main effect for time (P = 0.022) for peak blood flow which increased from 
baseline after 4 and 6 weeks (P = 0.018 and P = 0.008, respectively) before returning to near 
baseline levels (Fig. 4.2). However, subsequent one-way ANOVA did not detect any further 
effect in IPC or CON. There were no differences in FMD (relative or absolute) or SRAUC 
between IPC and CON or over time (Table 4.2; Fig. 4.3). 
However, following correction for baseline diameter; FMD was greater in IPC than CON (main 
effect of intervention; P < 0.001), and interaction effects were identified (location x 
intervention, location x time, intervention x time and location x intervention x time; P = 0.011, 
P < 0.005, P = 0.039 and P = 0.032, respectively). FMD (corrected) was greater at weeks 4 and 
6 (P = 0.023, P = 0.038, respectively) compared to week 0 (Fig. 4.4). 
 
4.3.3 Response to 5-min ischaemic exercise 
No differences were observed in maximum diameter and DC% between conditions (three-way 
ANOVA time x arm x location interaction, P = 0.395 and P = 0.612). Subsequent two-way 
ANOVA revealed there were no differences in maximum diameter and DC% between PROX 
and DIST (Table 4.1). To better understand the effects of cuff location, the PROX and DIST 
groups were subsequently collapsed (IPC) and compared with CON arm. There were no 
differences in maximum diameter or DC% over time between IPC and CON or over time 
(Table 4.2). There were main effects of location (P = 0.019) and training (P = 0.004) following 
correction for baseline diameter and DC% was greater in PROX than DIST and in IPC than 
CON. 
 
 
 
 
 
 
69 
 
Table 4.1 Brachial artery characteristics measured at weeks 0 (pre-training) 2, 4, 6 and 8 in proximally (PROX) and distally (DIST) 
(collapsed data for IPC and CON) arms  
Values are means ± SD. ‡ indicates a significant main effect with a two-way ANOVA. With a significant main effect of location post-hoc analysis was performed 
with an LSD t-test and significance (P < 0.05) between groups indicated by * . With a significant main effect of time post-hoc analysis was performed with a 
one-way ANOVA within each group and significance (P < 0.05) compared to week 0 indicated by †. BF indicates blood flow; SR, shear rate; FMD, flow 
mediated dilation; SRAUC, shear rate area under the curve; DC, dilatory capacity
 PROX arm DIST arm  2-way ANOVA p values 
 0 2 4 6 8 0 2 4 6 8 LOCATION TIME 
LOC x 
TIME 
Resting 
Diameter 
(mm) 
4.20±0.21 4.12±0.18 4.18±0.26 4.23±0.22 4.24±0.19 3.90±0.41 3.96±0.44 4.00±0.39 4.03±0.38 4.02±0.36 0.174 0.061 0.490 
BF 
(ml/min) 
193±90 182±69 223±62 210±76 213±60 143±58 137±52 170±47* 181±62 159±37* 0.032‡ 0.080 0.724 
SR (s-1) 226±98 225±83 263±70 249±102 245±71 205±66 185±37 234±68 239±65 216±38 0.149 0.088 0.821 
 Response to 5-min ischaemia  
Peak 
diameter 
4.58±0.31 4.51±0.22 4.64±0.40 4.62±0.34 4.56±0.26 4.24±0.38 4.34±0.39 4.40±0.40† 4.48±0.34† 4.41±0.32† 0.262 0.020‡ 0.122 
Peak BF  1106±202 1172±164 1274±149 1258±209 1106±209 910±313 901±300* 963±302* 1045±275* 953±313 0.030‡ 0.018‡ 0.239 
FMD 
(%) 
8.9±3.2 9.4±2.8 11.1±4.5 9.9±3.4 8.4±3.2 9.1±3.3 9.8±3.1 10.1±2.9 11.5±4.1 10.3±2.8 0.223 0.176 0.226 
SRAUC  4183±2156 3084±851 4510±1145 3878±1320 3913±1545 3389±1021 3447±792 4225±1766 4261±1638 3631±1240 0.629 0.078 0.136 
Response to 5-min ischaemic exercise   
Diameter 
(mm) 
4.16±0.21 4.07±0.17 4.17±0.26 4.21±0.22 4.18±0.20 3.91±0.40 3.97±0.41 3.96±0.39 4.00±0.34 3.99±0.37 0.636 0.058 0.997 
Max 
diameter  
4.93±0.29 4.83±0.12 4.96±0.29 4.97±0.28 5.00±0.25 4.59±0.29* 4.63±0.12 4.66±0.29* 4.71±0.28 4.70±0.25 0.077 0.119 0.877 
DC (%) 18.5±2.5 18.7±3.3 19.3±4.7 18.2±3.4 19.5±2.8 17.9±5.8 16.4±4.1 17.9±3.8 17.8±3.5 18.0±3.3 0.463 0.791 0.647 
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Table 4.2 Brachial artery characteristics measured at weeks 0 (pre-training) 2, 4, 6 and 8 in ischaemic preconditioning intervention (IPC) 
(collapsed data for PROX and DIST) and control (CON) arm.  
Values are means ± SD. ‡ indicates a significant main effect with a two-way ANOVA. With a significant main effect of location post-hoc analysis was performed 
with an LSD t-test and significance (P < 0.05) between groups indicated by * . With a significant main effect of time post-hoc analysis was performed with a 
one-way ANOVAwithin each group and significance (P < 0.05) compared to week 0 indicated by †. BF indicates blood flow; SR, shear rate; FMD, flow 
mediated dilation; SRAUC, shear rate area under the curve; DC, dilatory capacity. 
 IPC arm   CON arm   2-way ANOVA p values 
 0 2 4 6 8 0 2 4 6 8 IPC TIME 
IPC X 
TIME 
Resting 
Diameter 
(mm) 
3.99±0.36 3.99±0.37 4.07±0.38 4.12±0.38 4.12±0.36 4.10±0.35 4.09±0.34 4.11±0.30 4.13±0.27 4.14±0.25 0.511 0.058 0.943 
BF 
(ml/min) 
163±51 161±51 187±38 210±35 289±49 173±39 148±25 206±36 181±52 193±33 0.989 0.066 0.211 
SR (s-1) 210±49 209±52 236±21 264±40 220±36 220±55 193±25 262±36 223±54 241±23 0.824 0.064 0.140 
Response to 5-min ischaemia 
Peak 
diameter 
4.37±0.41 4.40±0.36 4.51±0.43 4.58±0.39† 4.48±0.33 4.45±0.38 4.46±0.30 4.53±0.04 4.52±0.26 4.49±0.03 0.657 0.014‡ 0.734 
Peak BF  995±280 994±305 1110±326 1162±292 1052±308 1021±285 1078±258 1127±244 1141±242 1008±242 0.730 0.022‡ 0.702 
FMD 
(%) 
9.3±3.8 10.2±3.2 10.9±4.1 11.3±3.3 9.0±3.4 8.7±2.6 8.9±2.6 10.3±3.4 10.1±4.3 9.7±2.7 0.552 0.170 0.668 
SRAUC  3201±1592 3062±917 4502±1477 4384±1435 3458±1266 3963±1853 3470±707 4234±1501 3755±1494 4085±1466 0.889 0.098 0.266 
Response to 5-min ischaemic exercise 
Diameter 
(mm) 
3.99±0.36 4.00±0.33 4.06±0.40 4.09±0.34 4.10±0.36 4.09±0.32 4.04±0.32 4.07±0.30 4.12±0.27 4.08±0.25 0.611 0.144 0.660 
Max 
diameter  
4.73±0.33 4.72±0.31 4.82±0.39 4.83±0.45 4.84±0.04 4.79±0.34 4.74±0.29 4.81±0.36 4.86±0.26 4.87±0.30 0.637 0.102 0.819 
DC (%) 18.9±5.2 18.2±3.7 19.0±4.3 18.2±3.1 18.2±3.5 17.4±3.5 16.9±4.1 18.2±4.2 17.9±3.9 19.3±2.6 0.484 0.793 0.617 
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Figure 4.1 Brachial artery peak reactive hyperaemic blood flow before, during and after 8 
weeks of IPC treatment in the PROX and DIST arms. IPC and CON groups have been collapsed. 
Values are ± SEM. * Significant (P < 0.05) difference to DIST; † Significant (P < 0.05) 
difference to week 2 (LSD post-hoc). 
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Figure 4.2 Brachial artery peak reactive hyperaemic blood flow before, during and after 8 
weeks of IPC treatment in the IPC and CON arms. PROX and DIST groups have been collapsed. 
Values are ± SEM. * Significant (P < 0.05) difference to week 0; # Significant (P < 0.05) 
difference to week 2 (LSD post-hoc). 
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Figure 4.3 Brachial artery FMD% before, during and after 8 weeks of IPC treatment in the IPC 
and CON arms. PROX and DIST groups have been collapsed. Values are ± SEM. 
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Figure 4.4 Brachial artery FMD(%) scaled according to baseline diameter before, during and 
after 8 weeks of IPC treatment in the IPC and CON arms  
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4.4 Discussion 
This study demonstrates brachial artery adaptations in response to 8 weeks exposure to an IPC 
stimulus. Specifically, there is a strong trend for a transient increase in brachial artery FMD 
following IPC that is evident after 6 weeks and which rapidly returns to baseline levels by 8 
weeks. This trend is significant when FMD is controlled for baseline diameter. A similar 
pattern is observed in resistance vessel adaptation where peak blood flow is enhanced after 4 
weeks of IPC, which is maintained at 6 weeks. These improvements are also evident in the 
contralateral arm and suggest that IPC acts locally and systemically to provide a stimulus for 
the brachial artery and downstream resistance vessels. Additionally, it may be that location of 
the IPC occlusion augments adaptation given the relatively greater blood flow responses when 
the stimulus is applied proximal to the brachial artery compared with distal application, 
although this difference appears to be limited to the resistance vessels. 
There was a clear trend for FMD to increase with IPC both locally and systemically. 
Although not significant, the magnitude of change in FMD at 6 weeks was greater compared 
to previous observations following a similar stimulus (Jones et al., 2014b). The functional 
enhancement following daily exposure to IPC in comparison to the lack of increase at 2 weeks 
in the current study initially suggests the frequency of exposure as an important determinant of 
improvements in endothelial function. However, this is contrary to observations of an 
improvement in FMD after 2 weeks of IPC applied three times per week in a similar manner 
to the present study (Jones et al., 2014b). This chosen frequency of application should work in 
synergy with the concept of late cardioprotection from IPC, which is evident for up to 4 days 
after application (Loukogeorgakis et al., 2005).  The trend in FMD increase is additionally 
delayed in comparison to alternative methods of shear rate manipulation, usually occurring at 
approximately 2 weeks after the onset of exercise training (Hunt et al., 2013; Tinken et al., 
2008) or local limb heating (Naylor et al., 2011) and the return to baseline rapid in comparison 
to a slower decline (over 2 - 4 weeks) with exercise (Tinken et al., 2008) and local heating 
(Naylor et al., 2011). Given the absence of structural adaptation, the rapid decline in FMD 
cannot be attributed to the shear rate normalisation as occurs with exercise (Laughlin, 1995; 
Green et al., 2012).  
Indeed, no structural changes were observed with IPC training in contrast to the 
established arterial remodelling that occurs with prolonged exercise training (longer than 4 
weeks) (Green et al., 2012; Laughlin, 1995). This supplements previous observations of an 
absence of alterations in rest diameter with 8 weeks of IPC (Jones et al., 2014b); although no 
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specific structural measurements (DC, maximum diameter in response to ischaemic exercise) 
were obtained in the latter study. The absence of change in resting artery diameter has 
previously been observed with repeated shear exposure, but the lack of improvement in DC in 
the present study appears contrary to the observation of an improvement following 8 weeks of 
local heating-induced shear (Naylor et al., 2011). It may be that participants in the present study 
became conditioned to the occlusive stimulus during IPC treatment, such that the DC stimulus 
for measurement did not elicit a maximal response, removing the potential to ascertain any 
enhancement in this measure. However, given the observed increase in FMD this seems 
unlikely, although this may in part explain the reduction in FMD after 8 weeks. Ischaemic 
handgrip exercise, an accepted marker of arterial remodelling (Naylor et al., 2005), is used to 
evoke maximum arterial diameter via an endothelium- and shear-dependent dilation response 
which is largely NO-independent (Tinken et al., 2010). The absence of any increase in 
maximum diameter with IPC may highlight the predominance of NO in the adaptive response 
to IPC training, given the improvement in FMD measures (NO-dependent) and absence of DC 
(largely NO-independent) augmentation. Despite this, external compressions are sufficient to 
increase eNOS phosphorylation (Yang, Talukder, Varadharaj, Velayutham and Zweier, 2013) 
which is critical to arterial remodelling with exercise (Sessa et al., 1994). IPC also increases 
expression of angiogenic factors (VEGF, MCP-1) which may play a role in arterial remodelling 
(Kimura et al., 2007; Prior et al., 2004; Roseguini, Mehmet Saylu, Whyte, Yang, Newcomer 
and Laughlin, 2010). This suggests that the current protocol itself provided an insufficient 
stimulus and / or period of exposure to induce structural adaptation. This divergence from 
observations with exercise additionally suggests that exercise induces additional stimuli 
resulting from muscle contraction (AMPK, adenosine) to induce structural adaptation.  
When FMD was scaled according to baseline artery diameter, a difference was observed 
between arms where the intervention arm (regardless of cuff location) exhibited significantly 
greater function compared to the contralateral arm. This was reiterated in scaled DC. Further, 
scaled FMD was enhanced at weeks 4 and 6 compared to week 0. Scaling in this manner 
controls for the possible bias induced by variations in baseline diameter (Atkinson and 
Batterham, 2013) although there was no apparent difference in resting diameter between the 
control and intervention arms at any time point. Thus it is possible that the local brachial artery 
adaptations are of greater magnitude than those observed systemically based on statistically 
scaled outcome measures.  
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Adaptation of resistance vessels, as assessed by peak reactive hyperaemic blood flow 
was observed in both intervention and control arms and exhibited a similar transient nature to 
the brachial artery FMD adaptations. In support of our findings, enhancements in local forearm 
blood flow (Kimura et al., 2007) and a trend for increased peak vascular conductance 
(Roseguini et al., 2011) have previously been observed after 4 weeks of IPC. The increase in 
peak blood flow in the present study (9.9% and 12.5% at 4 and 6 weeks, respectively) appears 
lower than the ~20% previously reported after 4 weeks (Kimura et al., 2007; Roseguini et al., 
2011). This may be attributed to the lesser frequency of training. Similarly, 8 weeks of IPC 
was insufficient to promote enhancements in cutaneous microcirculatory function (Jones et al., 
2014b). Nonetheless, given that the magnitude of peak reactive hyperaemic blood flow is 
determined by resistance vessel cross-sectional area (Naylor et al., 2005), IPC training 
improved the function and/or structure of resistance vessels, providing evidence of both a local 
and systemic effect throughout the vascular tree.  
Shear stress is proposed to be the predominant stimulus for vascular adaptation with 
exercise training (Laughlin et al., 2008; Tinken et al., 2010; Newcomer et al., 2011). Thus, it 
is fair to speculate that the repeated exposure to reactive hyperaemia with IPC plays a role in 
adaptation. Indeed, shear stress is the predominant stimulus for eNOS activation (Fisslthaler et 
al., 2000) and the early IPC response is dependent on the activation of eNOS (Yang et al., 
2013), increases in which  occur in a time-dependent manner (Tan, Qi, Gu, Urbaniak and Chen, 
2006). This may in part explain the continued trend for an increase in endothelial function with 
time via the production of NO, the availability of which is frequently referenced as an index of 
endothelial function (Maiorana et al., 2003). Mean shear rate is not significantly altered during 
IPC at pressures up to and including 150 mmHg and given the absence of significant findings 
by Roseguini and colleagues (2011), a requirement of mean shear for adaptation with IPC is 
professed. Shear stress is unlikely to explain the systemic effects of IPC, given the assumed 
increase in shear rate in the intervention arm only and other vasculogenic factors (EPC, MMP, 
VEGF) may play a role (Kimura et al., 2007; Oberkofler et al., 2014). The reductions in oxygen 
availability induced with external compression may also contribute, but although VEGF gene 
expression is upregulated by the induction of HIF-1, the role of this oxygen dependent factor 
in IPC-induced adaptations is disputed (Cai, Luo, Zhan and Semenza, 2013; Kalakech et al., 
2013). 
Despite the short half-life of NO (less than 10 seconds), red blood cells (RBC) act as 
“NO sinks” and synthesise, store and transport NO metabolic by-products (Cortese-Krott and 
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Kelm, 2014). Acute IPC is associated with decreases in stored forms of NO in the blood (nitrite 
and red blood cell nitric oxide [RBC-NO]), measures of which are an indicator of global NO 
availability (Rifkind et al., 2014) despite improving local NO availability (Tan et al., 2006). 
Observations of an immediate decrease in plasma nitrite support this trend but conversely, 
when the IPC stimulus is prolonged over 3 weeks, plasma nitrite is augmented (Sutkowska et 
al., 2009). The initial decrease may reflect the transfer of NO bioactivity to the remote arteries 
and storage in a form that allows for NO release under hypoxic stress (Rifkind et al., 2014) and 
may offer a possible explanation for the functional improvement with prolonged exposure. 
Indeed, the ‘erythrocrine function’ of RBC is becoming increasingly apparent (Cortese-Krott 
and Kelm, 2014). Potential roles for neuronal (Loukogeorgakis et al., 2005) and humoral 
(bradykinin, adenosine) mediation have also been implicated in the positive effects of remote 
IPC (Hausenloy and Yellon, 2008). 
Limitations 
There is a possibility that the results obtained were subject to the late phase of IPC protection 
as opposed to the training effects. The late phase begins 12-24 hours following IPC application 
and may last for 3-4 days (Laude, Beauchamp, Thuillez and Richard, 2002), which was within 
the timeframe that our functional (FMD) and structural (DC) assessments were made. However, 
when post-intervention measurements are made 8 days following cessation of repeated IPC, 
improvements in brachial artery and microvascular endothelial function remain apparent (Jones 
et al., 2014a), suggesting a sustained adaptation is evident. A further limitation is the absence 
of control group inclusion in our study to ensure a lack of experimental bias. Additionally, we 
did not directly measure the pressure transmitted to the vasculature during the ischaemic 
stimulus, although previous work suggests that more than 95% of pressure is transmitted to the 
tissue from external application (Crenshaw, Hargens, Gershuni and Rydevik, 1988), thus we 
can speculate that this holds true for the current intervention. 
In conclusion, 8 weeks of IPC exposure results in transient local and systemic 
improvements in brachial artery function that peak at 6 weeks before rapidly returning to 
baseline at 8 weeks. Transient improvements in both local and remote forearm resistance vessel 
capacity are also observed following 6 weeks of IPC. These results suggest IPC could be used 
as a non-invasive, accessible method of improving vascular function..  
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Chapter 5 - Endovascular biopsy - proof of concept 
5.1 Background 
The vascular endothelium plays a vital role in controlling vasomotor tone and inhibiting platelet 
aggregation via the production of both vasculotropic and vasculoregulatory molecules, whilst 
its dysfunction is generally accepted as the primary step in the development of atherosclerosis 
(Ross, 1993). These changes precede visible variations in angiographic or ultrasonic measures 
(Davignon and Ganz, 2004) and thus offer the potential for early diagnosis of CVD states. As 
previously discussed, the endothelium is required for the maintenance of vascular 
characteristics (Langille and O’Donnell, 1986) and vascular adaptations are evident with 
exercise training both in healthy (Green et al., 2012) and in those with known endothelial 
dysfunction (Hambrecht et al., 1998). The specific role of the endothelium in this process is 
relatively unknown, with the multifaceted mechanisms of adaptation yet to be fully elucidated. 
It is of interest to identify the molecular triggers of vascular endothelial dysfunction and 
adaptation which can be correlated with clinical phenotype measures (e.g. FMD), as this may 
allow for targeted intervention strategies (medications, rehabilitation therapies, physical 
activity / exercise interventions, gene transfer therapies) aimed at improving or preserving early 
endothelial function. These interventions may ultimately prove useful for those unable to 
undertake traditional exercise, or those at an increased risk of future cardiovascular events. 
 Due to current research into vascular adaptation being limited as a result of its inability 
to provide information regarding the specific fundamental molecular signals, a method of in 
situ cell extraction was developed with the aim of the detachment of EC from the vascular 
endothelium (Feng et al., 1999). The endovascular biopsy technique allows for the harvesting 
of viable EC from the vasculature for the purpose of characterisation and analysis and was 
originally proposed as a safe and reproducible method of harvesting EC (Feng et al., 1999). 
Briefly, and in reference to the protocol described by Feng et al (1999), a coaxial stainless steel 
wire is inserted into the iliac artery through a Potts needle and femoral sheath advanced over 
the wire. The wire is removed and cut directly into 25 mL of EC dissociation buffer. Following 
incubation, further washes and centrifugation ECs are resuspended in dissociation buffer before 
analysis (Feng et al., 1999). One further group has since demonstrated a similar biopsy 
technique and  related relevant gene and protein expression to vascular health status (Colombo 
et al., 2002; Feng et al., 2005; Hambrecht et al., 2003; Onat et al., 2007; Silver et al., 2010). 
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In order to investigate the mechanisms contributing to the adaptations witnessed with 
exercise training, this study aimed to develop and implement the endovascular biopsy 
technique, combined with associated genetic and proteomic analysis, novel to UK institutions 
and currently conducted in few additional worldwide institutions. In an initial “proof of concept” 
phase, a number of cell harvests were collected from participants to provide preliminary data 
and to allow for improvement of methodologies. The development of the technique was 
initially based on methods published by the aforementioned groups but subsequently improved 
in relation to post-harvest processing techniques, improving EC yield and quality of genomic 
and protein analysis. 
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5.2 HUVEC pilot work 
Before analysing primary cells extracted directly from patients, improvement of the analytical 
techniques was conducted on a cell line in culture. This allowed for preservation of the 
restricted number of samples obtained from endovascular biopsies. Specific EC culture 
techniques following initial cell culture training with mouse myoblasts (C2C12) were 
performed using HUVEC. HUVEC were kindly donated by colleagues at University College 
London (UCL). HUVEC represent a model of EC to allow for the determination of the 
physiology and function of such vascular cells in vitro (Baudin, Bruneel, Bosselut and 
Vaubourdolle, 2007). All HUVEC utilised throughout culture and experimental work ranged 
from passage 3 to passage 7, after which cells became unviable.  
 
5.2.1 Cell revival and culture 
A defined EC media (0.02 ml/ml FCS; 0.004 ml/ml EC growth supplement; 0.1 ng/ml 
epidermal growth factor [recombinant human]; basic fibroblast growth factor [recombinant 
human]; insulin-like growth factor [long R3 IGF-1]; vascular endothelial growth factor 165 
[recombinant human]; ascorbic acid; heparin and hydrocortisone) (Promocell, Heidelberg, 
Germany) was used for growth of HUVEC. Cells were seeded in a 75 cm2 culture flask at a 
density of 500,000 cells. HUVEC reached confluence after ~10 days and exhibited the expected 
monolayer cobblestone appearance (Baudin et al., 2007) (Fig. 5.1). Cells were trypsinized at 
~80% confluence and passaged.  
 
 
 
 
82 
 
     
Figure 5.1 Phase-contrast image of HUVEC exhibiting the cobblestone appearance 10 days 
after placing in growth medium at 10x (A) and 20x (B) magnification. Scale bars represent 100 
µm. 
 
5.2.2 Media improvement 
The original medium in which HUVEC were cultured was ready mixed with supplemental 
factors. It was of interest to investigate HUVEC culture in a medium lacking the additional 
factors which may not have been beneficial or ultimately required to provide the diverse 
nutritional requirements for successful HUVEC growth. A culture medium was prepared based 
on previous research involving the culture of HUVEC (Jaffe, Nachman, Becker and Minick, 
1973; Hotchkiss, Ashton, Mahmood, Russel, Sparano and Schwartz, 2002; Baudin et al., 2007) 
using an M199 ‘stock’ solution (0.01 ml/ml 0.2M glutamine; 0.015 ml/ml 1M HEPES; 0.018 
ml/ml 7% (w/v) sodium bicarbonate; 0.01 ml penicillin / streptomycin; 0.2 ml/ml FCS; 0.747 
ml/ml M199 ‘stock’ solution).  
 Cells were plated in to a standard 6 well culture plate at a seeding density of 50,000 
cells per 10 cm2 well and incubated at 37ºC and 5% CO2 for 96 hours. Cells were fixed with 
methanol acetone after 24 hours and at subsequent 24 hour time-points up to a final time of 96 
hours, with 3 wells per time-point for each medium. Each well was supplemented with 2 ml of 
either ready-made or M199 medium which remained unchanged throughout the 96 hour period 
and representative phase-contrast images were obtained at each time point (Fig. 5.2). In 
accordance with previous cultures, HUVEC exhibited the expected cobblestone appearance 
when grown in the ready-made medium. Conversely, no growth of HUVEC was observed 
when grown in complete M199 medium. Although initially surprising that no success was 
experienced with the latter medium despite it being an exact replica of that used in the 
B A 
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previously discussed research, it may be that the greater passage of HUVEC represented less 
robust cells which subsequently required the additional supplements added to the ready mixed 
medium. Nonetheless, for future HUVEC work the defined EC media was used. 
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Figure 5.2 Phase-contrast images of HUVEC at 10x magnification at 24 (top), 48 (second top), 
72 (second bottom) and 96 (bottom) hours grown in defined medium (left) or in complete M199 
medium (right). Scale bar represents 100 µm. 
24h 24h 
48h 48h 
72h 72h 
96h 96h 
85 
 
5.2.3 Immunocytochemistry 
Cell harvests obtained from endovascular biopsies cannot guarantee EC isolation upon 
immediate extraction due to the presence of additional contaminating factors present in the 
blood in vivo. Confirming the origin of cells is crucial to ensure targetted future analysis. To 
assess the phenotype of cells, immunocytochemical techniques were employed. 
 
CD31 improvement 
Cluster of differentiation-31 (CD31) or platelet EC adhesion molecule-1 (PECAM-1) is 
constitutively expressed on EC surfaces and is highly abundant at intercellular junctions 
(Hewett and Murray, 1993). Although vWF appears to be the most widely accepted marker of 
EC (Feng et al., 1999; Silver et al., 2010), CD31 was deemed superior to the latter given that 
it is evident on endothelia which do not express vWF when analysed using 
immunocytochemistry techniques (Kuzu, Bicknell, Harris, Jones, Gatter and Mason, 1992). 
 For immunocytochemistry, HUVEC were plated on to 0.2% gelatin coated coverslips 
within a 6 well culture plate and grown for 96 hours to ~50-80% confluence. Gelatin coating 
was performed to enhance the ability of cells to attach to the surface of the coverslips. Media 
was aspirated from wells and cells were twice washed with cold PBS before being fixed by 
incubation with 2 ml methanol acetone for 15 minutes. Cells were washed with PBS before 
coverslips were mounted on to individual platforms designed to support one coverslip. Non-
specific binding sites were blocked with 100 µl of blocking solution (5% goat serum; 2% triton; 
TBS) for 30 minutes. Blocking solution was then removed and cells were washed with TBS. 
Coverslips were then incubated with 100 µl primary rabbit anti-human CD31 antibody solution 
(1:250 dilution in 2% goat serum; 0.2% triton; TBS) for 2 hours. After an additional wash with 
TBS, coverslips were incubated with 100 µl goat anti-rabbit IgG TRIT-C solution (1:200 
dilution in 2% goat serum; 0.2% triton; TBS) and protected from the light for 1 hour. Following 
a further TBS wash, cells were incubated with DAPI (1:1000 dilution) in darkness for 15 
minutes. Washes were performed a further 3 times. Each coverslip was then removed from the 
staining platform and mounted on to a glass slide with 8 µl of mowiol and left to dry overnight. 
Slides were imaged using a Leica DM2500 fluorescent microscope (Leica Microsystems Ltd, 
Switzerland) (Fig. 5.3). Although it was initially expected that expression would primarily be 
observed at the borders of EC, because HUVEC did not reach confluence before fixation, 
positive staining instead appeared throughout the cell body.  
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Figure 5.3 Immunocytochemical staining of HUVEC 96 hours after being plated in growth 
medium at 10x (A) and 20x (B) magnification. Staining for CD31 appears red; nuclei stained 
blue with DAPI. Scale bars represent 100 µm. 
 
 Modifications to the immunocytochemical protocol were subsequently undertaken to 
ensure improved methods and image quality, which would ultimately ensure greatest image 
quality of the primary cell line obtained from future endovascular biopsies. Secondary antibody 
concentrations and incubation times were manipulated (Table 5.1) and images were taken 
throughout the culture period and compared to the original protocol outcome (Fig. 5.4). All 
slides were exposed to equivalent duration and intensity. From these images it was concluded 
that the optimal intensity appeared at a secondary antibody concentration range of 1:100 to 
1:200, following which a greater incubation time enhanced intensity (and ultimately resulted 
in overexposure [Fig. 5.4D]) compared to original conditions. For all future 
immunocytochemical analysis the CD31 antibody was used at an incubation time of 2 hours at 
a concentration of 1:250, whilst the secondary was used at a concentration of 1:200 with 
incubation duration of 2 hours. 
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Table 5.1 Modifications to the immunocytochemical staining protocol for CD31 
 Trial A Trial B Trial C Trial D 
 Primary antibody 
Concentration 1:250 1:250 1:250 1:250 
Incubation time (hours) 2 2 2 2 
 Secondary antibody 
Concentration 1:200 1:100 1:100 1:400 
Incubation time (hours) 2 1 2 12 
 
     
     
Figure 5.4 Fluorescent microscopy images of HUVEC using different secondary antibody 
staining protocols, taken at 40x magnification 72 hours after plating. Staining for CD31 appears 
red; nuclei stained blue with DAPI. Antibody at 1:200 for 2 hours (A), at 1:100 for 1 hour (B), 
at 1:100 for 2 hours (C) and at 1:400 for 12 hours (D). Scale bar represents 50 µm. 
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In order to test the specificity of the antibodies, negative control images were obtained 
under identical conditions to the original protocol for the CD31 positive images but lacking 
either the primary or secondary antibody at 72 hours (Fig. 5.5). Although a successful negative 
control was obtained when the protocol lacked secondary antibody, when the primary antibody 
was excluded the resultant image appeared highly comparable to those obtained for positive 
controls, in both positive and background staining intensities, suggesting a high degree of non-
specific secondary antibody binding.  
 
     
Figure 5.5 Negative controls for HUVEC CD31 staining at 40x magnification, 72 hours after 
plating, without primary (A) or secondary (B) antibodies. Staining for CD31 appears red; nuclei 
stained blue with DAPI. Scale bars represent 50 µm. 
  
 Improvement of the blocking protocol was undertaken as it was speculated that this step 
was problematic and conducive to the observed non-specific binding. Variations in the 
blocking protocol are described in Table 5.2 and images obtained at 72 hours are presented 
(Fig. 5.6). Modification of the blocking step had minimal effect on the degree of non-specific 
binding as determined by staining intensity. The secondary antibody was subsequently replaced 
with an alternative goat anti-rabbit IgG H&L (Chromeo 488) antibody (Abcam, UK). 
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Table 5.2 Blocking modifications made in an attempt to minimise non-specific binding of 
the secondary antibody. 
 Trial A Trial B Trial C 
Serum concentration 2% 5% 5% 
Serum batch Original Original Fresh 
Ambient temperature (ºC) 20-22 37 20-22 
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Figure 5.6 Fluorescent microscopy images of HUVEC using different blocking protocols, 
taken at 40x magnification; Positive controls (left) and negative controls (right) for each 
condition; 2% original serum incubated at 20-22ºC (A), 5% original serum incubated at 37ºC 
(B), 5% fresh serum incubated at 20-22ºC (C).  Staining for CD31 appears red; nuclei stained 
blue with DAPI. Scale bars represent 50 µm. 
 
 The goat anti-rabbit IgG H&L (Chromeo 488) antibody was tested according to the 
safety data sheet guidelines and was applied at a concentration of 1:1000 following an 
equivocal protocol as the original for CD31 staining (Fig. 5.7A). Once again, the negative 
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control suggested a degree of non-specific binding (Fig. 5.7B). The blocking protocol was 
again modified via blocking at 37ºC as opposed to room temperature and doubling incubation 
time to 60 minutes. Although intensity was somewhat attenuated following improvement, the 
presence of non-specific binding was still apparent (Fig. 5.7C). 
 
     
 
Figure 5.7 Fluorescent microscopy images of HUVEC using Chromeo 488 secondary antibody, 
taken at 20x magnification; Positive control (A); negative control (B) and positive control after 
blocking improvement (C). Staining for CD31 appears green; nuclei stained blue with DAPI. 
Scale bars represent 50 µm. 
 
 The presence of non-specific binding despite the alternative secondary antibody and 
improvement of the blocking protocol prompted further investigation into obtaining successful 
immunocytochemical results for the determination of CD31 in HUVEC. Coverslip coating is 
essential in promoting cell adherence. Previously, 0.2% gelatin coating was adopted in line 
C 
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with preliminary mouse C2C12 work and had previously proved successful in encouraging 
adherence of cells of varying origin in our group. However, HUVEC can also attach to other 
matrices such as poly-L-lysine (Jelic et al., 2010; Silver et al., 2010). Additionally, a further 
variable not previously considered was the source of the protein used for blocking. Various 
protocols exist including the use (as above) of animal serum not “involved” in the reaction (e.g. 
goat derived when using a mouse anti-human antibody) or extracted protein such as BSA. To 
investigate whether modifications in the coverslip coating or blocking serum would affect the 
immunocytochemical outcome, HUVEC were plated on to coverslips within a 6 well culture 
plate with no prior coating, or having been coated with either 0.2% gelatin or 0.01% poly-L-
lysine. Further, after 72 hours in growth medium, these cells were exposed to blocking 
solutions originating from either the original goat serum or replacement BSA serum prior to 
the established immunocytochemistry protocol. Although goat serum was included in both the 
primary and secondary antibody solutions, BSA was included in the blocking solution only. 
This was based on the previously established protocols being followed. Fluorescent images 
were taken for comparison following 72 hours in growth medium (Fig. 5.8). 
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 Goat serum BSA 
 Positive control Negative control Positive control Negative control 
No 
coating 
    
Gelatin 
coated 
Technical error 
   
Poly-L-
lysine 
coated 
    Figure 5.8 Immunocytochemical staining of HUVEC plated on coverslips with no coating 
(top), 0.2% gelatin coating (middle) or poly-L-lysine (bottom) coating and blocked with goat 
serum (left) or bovine serum albumin (BSA) (right), alongside their respective negative 
controls, taken at 20x magnification. CD31 is stained green; nuclei are stained blue with DAPI. 
Scale bars represent 100 µm. 
  
 As with previous improvement attempts, minimal differences in staining intensity were 
evident between positive and negative control images. However, blocking of HUVECS coated 
on to poly-L-lysine slides with BSA appeared to result in the relatively greatest fluorescence 
intensity therefore, this method of blocking was utilised in future immunocytochemical work. 
Previous groups have found success with similar protocols for the identification of CD31, but 
increasing exposure to tryspin-ethylenediaminetetra-acetic acid (EDTA) decreases detection of 
CD31 (Mutin, George, Lesaule and Sampol, 1996) and it may be speculated that the trypsin 
utilised during passage affected marker expression. 
 
eNOS identification 
As a result of the difficulties established with obtaining positive CD31 staining in HUVEC, the 
CD31 antibody was replaced with a rabbit anti-human eNOS primary antibody (Abcam, UK) 
and was used in conjunction with the goat anti-rabbit IgG H&L (Chromeo 488) secondary 
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antibody used previously. eNOS, a synthase which generates NO in the vasculature, has been 
demonstrated to be present in all EC and exhibits subcellular localisation in membrane fractions 
of cultured HUVEC (Sessa et al., 1995; Li et al., 2007). HUVEC were again cultured for 72 
hours in growth medium before immunocytochemical analysis, in a protocol matched to that 
used for CD31 identification, with the exception of primary antibody incubation for 2 hours at 
1:100 in accordance with the product data sheet. 
Following successful eNOS imaging (Fig. 5.9), application suite intensity and duration 
settings were transferred to samples previously unsuccessfully stained for CD31. When 
exposure settings were applied to CD31 stained samples these subsequently lacked positive 
staining in both the positive and negative controls and exhibited only positive DAPI 
fluorescence. This reinforced the outcome regarding the unsuitability of CD31 expression as a 
positive marker in HUVEC.  
     
Figure 5.9 Fluorescent microscope images of HUVEC taken at 20x magnification. Positive 
control (A) and negative control (B). Staining for eNOS appears green; nuclei stained blue with 
DAPI. Scale bars represent 50 µm. 
 
VEGFR-2 identification 
VEGFR-2, a tyrosine kinase receptor for VEGF plays a key role in vascular development and 
the regulation of vascular permeability. It is expressed mostly on vascular EC (Mustonen and 
Alitalo, 1995), and thus represents another key protein of interest. In order to test the viability 
of the staining protocol for detection of this protein on HUVEC, a rabbit anti-human polyclonal 
to VEGFR-2 antibody (Abcam, UK) was selected and used in conjunction with goat anti-rabbit 
IgG H&L (Chromeo 488). The staining protocol used was matched to that used for eNOS 
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identification, with primary antibody incubation for 2 hours at 1:250 in accordance to the 
product datasheet. Fluorescence was evident and exhibited subcellular localisation of VEGFR-
2, which when in the absence of VEGF as in this instance, appears cytosolic with time spent in 
basal medium (Fig. 5.10). Should these HUVEC have been subsequently stimulated with 
VEGF, a shift to nuclear localisation would likely be evident (Santos et al., 2007). The negative 
control in the absence of the primary antibody exhibited no fluorescence and hence the 
presence of non-specific binding of the secondary antibody was rejected. Expected staining 
patterns were produced and the antibodies and protocol were deemed satisfactory for future 
use in endovascular biopsy sample immunocytochemical identification of both eNOS and 
VEGFR-2. 
 
     
Figure 5.10 Fluorescent microscopy images of HUVEC taken at 20x magnification, exposure 
settings matched to those used above for eNOS imaging. Positive control (A) and negative 
control (B). Staining for VEGFR-2 appears green; nuclei stained blue with DAPI. Scale bars 
represent 50 µm. 
 
Multiple staining 
A number of proteins would be targeted for analysis in cells obtained using the endovascular 
biopsy technique, therefore it was investigated whether multiple proteins could be identified 
from a single coverslip given the valuable and expected limited harvesting of primary ECs. 
Thus, immunocytochemical analysis was used to identify eNOS simultaneously with VEGFR-
2 in HUVEC previously fixed at 72 hours. A double staining protocol was employed, using a 
sequential approach for primary antibodies raised in rabbit, identical to those used for 
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previously improved single protein identification. This double staining protocol was similar to 
those used for single proteins, with the addition of a further blocking step with 5% goat serum 
and 0.2% triton immediately following TBS washing after the preliminary secondary antibody 
incubation period, subsequently followed by primary and secondary incubations for the 
additional protein of interest and the final DAPI staining as standard. Immunofluorescent 
images were obtained for each protein individually and for both combined (Fig. 5.11) and both 
eNOS and VEGFR-2 expression exhibited similar subcellular expression as previously 
reported (Shi et al., 2012; Tang et al., 2012). 
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Figure 5.11 Fluorescent microscopy images of HUVEC taken at 20x (left) and 40x (right) 
magnification, exposure settings matched to those used above for eNOS imaging. Staining for 
eNOS appears red (A); VEGFR-2 appears green (B); nuclei stained blue with DAPI (C); image 
overlay (D). Scale bars represent 50 µm. 
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Negative control images, lacking the primary antibodies for eNOS or VEGFR-2, or 
lacking both antibodies were obtained to verify specific binding of each secondary antibody, 
using TRIT-C and Chromeo 488 to identify eNOS and VEGFR-2, respectively. When the 
protocol was completed lacking both primary antibodies, a satisfactory negative control image 
was obtained, stains being visible from DAPI only (Fig. 5.12C). This was also true with the 
negative control for VEGFR-2, with only TRIT-C and DAPI fluorescence present (Fig. 5.12B). 
However, TRIT-C fluorescence was still apparent in the negative control for eNOS, suggesting 
the presence of non-specific binding of the secondary antibody (Fig. 5.12A). As TRIT-C 
incubation was secondary to the staining protocol for VEGFR-2, it is plausible to speculate that 
TRIT-C bound to sites on the VEGFR-2 primary antibody additional to eNOS primary antibody 
binding, possibly due to the host animal for the primary antibodies being identical. 
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Figure 5.12 Fluorescent microscopy overlay images of HUVEC taken at 20x (left) and 40x 
(right) magnification, exposure settings matched to those used above for positive double 
staining. Negative control for eNOS plus positive control for VEGFR-2 (A); negative control 
for VEGFR-2 plus positive control for eNOS (B); negative control for both eNOS and VEGFR-
2 (C); staining for eNOS appears red; VEGF-R2 appears green; nuclei stained blue with DAPI. 
Scale bars represent 50 µm.  
 
In an attempt to solve the problem of non-specific binding of the TRIT-C antibody, the 
goat serum was replaced with rabbit serum within the blocking solution. Using a serum raised 
in the same species as the primary antibody should block free binding sites of the anti-rabbit 
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immunoglobulin, thus minimising non-specific binding of the additional secondary antibody 
(Pirici et al., 2009). However, as with the previous trial using goat serum, despite a satisfactory 
negative control image being obtained for VEGFR-2 (Fig. 5.13B), non-specific binding was 
still evident when staining for eNOS (Fig. 5.13A). Despite numerous efforts to improve the 
multiple staining protocol, it was concluded that for reliability of the procedure, proteins would 
be stained separately in future samples and that a greater yield of primary cells for this purpose 
would be required. 
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Figure 5.13 Fluorescent microscopy overlay images of HUVEC taken at 20x (left) and 40x 
(right) magnification, exposure settings matched to those used above for positive double 
staining. Negative control for eNOS plus positive control for VEGFR-2 (A); negative control 
for VEGFR-2 plus positive control for eNOS (B); positive control for both eNOS and VEGFR-
2 (C); staining for eNOS appears red; VEGFR-2 appears green; nuclei stained blue with DAPI. 
Scale bars represent 50 µm. 
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5.3 EC collection 
5.3.1 Participants 
All participants were male or female patients undergoing a PCI and had previously provided 
written consent as a patient of the BRICCS database, a system within the Leicester 
Cardiovascular Biomedical Research Unit designed to capture clinical information about 
cardiovascular patients seen in University Hospital of Leicester, in line with ethical agreement. 
Samples were obtained during coronary angiogram procedures under surgical conditions from 
a total of 14 patients. 
 
5.3.2 Biopsy of human EC 
EC were collected from 3 areas of the vasculature: the brachial artery using a 3 mm J-wire 
(GuideRight, St. Jude Medical, England); a coronary artery using a guidewire; and via direct 
detachment from the pre-inflation coronary balloon upon removal following stent insertion. 
Models and sizes of coronary guidewires and balloons differed between subjects depending on 
arterial characteristics with the exception of the standard brachial wire. The selection of these 
sites was based predominantly on pre-determined access of the surgery, with the addition of 
the brachial artery as a gauge of the peripheral vasculature. Following the insertion of a cannula 
in to the radial artery, a guidewire was advanced through the cannula into the artery and a 
sheath inserted. Sequential guidewires were then advanced through the sheath and a forward 
and backward motion at the site of interest disrupted the endothelial lining before subsequent 
removal of the guidewire. Wires were immediately placed into 50 ml conical tubes containing 
25 ml of EC dissociation buffer (0.5% BSA, 2 mmol/L EDTA, 100 μg/mL heparin in Ca2+- 
and magnesium-free PBS; Feng et al., 1999), kept at 4ºC and were transported from the site of 
extraction to the laboratory following complete sample collection.  
 
EC for immunocytochemistry 
After every full collection, each wire was washed inside the tube for a minimum of 10 minutes 
in dissociation buffer, before the wire was discarded. The protocol used for cell recovery was 
based on that used by Dinenno et al (2001) and was adapted as follows: Tubes were centrifuged 
at 400 relative centrifugal force (RCF) at 4ºC for 7 minutes. The supernatant was aspirated 
leaving ~400 μl remaining with the cell pellet. This volume was left due to the poor ability of 
EC to form a structured pellet. One ml formaldehyde solution (3.7% formaldehyde solution 
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with PBS) was then pipetted into the sample tube without resuspending and incubated for 10 
minutes. A further 15 ml PBS was added and the solution resuspended and centrifuged at 400 
RCF and 4ºC for a further 5 minutes. The supernatant was aspirated with ~400 μl remaining 
with the cell pellet, and a further 12 ml PBS was added and the solution resuspended. Tubes 
were centrifuged at 400 RCF and 4ºC for a further 6 minutes. The supernatant was aspirated 
with ~2 ml remaining and the pellet resuspended. The resulting solution was spread evenly 
over 4 slides coated with a PAP pen such that 4 slides were obtained per wire. Slides were 
placed in an incubator at 37ºC for 5 hours to remove excess liquid and then stored protected 
from the light at -80ºC until analysis.  
 
EC for RT-PCR 
Cells destined for RT-qPCR were processed as above but were not exposed to formaldehyde. 
Following final resuspension, the resulting solution was immediately snap frozen in liquid 
nitrogen and stored at -80ºC until analysis. 
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5.4 Immunocytochemistry of harvested EC 
Following the successful improvement of immunocytochemistry of HUVEC, these techniques 
could be transferred to endovascular biopsy samples. Slides from one patient (3 slides per site 
[coronary, balloon, brachial]) were removed from the freezer and left at room temperature for 
5 minutes and were then rehydrated by adding 400 µl PBS and left for a further 10 minutes 
before removal of liquid. Each slide was then incubated with 200 μl of 1% BSA blocking 
solution for 1 hour before removal. Slides were incubated with 200 µl of respective primary 
antibody solutions for 2 hours and subsequently rinsed with PBS. Secondary Chromeo488 
antibody at a concentration of 1:1000 was then added to each slide and incubated for 1 hour 
and protected from the light. Slides were again washed with PBS, this was removed and slides 
were incubated with DAPI at 1:10,000 for 15 minutes before rewashing with PBS. Samples 
were imaged using a fluorescent microscope (Leica DM2500 fluorescence microscope, Leica 
Microsystems Ltd, Switzerland) with constant intensity and duration settings matched to those 
used in pilot work with HUVEC using Leica application suite (Version 3.7.0, Leica 
Microsystems Ltd, Switzerland). Slides were stained for CD31 (Fig. 5.14), eNOS (Fig. 5.15) 
and VEGFR-2 (Fig. 5.16). Full protocols used for all immunocytochemical procedures with 
primary cells were matched to those used in preliminary HUVEC pilot work (due to the 
requirement for a marker of EC lineage, CD31 was targeted despite the lack of success in 
identification in HUVEC). Coverslips were subsequently fixed over the slides with 8 µl of 
mowiol, protected from the light and stored at 4ºC. 
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Figure 5.14 Fluorescent microscopy images of scrapes obtained from the coronary balloon (A), 
brachial artery (B) and coronary artery (C) in one patient using Chromeo488 secondary 
antibody, taken at 20x (left), 40x (middle) and 100x (right) magnification. Staining for CD31 
appears green; nuclei stained blue with DAPI. Scale bars represent 50 µm. 
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Figure 5.15 Fluorescent microscopy images of scrapes obtained from the coronary balloon (A), 
brachial artery (B) and coronary artery (C) in one patient using Chromeo488 secondary 
antibody, taken at 20x (left), 40x (middle) and 100x (right) magnification. Staining for eNOS 
appears green; nuclei stained blue with DAPI. Scale bars represent 50 µm. 
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Figure 5.16 Fluorescent microscopy images of scrapes obtained from the coronary balloon 
(A), brachial artery (B) and coronary artery (C) in one patient using Chromeo488 secondary 
antibody, taken at 20x (left), 40x (middle) and 100x (right) magnification. Staining for 
VEGFR-2 appears green; nuclei stained blue with DAPI. Scale bars represent 50 µm. 
 
Despite confidence that the resultant fluorescent images represented a true reflection of 
the presence of respective proteins, images obtained were not comparable to those obtained 
from the previous groups who had obtained EC using a similar biopsy technique. Original work 
published by the founders of the endovascular biopsy for use in vascular physiology provided 
images of positive identification of various proteins of interest which provided initial evidence 
of differential expression of these proteins in arteries from those of diverse vascular health 
status (Feng et al., 1999; Silver et al., 2010). However, when comparing the previous findings 
with the immunocytochemical work evidenced in the present work, disparate findings are 
evident. For example, previously published images presented as EC exhibiting positive staining 
for eNOS show no characteristic morphological traits of EC and given that no nuclear DNA 
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has been identified in these images, evidence that staining is in fact at minimum of a cell is 
lacking (Silver et al., 2010). Further, the original article that provided details of the protocol, 
method and safety of the technique provided images of staining for various markers of EC 
origin (Feng et al., 1999), for example vWF and ACE. These images contain background noise 
from the secondary antibody and therefore indistinct positive protein staining. Moreover, in the 
work by Feng et al. (1999) there is no evidence of nuclear DNA to identify that images are in 
fact of a cellular nature and background colour is, rather than black as is expected, a shade of 
the secondary antibody fluorescence, suggesting over-exposure through the microscope 
application suite. Nonetheless, this previous research has been published and accepted as 
correct. The repetition of negative controls throughout the current improvement techniques 
provides definitive evidence that wherever possible, methods were ensured to confirm that true 
positive staining was attained. This disparity with previous research may provide in part an 
explanation as to why images obtained from the present proof of concept scrapes do not appear 
as originally expected, given that expectations were based on this select group of previous 
findings and HUVEC cell culture research. 
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5.5 EC yield 
CD31 staining was implemented as a marker of EC origin and was thus used as a method for 
quantifying the number of EC obtained from each sample. Despite a lack of successful 
identification in HUVEC, CD31 staining presented positive when applied to primary EC 
samples, which may possibly be explained by a loss of HUVEC lineage markers with the 
relatively greater passage number (Prasad Chennazhy and Krishnan, 2005). 
Immunocytochemical detection of CD31 was subsequently deemed a suitable method for 
primary EC identification. A cumulative frequency analysis was conducted using Image J 
software (Image J, http://imagej.nih.gov/ij/ V1.46) to determine the optimal number of images 
required to reliably provide a count of cell number using positive CD31 staining as the pre-
requisite (Fig. 5.17). The number of CD31 positive cells per field of view were subsequently 
taken from 6 images per site in accordance with the cumulative frequency analysis and 
multiplied by a factor determined by slide dimensions, which differed slightly between slides 
according to the area of the PAP pen outline. Mean cell counts for each patient sampling site 
and the percentage of total cell number of which were EC can be seen in Table 5.3.  
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Figure 5.17 Cumulative frequency analysis of the number of CD31 positive cells observed at 
20x magnification over 13-16 images. * represents the number of images required to obtain the 
mean number of CD31 positive cells. 
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Table 5.3 Mean EC counts taken at each site from proof of concept samples expressed as 
total cells and as a percentage of total cell count obtained from each site. 
Site Coronary Balloon Brachial 
Mean EC number per sample site 3915 ± 1079 4889 ± 1163 2860 ± 999 
Percentage of total cell count per sample site 40 20 4 
Values are means ± SD. 
 
 A one-way ANOVA determined that there was no difference in the number of EC 
obtained between sites (P > 0.05). The limited research previously conducted in to the 
endovascular biopsy has reported EC numbers ranging from approximately 200 to 1000 from 
those with no known endothelial dysfunction (Colombo et al., 2002; Feng et al., 1999), whilst 
a relatively smaller number of cells are obtained from stenotic carotid arteries than arteries and 
veins (Feng et al., 1999). The present data suggested a slightly greater yield of EC per 
guidewire compared with previous research, but this may be a reflection of the absence of a 
separation protocol (i.e. with the addition of an RBC lysing buffer or purification with magnetic 
beads) adopted at this point as used previously (Feng et al., 1999; Feng et al., 2005).  
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5.6 Cell separation 
During immunocytochemical analysis and as can be seen from the EC percentage of total cell 
count (Table 5.3), it was crucial to lyse contaminating cells, specifically RBC from the total 
sample. This would allow for the determination of the source of any future protein and RNA 
quantified, as proteins typically found in contaminating cells may effectively mask any signal 
related to EC expression. 
 A standard protocol for RBC lysis utilises the addition of hypotonic NaCl. Therefore, 
such a step was incorporated in subsequent sample collections which were initially deposited 
into dissociation buffer, centrifuged and washed 3 times with PBS as standard. PBS was 
aspirated leaving the cell pellet and was replaced with 0.5 ml distilled water. Each sample tube 
was then subjected to high speed vortexing for precisely 10 seconds to allow for lysis of RBC. 
NaCl was added at a concentration of 1 M such that after addition to the cell solution, the final 
osmolality was 140 mmol. The contents of the tube were again washed with PBS and 
centrifuged 3 times. Lysate was subsequently filtered through a 100 µm and 40 µm cell strainer 
to remove debris which may have contaminated future analysis. The pellet was collected and 
resuspended in 1 ml PBS before being snap frozen in liquid nitrogen and stored at -80ºC until 
analysis. 
 
5.6.1 Immunocytochemistry of lysed samples 
In order to determine the success of the NaCl lysis technique, cell samples were processed in 
accordance with the previous staining protocol and fixed on to poly-L-lysine slides. Samples 
were then stained for CD31 in a matched protocol to that previously described to determine the 
presence of EC within the remaining solution. Duration and intensity were also matched to 
those used in previous protocols. As in the unlysed samples, EC stained positively for CD31, 
as shown by a high abundance of relatively evenly distributed fluorescent signals throughout 
the cells, although relatively fewer cells were observed per field of view (Fig. 5.18). 
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Figure 5.18 Fluorescent microscopy images of scrapes obtained from the coronary artery (A) 
and brachial artery (B) using Chromeo488 secondary antibody in one patient following lysis 
with NaCl, taken at 40x magnification. Staining for CD31 appears green; nuclei stained blue 
with DAPI. Scale bars represent 50 µm. 
 
Total EC counts were taken from 6 images per site in accordance with the previously 
conducted cumulative frequency analysis. Mean cell counts for each site and the EC percentage 
of total cell number as determined by positive DAPI fluorescence can be seen in Table 5.4. A 
one-way ANOVA determined no difference between sites (P = 1.00). 
 
Table 5.4 Mean EC counts taken at each site from proof of concept samples following 
lysis with NaCl, expressed as total cells and as a percentage of total cell count obtained 
from each site.  
Site Coronary Balloon Brachial 
Mean EC number per sample site 2097 ± 1354 2079 ± 818 2102 ± 2447 
Percentage of total cell count per sample site 83 70 54 
Values are means ± SD. 
 
 In order to determine the success of the NaCl lysis technique, cell counts before and 
after lysis were compared. The lysis technique appeared to lower the total EC yield (P > 0.05 
at all sites) (Fig. 5.19A) but concurrently increased the number of EC relative to total cell count 
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(P = 0.002) (Fig. 5.19B), suggesting a likely reduction in the contaminating cells within the 
samples, speculated to be RBC, peripheral blood mononuclear cells (PBMC) (lymphocytes, 
monocytes, macrophages) and/or contiguous material from the vessel wall. 
 
 
 
 
Figure 5.19 Total EC count (A) and percentage total cell yield (B) at each site on unlysed 
samples (open bars) compared to the NaCl lysis technique (closed bars). Values are ± SD. * P 
< 0.005 compared to unlysed samples. 
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their lack of nuclear DNA and subsequent negative staining of DAPI. One further sample from 
each collection site was therefore stained with a Wright stain kit (Sigma, Poole, England, UK) 
to establish the successful lysis of RBC from samples. Wright stains are used to differentiate 
the components of peripheral blood due to differential staining of erythrocytes and of the nuclei 
and cytoplasm of lymphocytes and leucocytes as well as the granulations of the latter (Wright, 
1902). It was expected that should contamination of blood cells be present, there would be blue 
/ black staining throughout the sample. Light microscopy revealed minimal contamination of 
the samples (Fig. 5.20A) when compared to a full blood smear (Fig. 5.20B). Biopsy samples 
contained very few cells lacking a blue nuclear stain (Fig. 5.20A) compared to full blood in 
which the majority of cells lacked any positive nuclear staining and exhibited predominant pink 
staining of erythrocytes (Fig. 5.20B). The prospect of a proportion of the cells identified as EC 
based on CD31 positivity being EPC should be taken in to consideration. Nonetheless, the 
combination of CD31 positivity and lack of red cell presence deemed the lysis technique 
successful in purifying EC from primary cell samples sufficiently for future quantification. 
 
     
Figure 5.20 Phase-contrast image of representative endothelial biopsy sample from the 
brachial artery (A) and full blood smear (B) stained with Wright stain solution, taken at 40x 
magnification. Scale bars represent 50 µm. 
 
 Following determination of the success of the lysis technique and immunocytochemical 
analysis of CD31, cells from the same sample collection were subsequently stained for eNOS 
in a protocol matched to that previously described for unlysed samples. Once again, lysed 
samples provided the expected fluorescence pattern of scattered high intensity signal 
throughout the cell (Fig. 5.21). 
A B 
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Figure 5.21 Fluorescent microscopy images of scrapes obtained from the coronary artery (A) 
and brachial artery (B) of one patient using Chromeo488 secondary antibody, taken at 40x 
magnification. Staining for eNOS appears green; nuclei stained blue with DAPI. Scale bars 
represent 50 µm. 
 
5.6.2 RT-qPCR 
Due to the requirement for precise measurement of genes of interest in biopsy samples, the use 
of RT-qPCR was investigated as a technique to quantitatively determine the gene expression 
encoding key proteins of interest to vascular health. Despite the relatively small number of EC 
obtained per sample and previous groups focussing on single cell RT-PCR (Feng et al., 1999), 
or linear RNA amplification prior to PCR (Onat et al., 2007) in similar biopsy samples, the aim 
of this work was to determine if quantitative RT-qPCR could be successfully employed and 
improved in samples of very few cell numbers. 
 
RNA extraction 
Based on previous work (Feng et al., 1999; Onat et al., 2007), RNA was isolated using a phenol-
free extraction method. RNA was isolated from purified cells from 8 samples using RNeasy 
micro kit (Qiagen, Crawley, UK) in accordance with the manufacturer’s instructions. This 
method allows for consistent RNA yields despite a small amount of initial material, crucial 
when dealing with small samples such as the endothelial scrapes which contained 
approximately 2000 EC. Briefly, samples were lysed and homogenised in a guanidine-
thiocyanate-containing buffer to inactivate RNases. One volume of 70% ethanol was added to 
improve binding conditions before addition of the sample to an RNeasy spin column where 
contaminants were removed through washing with guanidine-thiocyanate-containing buffers, 
A B 
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whilst the total RNA bound to the membrane. RNA was subsequently eluted in RNase free 
water.  RNA concentration and purity were assessed by UV spectroscopy using a Nanodrop 
2000 Spectrophotometer (ThermoScientific, Leicestershire, England) and yielded low (5.75 ± 
3.09 ng/µl) but sufficient quality (260/280 ratio 2.07 ± 0.26) RNA quantities to proceed with 
RT-PCR.  
 
RT-qPCR 
One-step quantitative PCR was used to quantify expression of eNOS and VEGFR-2 mRNA 
levels in cell samples. Relative RNA was quantified fluorometrically in triplicate (9.5 ng of 
RNA in a total reaction volume of 20 µl) using QuantiFast SYBR Green one step RT-PCR Kit 
(Qiagen) on an Mx3005p QPCR cycler (Stratagene, Agilent Technologies). The QuantiFast 
SYBR Green one step RT-PCR Kit contained Taq polymerases, Quantifast SYBR Green RT-
PCR buffer, SYBR green dye, ROX dye and RT mix. The SYBR green upon binding to double-
stranded DNA yields a strong fluorescent signal to provide highly sensitive quantification. The 
reaction volume comprised 9.5 µl RNA, 10 µl SYBR Green master mix, 0.2 µl reverse 
transcriptase mix and 0.15 µl of each forward and reverse PCR primers. Primers were designed 
by Sigma in accordance with the guidelines presented in Table 5.5 and the nucleotide 
sequences are presented in Table 5.6. The experimental protocol was as follows: 50°C for 10 
minutes [RT] and 95°C for 5 minutes (PCR initial activation step), 40 cycles of denaturation 
at 95°C for 10 seconds and annealing/extension at 60°C for 30 seconds. Dissociation / melting 
curve analyses were performed on completion to confirm reaction specificity. The 2-∆∆Ct 
method was used to quantify change in mRNA content and normalised to the reference gene 
RNA polymerase II (RPII) (Fig. 5.22).  
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Table 5.5 Guidelines for primer design provided to Sigma. 
Property Requirement 
Primer length 18-30 nucleotides 
Sequence GC content 40-60% 
3’-end stability <3 G or C nucleotides 
Complementarities Avoid primer self- or cross-annealing stretches >4bp 
Tm 63-67ºC 
 <4ºC between forward and reverse primer 
Tm indicates melting temperature. 
 
Table 5.6 Primers utilised for the examination of eNOS and VEGFR-1 mRNA expression 
in cell samples obtained using the endovascular biopsy technique from all sites. 
Target Gene Primer Sequence NCBI reference sequence 
eNOS F = CAAGTTGGAATCTCGTGAA         
R = TGTGAAGGCTGTAGGTTAT 
NM_001160111 
VEGFR-2 F = AGCAGGAATCAGTCAGTAT         
R = TTACTTCTGGTTCTTCTAACG 
NM_000459 
eNOS indicates endothelial nitric oxide synthase; VEGFR-2, vascular endothelial growth 
factor receptor-2. 
 
Despite successful amplification of eNOS expression, as a likely result of low RNA 
yields, inflection points for VEGFR-2 appeared late in the RT-qPCR cycle (Table 5.7; Fig. 
5.22). In order to ensure accurate and complete data retrieval, the denaturation and extension 
cycle number was increased from 40 to 60 cycles (Table 5.8; Fig. 5.23).  
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Table 5.7 Ct values corresponding to the RT-qPCR amplification plot shown in Fig. 5.22 
following 40 cycle RT-qPCR of samples of one participant, eNOS endothelial nitric oxide 
synthase; VEGFR-2 vascular endothelial growth factor receptor-2; RPII ribosomal protein-II. 
Gene of interest Gene of interest Ct RPII Ct 
eNOS 28.07 39.34 
 29.95 No Ct 
 28.52 No Ct 
VEGFR-2 53.99 39.34 
 35.51 No Ct 
 35.69 No Ct 
 
 
Figure 5.22 RT-qPCR amplification curve following a 40 cycle protocol amplified with RPII, 
eNOS and VEGFR-2 primers. 
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Table 5.8 Ct values corresponding to the RT-qPCR amplification plot shown in Fig. 5.23 
following 60 cycle RT-qPCR of samples of one participant, eNOS endothelial nitric oxide 
synthase; VEGFR-2 vascular endothelial growth factor receptor-2; RPII ribosomal protein-II. 
Gene of interest Gene of interest Ct RPII Ct 
eNOS 27.75 44.42 
 27.81 46.02 
 27.49 46.46 
VEGFR-2 37.61 51.09 
 34.2 44.61 
 48.46 42.1 
 
 
Figure 5.23 RT-qPCR amplification curve following a 60 cycle protocol amplified with RPII, 
eNOS and VEGFR-2 primers.  
 
Although expression of eNOS and VEGFR-2 provided both inter- and intra-sample 
reliability, expression levels of RPII were highly variable between samples, possibly due to the 
121 
 
low template amount. Due to the variability in RPII and the unsuitability of other housekeepers, 
specifically glyceraldehyde-3-phosphate dehydrogenase (GAPDH) owing to its relationship 
with endothelial function (Khan, Choong, Du and Jovanović, 2013), absolute quantification of 
mRNA levels was subsequently undertaken. This removed the requirement of a housekeeping 
gene and allowed for direct comparison of expression between samples.  
Serial dilutions of standard were prepared to cover the expected quantification range 
within samples using the undiluted stock RNA as the top standard. A 5-point 5 fold serial 
diluted standard curve was prepared. Unknown samples were run for eNOS against the 
standard curve such that the PCR system could determine the respective starting quantity per 
sample. An accurate standard curve was obtained for eNOS expression with the desired 
efficiency (-3.23 representing an efficiency of 1) (Fig. 5.24). Standard number 5 was removed 
from the standard curve due to the absence of a Ct, likely due to the high dilution of the sample. 
 
 
Figure 5.24 Graphical representation of a linear regression analysis of the eNOS standard 
curve generated from PCR product displaying standard samples (closed circles) and unknown 
samples (open triangles). 
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Gene copy number was calculated for each standard using the following equation: 
𝐶𝑜𝑝𝑦 𝑛𝑢𝑚𝑏𝑒𝑟 =
𝐶 × 10−9
(𝑇 × 340)
 × 6.022 × 1023  
Where C is the starting concentration of the standard (ng / µl); T is the product base pair length 
and 340 is equivalent to the average molecular weight of one ribo base in Daltons. The starting 
quantities of each initial sample could subsequently be determined via extrapolation from the 
standard curve using sample Ct values (sample A: 33,622 ± 159 copies / ng RNA; sample B: 
20,331 ± 1459 copies / ng RNA) (Table 5.9). 
 
Table 5.9 Ct and copy numbers of eNOS for samples obtained from 2 patients used as proof 
of concept of absolute RT-qPCR 
Sample number eNOS Ct eNOS copy number 
1 27.57 33,656 
 27.57 33,449 
 27.56 33,760 
2 29.28 19,842 
 29.39 19,179 
 28.95 21,972 
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5.7 Application of analytical techniques 
Several errors were evident following the process of improvement of the endovascular biopsy 
technique that warrant noting. Although CD31 identification was deemed unsuccessful in 
HUVEC, there was an apparent lack of primary antibody optimisation despite manipulation of 
secondary antibody incubation protocols. Manipulation of primary antibody incubation may 
have resulted in positive CD31 identification in HUVEC. Further, the limited light microscopy 
imaging and absence of available confocal microscopy techniques for the current improvement 
methods prevented detailed quantification and localisation of proteins within EC. Additionally, 
a successful multiple staining protocol could not be established. Antibodies raised in alternative 
hosts were not selected (primary and secondary antibodies were raised in rabbit), which may 
have reduced the observation of non-specific binding and rendered the protocol successful. 
Nonetheless, following the successful execution of EC harvesting, subsequent sample 
processing and the improvement of analysis via both immunocytochemistry and gene 
expression of these cells, the endovascular biopsy was deemed a successful technique for the 
investigation of EC characteristics. This provided the basis for future investigation into the 
cellular characteristics of specific populations with known vascular dysfunction or indeed 
adaptation to exercise interventions. 
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Chapter 6 - The use of a novel endovascular biopsy technique to quantify 
gene expression in a clinical population: proof of concept 
6.1 Introduction 
Endothelial dysfunction plays a primary role in the development of CVD (Ross, 1993). In 
healthy vessels, the endothelium is involved in modulating vascular tone and exhibits 
antiatherogenic properties via the release of numerous vasoactive and vasculotropic factors, 
where the quiescent EC express a vasodilatory and anticoagulant phenotype. Perturbations in 
EC function e.g. injury to cells from oxidative stress stimulates a cascade of events, increasing 
adherence and infiltration of EC and the surrounding vascular wall, culminating in the 
formation of foam cells and the development of atherosclerotic plaque (Quyyumi, 1998). The 
highly influential role of the endothelium in health (Quyyumi, 1998) and vascular adaptation 
(Green et al., 2004; Tinken et al., 2010) suggests it as an area of great investigative importance 
in clinical research, one which is currently largely untapped for its therapeutic potential due to 
the difficulties in accessing the endothelium. Given the highly invasive nature of arterial 
endothelial sampling, ex vivo work has previously been performed in vitro and in animal 
models. However, a recent history spanning 15 years has introduced a method of harvesting 
EC from human arteries thus allowing investigation of endothelial health at a cellular and 
molecular level.   
 Originally developed in 1999 (Feng et al.), the endovascular biopsy technique offers a 
novel and viable method of extracting EC from intact vasculature with the aim of direct analysis 
of endothelial health at a cellular level. The original work documented the process of inserting 
a stainless steel guidewire in to the iliac artery of patients undergoing endovascular surgery, 
interrupting the lining of the vessels and the subsequent ex vivo analysis of extracted EC. Since 
the establishment of this work, only a few groups have developed the technique and provided 
data in various cohorts of known vascular dysfunction e.g. in ageing, obesity and coronary 
heart failure (Colombo et al., 2002; Donato et al., 2007; Donato et al., 2008; Jelic and Le Jemtel, 
2008). Advancements have been made in the EC yield, increasing the number of viable EC 
from approximately 200 (Feng et al., 1999) to 1000 (Colombo et al., 2002) whilst qPCR is 
performed to determine gene expression (Onat et al., 2007) in addition to 
immunocytochemistry. The use of this technique has subsequently been validated (chapter 5) 
resulting in an increase yield to 2000 following EC isolation and both protein and gene 
expression analysis performed. Groups have utilised this technique in both forearm arteries 
(Feng et al., 1999; Donato et al., 2007) and veins (Onat et al., 2007) and evidence suggests that 
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there is a strong correlation between the expression of some genes, such as NF-kB and COX-
2 between arterial and venous EC, but not in others such as eNOS (Colombo et al., 2002). 
Given that endothelial function (and hence dysfunction) is typically measured indirectly by 
FMD in the conduit arteries, this lack of arterio-venous correlation of eNOS, the key enzyme 
involved in dilation through the synthesis of NO release (Moncada et al., 1988) highlights the 
requirement for arterial sampling of EC when investigating a range of genes.  
Recently, the pioneers of the endovascular biopsy technique have provided evidence 
from the ex vivo harvesting of EC from the aortas of patients with T2DM which suggests 
induction of RAGE (Feng et al., 2005). In its perpetuation, RAGE results in chronic 
inflammation (Sessa et al., 2014) and in conjunction the observed association with MCP-1, this 
provided novel molecular evidence of vascular inflammation with T2DM from intact vessels. 
Despite diabetes affecting more than 220 million people worldwide (Setacci, De Donato, 
Setacci  and Chisci, 2009) and CVD being the main cause of death in those with T2DM (Rydén 
et al., 2007), few studies have taken advantage of the ability to harvest EC from a diabetic 
population to assess the expression of genes and proteins relevant to the clinical development 
of vascular dysfunction, especially in conduit arteries. In vivo research has identified increased 
arterial stiffness in those with T2DM (Ravikumar, Deepa, Shanthirani and Mohan, 2002; 
Rydén et al., 2007) whilst endothelial dysfunction has also been demonstrated in the vessels of 
these patients (Schalkwijk and Stehouwer, 2005). The underlying mechanisms behind the 
development of endothelial dysfunction with T2DM currently lack substantial elucidation. 
Endothelial dysfunction is primarily a result of a lack of NO bioavailability (Cai and 
Harrison, 2000), which may be caused from excessive degradation of NO or reduction in the 
activity of eNOS, the enzyme responsible for the conversion of L-arginine to NO in the 
vasculature. Although little is known about endothelial dysfunction attributed to 
hyperglycaemia, continued exposure to high glucose actually results in an upregulation of 
eNOS in cultured human aortic EC (Cosentino, Hishikawa, Katusic and Lüscher, 1997), 
suggesting that dysfunction with diabetes may be attributable to the degradation of NO as 
opposed to diminished eNOS expression. As yet, no studies have been conducted in humans 
investigating the expression of eNOS in the intact vasculature in diabetics compared with their 
healthy counterparts, despite the implications for future potential therapeutic targets. 
Consequently, this study aimed to assess the viability and reliability of the endovascular 
biopsy technique in a cross sectional population, specifically individuals with known T2DM 
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as compared with non-diabetic controls, in order to provide preliminary biopsy proof of 
concept data. The former group served as a cohort of clinical significance, who exhibit 
previously established endothelial dysfunction. Further, this study aimed to determine the 
ability of the endovascular biopsy technique to detect potential differences in expression of 
genes and proteins of interest to vascular health, specifically eNOS, between a T2DM 
population and their non-diabetic counterparts.  
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6.2 Methods 
6.2.1 Participants 
Patients were randomly selected from individuals undergoing PCI between July 2013 and July 
2014 and aged between 30 and 65 years. Of a total of 11 patients presenting with symptomatic 
cardiac abnormalities, 5 exhibited known T2DM (T2DM); the control group of 6 patients were 
non-diabetic (CON). All patients provided informed consent under the BRICCS database 
(University Hospital Leicester) and the specific removal of EC had been further approved by 
the review board. 
 
6.2.2 EC collection 
Stainless steel guidewires were used to extract EC from the brachial artery as previously 
described (5.3). Briefly, one 3 mm J-shaped endovascular guidewire was inserted in to the 
radial artery via an angiocatheter. The guidewire was advanced for approximately 10 cm and 
subjected to a repeated forward and backward movement to extricate EC from the arterial lining. 
Immediately following removal from the artery, tips of guidewires were removed and washed 
in a tube containing EC dissociation buffer (0.5% BSA, 2 mmol/L EDTA, 100 μg/mL heparin 
in Ca2+- and magnesium-free PBS.  
 
6.2.3 Endothelial cell purification 
After centrifugation and removal of dissociation buffer, samples were washed three times in 
PBS and processed as previously described (5.3.2; 5.6). Briefly, EC were purified by red cell 
lysis with NaCl. If cells were destined for immunohistochemistry, they were fixed with 3.7% 
paraformaldehyde on to poly-l-lysine coated slides and following incubation for 5 hours at 
37ºC, were stored at -80ºC until analysis. Those cells destined for RT-qPCR were resuspended 
in PBS and stored at -80ºC until analysis. 
 
6.2.4 Immunocytochemistry 
Cells were rehydrated in PBS and simultaneously rendered permeable with 0.2% triton. Non-
specific binding sites were blocked with PBS-1% BSA solution for 1 hour before 
immunocytochemical analysis was performed as previously described (5.4). Briefly, cells were 
incubated with primary antibodies against CD31 (Abcam, UK) or eNOS (Abcam, UK), 
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followed by goat anti-rabbit IgG conjugated to Chromeo-488antibody (Abcam, UK) and finally 
DAPI to stain for nuclear contents. Antibodies had previously been tested with a HUVEC cell 
line to generate negative control images (5.4). Slides were mounted with Mowiol, stored at 4ºC 
and protected from light until analysis. Analysis was performed using a Leica DM2500 bright 
field microscope (Leica DM2500 fluorescent microscope, Leica Microsystems Ltd, 
Switzerland), set at constant exposure settings to minimise background and improve image 
quality. Total cell number was determined by EC morphology and positive CD31 
immunofluorescence. Mean pixel intensity was determined for eNOS immunofluorescence 
using image processing software software (Image J, http://imagej.nih.gov/ij/ V1.46). A single 
investigator analysed all samples and was blinded to subject identity prior to the full 
immunocytochemistry and quantification protocol. 
 
6.2.5 RT-qPCR 
Total RNA was extracted using RNeasy micro kit (Qiagen, Crawley, UK) and one-step 
quantitative PCR was used to quantify expression of eNOS mRNA levels in cell samples as 
described previously (5.6.2) with the following modifications: relative RNA was quantified 
fluorometrically in triplicate (5 ng of RNA in a total reaction volume of 5 µl) using QuantiFast 
SYBER Green one step RT-PCR Kit (Qiagen) on a ViiA 7 Real-Time PCR System (Applied 
Biosystems, Life Technologies, UK) as follows: one cycle at 50°C for 10 minutes [RT] and 
95°C for 5 minutes (PCR initial activation step), 60 cycles of denaturation at 95°C for 10 
seconds and annealing/extension at 60°C for 30 seconds. Dissociation / melting curve analysis 
was performed on completion to confirm reaction specificity (Appendix D). Absolute 
quantification was conducted by creating a standard curve for eNOS using 1 in 4 dilutions, the 
top standard being undiluted stock RNA. The starting quantities of each initial unknown sample 
were determined via extrapolation from the standard curve using the Ct values at linearity. 
Gene copy number was subsequently calculated for each standard using the following equation: 
𝐶𝑜𝑝𝑦 𝑛𝑢𝑚𝑏𝑒𝑟 =
𝐶 × 10−9
(𝑇 × 340)
 × 6.022 × 1023  
Where C is the starting concentration of the standard (ng / µl); T is the product base pair length 
and 340 is equivalent to the average molecular weight of one ribo base in Daltons.  
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6.2.6 Statistical analysis 
A Shapiro-Wilk test was used to confirm normal distribution and a Mauchley test of sphericity 
to verify homogeneity of variance. Independent t-tests were conducted to compare the 
differences between the two groups. To determine the magnitude of differences between groups, 
effect sizes were calculated based on the standardised mean difference between the two groups. 
All data are presented as mean ± standard deviation (SD) and significance was accepted as P 
< 0.05. 
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6.3 Results 
6.3.1 EC extraction 
EC were successfully extracted from the brachial arteries of participants and a greater number 
obtained per guidewire from CON than T2DM (6819 ± 6266 and 4654 ± 2944 cells, 
respectively; P = 0.021) as determined by positive CD31 immunofluorescence (Fig. 6.1).  
 
     
a.                                                                  b.  
Figure 6.1 Representative immunofluorescent images for CD31 obtained from non-diabetic 
(CON) (a) and diabetic (T2DM) (b) groups taken at 20x magnification. Blue represents DAPI; 
green represents CD31. Scale bar represents 50 µm. 
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6.3.2 EC eNOS protein expression 
Mean eNOS pixel intensity was not different between groups (67 ± 34 vs. 93 ± 28 in CON and 
T2DM, respectively; P > 0.05), but exhibited an effect size of 0.83 for T2DM vs. CON (Fig. 
6.2), suggesting 79% of CON would have eNOS protein expression below the average 
expression of T2DM. 
 
 
      
 
 
Figure 6.2  Mean EC pixel intensity of endothelial nitric oxide synthase (eNOS) in non-
diabetic (CON) (closed bar) and diabetic (T2DM) (open bar) groups and representative 
immunofluorescent images taken at 100x magnification (P > 0.05). Green represents eNOS. 
Values are mean ± SD. Scale bar represents 50 µm. 
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6.3.3 EC eNOS mRNA expression 
A standard curve was obtained for eNOS (Fig. 6.3) and provided an efficiency of -3.11 and r2 
value of 0.98. 
 
 
Figure 6.3 Standard curve generated from PCR showing the Ct and endothelial nitric oxide 
synthase (eNOS) copy numbers of serially diluted standards (closed circles) and copy numbers 
of CON (closed triangles) and T2DM (open triangles) using Ct values at linearity (r2 = 0.98, m 
= -3.12, C = 60.262). 
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eNOS copy number was not different between groups (23,611 ± 16,266 vs. 27,918 ± 
16,682 copies / ng RNA in CON and T2DM, respectively; P > 0.05) (Table 6.1), but exhibited 
an effect size of 0.26 for T2DM vs. CON (Fig. 6.4), suggesting 60% of CON would have eNOS 
gene expression below the average expression of T2DM. 
 
Table 6.1 Mean Ct and copy numbers of eNOS for diabetic (T2DM) and non-diabetic (CON) 
samples obtained in triplicate 
Group eNOS Ct eNOS copy number 
T2DM 26.31 55,397 
 29.78 18,160 
 28.19 30,287 
 29.73 18,443 
 29.93 17,305 
CON 31.76 9,590 
 32.29 8,081 
 27.64 36,137 
 26.60 50,398 
 29.08 22,710 
 30.42 14,753 
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Figure 6.4 Mean copy number / ng total RNA of endothelial nitric oxide synthase (eNOS) in 
non-diabetic (CON) (closed bar) and diabetic (T2DM) (open bar) groups (P > 0.05). Values 
are mean ± SD. 
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6.4 Discussion 
This study provides proof of concept observations that the endovascular biopsy technique can 
be implemented to extract EC from the surface of the conduit arteries and that these cells can 
be subjected to successful isolation and molecular analysis. In particular, extracted EC can be 
investigated to identify variations in EC gene and protein expression in a clinical population. 
Specifically, eNOS gene expression tends to be enhanced in a small group of diabetic patients 
undergoing PCI for symptoms of cardiac abnormality compared to non-diabetic PCI patients. 
This trend is mirrored and slightly augmented for eNOS protein expression.  
Although we did not assess endothelial function directly (i.e. FMD), the diabetic 
participants in the present study exhibited cardiac abnormalities of sufficient magnitude to 
warrant PCI and therefore present as a group that exhibit expected endothelial dysfunction of 
the coronary or peripheral vascular system. Indeed, diabetic patients have previously been 
identified as a group with established endothelial dysfunction (FMD of 5.0 ± 3.7% vs. 9.3 ± 
3.8% in diabetic and control subjects, respectively) (Clarkson et al., 1996; De Vriese, 
Verbeuren, Van de Voorde, Lameire and Vanhoute, 2000). Therefore, it may be hypothesised 
that T2DM patients would express differential levels of genes and proteins of interest to 
vascular health, the primary of which being eNOS given its role in the synthesis of NO, the 
predominant vasodilator released by the endothelium. Although not significant, the large effect 
size in eNOS expression (0.83) suggests that a minimum of 79% of non-diabetics would exhibit 
eNOS protein expression below the average diabetic participant. Further, despite a relatively 
lower effect size of diabetes on gene expression (0.26), this nonetheless mirrors the trend in 
protein expression and suggests a minimum of 60% of non-diabetics would exhibit a reduced 
eNOS gene expression compared to the average diabetic. It is probable that this up-regulation 
of eNOS, albeit slight, represents a compensatory mechanism and although not measured in 
the present study, likely presents alongside a reduction in NO bioavailability (Li, Wallerath, 
Münzel and Föstermann., 2002). However, due to the small number of participants included in 
the present study and apparent effect sizes, it is fair to speculate that should participant number 
and hence statistical power be increased that this trend may become increasingly apparent.  
 In support of the current findings, the aortas of diabetic rats exhibit a 3-fold 
augmentation of eNOS despite a reduction in NO bioavailability (Hink et al., 2001). 
Additionally, animal models have provided evidence of an unchanged or augmented eNOS 
expression in atherosclerosis (Kanazawa et al., 1996) whilst eNOS mRNA expression appears 
to be indifferent between diabetic and non-diabetic rat hearts (Felaco et al., 2001). Additionally, 
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prolonged exposure to hyperglycaemia in cultured human aortic EC increases eNOS gene and 
protein expression and conversely to animal studies, subsequent NO release (Cosentino et al., 
1997). Interestingly, brachial artery EC eNOS protein expression has a tendency to increase in 
older people when extracted using the endovascular biopsy technique whilst a lower FMD is 
concurrently observed, despite a lack of relationship between eNOS and FMD (Donato et al., 
2009). The latter is one of few studies that provides direct evidence of arterial EC eNOS 
expression and simultaneous in vivo functional measurements and suggests the manifestation 
of a compensatory mechanism of eNOS with a reduction in endothelial function, a relationship 
that may indeed be speculated in the present study. 
The trend in eNOS expression with vascular dysfunction as indicated in the present 
study and the supporting research is likely due a hydrogen peroxide (H2O2)-induced increase  
(Förstermann and Münzel, 2006), production of which is augmented in vascular disease states 
(Drummond, Cai, Davis, Ramasamy and Harrison, 2000). Conversely, the upregulation of 
reactive oxygen species in diabetes (Hink et al., 2001) may provide a possible explanation for 
the reduction in endothelial function in this population due to the scavenging of NO to form 
peroxynitrite (ONOO-) which leads to eNOS uncoupling and dysfunction (Förstermann and 
Münzel, 2006).  Further, pathological conditions such as diabetes with the associated oxidative 
stress, results in excessive depletion of cofactor for eNOS BH4, uncoupling the enzyme and 
rendering it dysfunctional, subsequently reducing NO production (Li et al., 2002). Research 
surrounding the differences in expression has previously been limited to animals and cell 
culture models. Due to the multifactorial stimuli involved in the development of endothelial 
dysfunction and atherosclerosis, such models cannot provide an environment wholly matched 
to the conditions experienced in vivo in humans. Indeed, changes in eNOS gene expression 
previously reported appear to vary according to the models utilised. This study extracted EC 
from a peripheral conduit artery and appears to support previous in vitro work. 
The successful harvesting of EC using a similar method has previously been reported 
in various clinical populations (Colombo et al., 2002; Donato et al., 2007; Feng et al., 1999; 
Silver et al., 2007). The extraction method utilised in the present study appeared to harvest a 
greater yield of EC per guidewire (~4000) as compared to previous research, with numbers 
previously ranging from approximately 250 (Feng et al, 1999) to 1000 (Colombo et al., 2002) 
cells. This is likely to be a result of differences in post-harvest processing, mainly EC 
purification methods. The number of cells successfully extracted from diabetic patients was 
lower than that from non-diabetics in the present study which has not previously been reported, 
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although there was a large variation in cell number. The difference between groups may be an 
artefact of the variation between samples or there may be a pathophysiological explanation 
such that EC viability may be reduced in diabetics, reducing the potential for positive CD31 
immunocytochemical identification. Indeed, it has been demonstrated in cultured human EC 
that high glucose concentrations accelerate cell death and decrease replication (Lorenzi, 
Cagliero and Toledo, 1985). Further, the number of EPC (bone marrow-derived circulating 
stem cells required for EC maintenance and repair) obtained from diabetic patients is lower 
than from control patients whilst their function is also impaired (Loomans et al., 2004). The 
current data appears to confirm a degree of difference in viable EC numbers obtained from 
diabetics compared with non-diabetics and suggests potential endothelial damage in diabetic 
patients but due to the novel nature of this work, this is somewhat speculative and requires 
further research. 
Limitations 
One limitation of this study is the small sample size. Indeed, the presence of moderate to large 
effect sizes despite a lack of statistical significance suggests the requirement for a larger pool 
of participants. Additionally, although EC yield was enhanced compared to previous 
observations, the relatively small number of EC extracted from each guidewire resulted in 
larger than expected standard deviations within each variable, thus it would be of benefit to 
increase cell yield via multiple extractions. However, both the comfort of the participant and 
the effect of wall disturbance on EC properties would require consideration given the increased 
risk of the occurrence of coronary artery dissection, spasm or thrombus formation.  
EC were extracted from the brachial artery rather than the coronary vasculature which 
may not be entirely comparable to the expression evident in the coronary vessels (Sumpio et 
al., 2002), but nonetheless provide a basis for comparison between clinically relevant groups. 
EC from the coronary arteries and pre-inflation coronary balloons were indeed collected from 
patients during this research but examination of these cells was beyond the scope of this thesis. 
Unfortunately, anthropometrical and additional medical information was not collected 
for the participants and given that both diabetics and non-diabetics presented with some form 
of cardiac abnormalities, the possibility that these additional factors may have resulted in the 
observed trends cannot be excluded. Additionally, no in vivo measurements of endothelial 
function (FMD) were obtained, preventing a comparison between the EC observations and 
whole body physiological parameters of vascular health status, subsequently reducing the 
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clinical impact. Attempts have been made to provide an association between FMD and EC 
parameters in this manner, whereby a correlation was observed between endothelial oxidative 
stress and FMD in healthy males (Gurovich, Avery, Holtgrieve and Braith, 2014). However, 
this association was only evident when FMD was corrected for SRAUC, a disupted normalisation 
method (Atkinson et al., 2009). Further, EC were obtained from venous rather than arterial 
samples, presenting additional caveats given the physiological variations between arterial and 
venous EC (Colombo et al., 2002), the environmental haemodynamic differences between 
locations and the arterial in vivo measurments. 
The present study demonstrates an opportunity to employ the endovascular biopsy 
technique in clinical populations to aid in the elucidation of the mechanisms underlying 
endothelial dysfunction in these groups. Further work is required to assess additional proteins 
of interest to vascular health in larger cohorts, whilst also validating the use of peripheral 
vascular EC as a surrogate for the coronary vasculature. Additionally, it would be beneficial to 
correlate these molecular markers with in vivo measures of endothelial function (e.g. FMD). 
This endovascular biopsy technique has been validated for use in future research and 
providespotential to explore possible therapeutic targets in the treatment of endothelial 
dysfunction. 
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Chapter 7 - General discussion 
7.1 Key findings 
This thesis investigated vascular adaptations resulting from exercise and from the manipulation 
of the potential contributing stimuli. The methodology utilised 2D Doppler ultrasound and 
strain gauge plethysmography to determine characteristics throughout the vascular tree and 
involved the development of a novel endovascular biopsy technique to allow for the in situ 
extraction of vascular EC for analysis at the cellular and molecular level. Chapter 3 assessed 
adaptation of the forearm vascular hierarchy in a group of participants that perform regular 
chronic intermittent isometric training (i.e. rock climbers). To establish the role of various 
contributing factors to brachial artery adaptations with training, chapter 4 utilised IPC to assess 
the role of ischaemia / reperfusion (i.e. shear stress) to brachial artery adaptations over 8 weeks. 
In order to provide a cellular and molecular insight in to the role of EC for vascular adaptation, 
chapter 5 developed the endovascular biopsy technique to determine the viability of harvesting 
EC from the intact vasculature. Finally, chapter 6 determined the applicability of utilising the 
endovascular biopsy technique in cross-sectional investigations by providing an insight in to 
the EC molecular biology in a clinical population with expected endothelial dysfunction. The 
main findings of these studies are summarised below: 
1. A transient trend for conduit artery functional adaptation occurs as a result of repeated 
exposure to shear stress (chapter 4) and measures comparable to baseline or control 
levels following 8 weeks of exposure (chapters 3, 4). This effect is evident both locally 
and systemically (chapter 4) and is significant when controlled for baseline artery 
diameter. Conversely, conduit artery structural adaptation occurs only in the presence 
of exercise training (chapters 3, 4) and is absent in response to repeated shear stress 
alone.  
2. Vascular EC can be successfully extracted from intact arteries (chapters 5, 6) and are 
of a necessary quantity and quality to conduct immunocytochemical analysis, whilst 
containing sufficient mRNA quality and quantity to conduct RT-qPCR analysis of gene 
expression. 
3. EC extracted utilising the endovascular biopsy technique can provide novel cross-
sectional data that those with expected deviations from the norm in endothelial function 
may exhibit variations in EC molecular properties compared with controls (chapter 6). 
Specifically, diabetics exhibit a trend for increased expression of eNOS mRNA and 
protein in the brachial artery compared to non-diabetics. 
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7.2 Mediators of vascular adaptations to exercise 
The predominant stimuli implicated in vascular adaptation with exercise are haemodynamic 
mechanical (shear and circumferential stress) and chemical signals (metabolites released from 
contracting muscle, hypoxia, cytokines) (Whyte and Laughlin, 2010). This thesis investigated 
the long-term adaptations in rock climbers (chapter 3), the forearms of who are regularly 
exposed to intermittent ischaemia and isometric contraction (Macleod et al., 2007; Sadamoto 
et al., 1983). These factors were further investigated longitudinally via application of IPC 
(chapter 4). Due to the lack of non-invasive methodologies available, this thesis did not 
investigate the specific underlying mechanisms with exercise, therefore can only speculate as 
to the molecular stimuli to adaptation. 
 
7.2.1 Haemodynamic stimuli 
Shear stress is the mechanical stress resulting from blood flow through a vessel, whilst 
circumferential stress occurs as a result of blood pressure variation and subsequent vasodilation 
of the arterial walls. The pattern of brachial artery functional adaptations observed in this thesis, 
specifically a lack of enhancement in well-trained cohorts as compared to a trend for a transient 
increase following the onset of an IPC intervention (chapters 3, 4) provides additional support 
to the concept of a time course of adaptation as originally proposed by Laughlin (1995). 
Although this time course was originally defined based on changes observed with exercise, the 
observations in chapter 4 of a transient increase in function following 6 weeks of IPC provides 
additional data that functional adaptations in response to prolonged exposure to shear stress 
may follow a similar time course, albeit somewhat delayed. This trend also supports previous 
observations following chronic shear stress exposure with local heating (Green et al., 2010; 
Naylor et al., 2011). Conversely, despite an observed brachial artery structural enhancement in 
rock climbers (chapter 3) in accordance with the athlete’s artery hypothesis (Green et al., 2012), 
no structural adaptation was observed with an IPC intervention (chapter 4), supplementing 
previous observations of an absence of rest diameter enhancement with IPC (Jones et al., 
2014b). 
Exercise is known to cause acute variations in the magnitude of shear stress experienced 
by the vasculature (Thijssen et al., 2009a) whilst IPC offers the ability to determine the effects 
of shear stress in the absence of the metabolic confounders induced with exercise. Although 
not significant unless controlled for baseline diameter, the trend for a transient increase in FMD 
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of the brachial artery in both the intervention and control arm with IPC (15.9% increase at week 
6) provides additional support to previous observations that shear stress is instrumental in the 
enhancement of vascular function with exercise (Tinken et al., 2010; Tuttle et al., 2001). 
Further, it provides evidence that both local and systemic endothelial function is improved with 
repeated intermittent exposure to shear stress. This adds to previous observations of local and 
remote functional enhancement following daily IPC of the arm for 7 days (Jones et al., 2014a) 
and of local enhancement following 2 weeks of thrice weekly IPC (Jones et al., 2014b). Further, 
this work supplements previous methodologies of limb occlusion (to inhibit shear) (Tinken et 
al., 2010) and local limb heating (to induce shear) (Green et al., 2010; Naylor et al., 2011) in 
defining the crucial role for this tangential stress in the functional adaptation of conduit arteries. 
In comparison to the latter shear rate manipulation-induced steady enhancement in function up 
to 8 weeks, this thesis identified a transient increase more comparable to that witnessed with 
exercise training.  
Shear stress likely contributes to the adaptation of the conduit arteries via its detection 
by the vascular EC lining and the subsequent phosphorylation and activation of eNOS, 
increasing NO bioactivity (Fisslthaler et al., 2000). Additionally, shear stress may upregulate 
AMPK via Ca2+-CaMMKβ and Akt pathways (Zhang et al., 2006; Zhang et al., 2009), resulting 
in the subsequent upregulation of eNOS and VEGF. Shear may also act to increase VEGFR-2 
(Jin et al., 2003), MMPs (Prior et al., 2004) and vascular progenitor cells (Balligand et al., 
2009). Thus, shear stress influences numerous potential pathways which may contribute to 
vascular adaptation, hence why it has been suggested as the predominant stimulus for 
adaptation with exercise (Laughlin et al., 2008; Tinken et al., 2010; Newcomer et al., 2011). 
Whilst it would have been beneficial to determine the specific molecular signals responsible 
for the shear stress response, the timescale of endovascular biopsy development and 
improvement did not allow for this within the current thesis. 
The transient increase in peak reactive hyperaemic blood flow with IPC (chapter 4) 
supports the notion that shear stress stimulates resistance vessel adaptation, in line with 
previous observations (Tinken et al., 2010; Tuttle et al., 2001). Interestingly and unlike with 
exercise, the return to baseline in resistance vessel properties following 8 weeks of IPC 
suggests the requirement for additional stimuli to maintain the enhancement in resistance vessel 
capacity. It is plausible that, similar to the IPC effect on the conduit vessel, a functional 
improvement occurred in response to the intervention but that the stimulus was insufficient to 
promote any structural adaptations, as opposed to the resistance vessel structural improvements 
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possible in climbers, given the observed enhancement in peak reactive hyperaemic blood flow 
(chapter 3).  Peak blood flow however, does not distinguish between the functional and 
structural characteristics of resistance vessels and is merely a function of resistance vessel cross 
sectional area (Naylor et al., 2005), thus this thesis can only speculate regarding this theory. 
 
7.2.2 Chemical stimuli 
Hypoxia and metabolism 
The brachial artery structural adaptation observed with exercise training and absence of which 
with IPC alone suggests the involvement of additional factors to shear stress in the structural 
enlargement of conduit arteries. Indeed, both hypoxia and metabolic stimuli have been 
implicated in the adaptation of vessels to exercise, the former predominantly relating to 
resistance vessels and the microvasculature (Forsythe et al., 1996). It is likely that the forearms 
of rock climbers are subjected to a prevalence of ischaemia due to the predominance of 
sustained isometric contractions (Sadamoto et al., 1983) and that the continued exposure to 
hypoxic conditions contributed to the relatively greater resting, peak and maximal (11.8, 11.7, 
15.3%, respectively) brachial artery diameters in climbers compared to controls in chapter 3.  
However, although in vitro work has simulated reductions in oxygen tension and 
observed an upregulation of VEGFR-2 and eNOS (Resnick, Einav, Chen-Konak, Zilberman, 
Yahav and Shay-Salit, 2003), whilst also stimulating an increase in circulating EPCs (Laufs et 
al., 2004), animal models dispute the relevance of such observations in relation to humans. 
Specifically, the role of hypoxia in arteriogenesis is refuted and observations that arteriogenesis 
occurs in non-hypoxic tissue (Buschmann and Schaper, 1999) contribute to this argument. 
Indeed, an absence of VEGF expression is observed in vessels following femoral artery 
occlusion in a rabbit model of collateral artery growth, despite an increase in vessel diameter 
(Deindl et al., 2001). Thus the structural adaptation of the conduit artery in rock climbers was 
unlikely stimulated by the hypoxia. This may also in part explain the minimal differences that 
were observed in the longitudinal characteristics of the brachial artery between proximal and 
distal cuff placements with IPC (chapter 5). Cuff placement in this manner theoretically 
manipulates the degree of oxygen saturation experienced by the brachial artery (proximal cuff 
placement induced hypoxia to the downstream artery) and the few differences between 
placements suggests that the role played by hypoxia may not be highly influential in the 
functional and structural adaptation of the conduit vessels with exercise training.  
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The greater peak reactive hyperaemic blood flow both in climbers compared with 
controls (chapter 3) and transient increase following 4 weeks of IPC (chapter 4) is a function 
of augmentation in resistance vessel cross-sectional area (Naylor et al., 2005). The transient 
increase in peak reactive hyperaemic blood flow with IPC but sustained enhancement in 
climbers vs. controls suggests the requirement of the additional confounders associated with 
exercise in the continued augmentation in resistance vessel properties. Adaptation of the 
resistance vessels can occur with local tissue hypoxia via augmentation of HIF-1 (Forsythe et 
al., 1996) and  a resultant upregulation in the transcription of VEGF mRNA,  protein levels and 
its receptors (VEGFR-1/VEGFR-2) (Semenza, 2007). It may also result from an increase in 
EPCs (Sandri et al., 2011) which home to sites of ischaemic tissue and differentiate in to EC 
(Urbich and Dimmeler, 2004), although this does not explain the systemic effect with IPC 
given the localisation of the ischaemic stimulus during the intervention. Further, the enhanced 
capillary filtration capacity in climbers may have been stimulated by reductions on oxygen 
tension in the forearm. Indeed, hypoxia has been implicated in angiogenesis via the induction 
of HIF-1α (Krock, Skuli and Simon, 2011) which can induce expression of VEGF and its 
receptors (VEGFR-1, VEGFR-2) (Carmeliet, 2000). 
Additionally, the metabolic factors released from contracting muscle with exercise 
(adenosine, K+, lactate, CO2, ATP) have previously been implicated in adaptation. The conduit 
vessel remodelling in exercise trained climbers (chapter 3) suggests that the factors released 
from contracting muscle may be required for conduit vessel structural adaptation. The lack of 
structural enhancement with IPC training (chapter 4) provides further indication of this, 
however their potential role can only be speculated based on previous research.  
The role of AMPK in adaptation of the vasculature is becoming increasingly apparent, 
acting via its phosphorylation of eNOS at Ser1177 (Morrow et al., 2003). The metabolic cost of 
muscle contraction with exercise leads to an increase in the AMP-to-ATP ratio and subsequent 
activation of AMPK, likely occurring concurrently with a shear stress-induced Ca2+-CaMKKβ 
AMPK activation (Zhang et al., 2006). Indeed, the metabolic activation of AMPK may in part 
explain the observed structural adaptation of the brachial artery in climbers (chapter 3) but 
absence of any remodelling with IPC alone (chapter 4). Additional to its activation of eNOS 
(Chen et al., 1999), AMPK also acts to upregulate VEGF via the induction of PCG-1α (Leick 
et al., 2009).  This thesis provides additional support that the upregulation of AMPK may be 
instrumental in promoting remodelling of the conduit arteries, potentially through both eNOS 
and VEGF upregulation. 
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The close proximity of resistance vessels to the contracting muscle with exercise may 
have contributed to the sustained augmentation in resistance vessel capacity in climbers as 
compared with the transient adaptation as observed with IPC. Previous observations with shear-
induced increases in blood flow observed minimal difference in peak reactive hyperaemic 
blood flow (Naylor et al., 2011), suggesting that additional factors with exercise are required 
for adaptation. This thesis partially supports this data in that although adaptation was observed, 
this returned to baseline by 8 weeks of IPC but remained greater than controls in climbers. 
However, in contrast to the latter study IPC promoted a transient increase in resistance vessel 
function and / or structure.  
In vivo work alone is insufficient to provide a definitive mechanism underlying the 
observed adaptations with both exercise training and IPC. Based on the observations within 
this thesis and from previous research, potential mechanisms have been postulated. 
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7.3 Applicability of the endovascular biopsy technique  
Although the stimuli responsible for the evident vascular adaptations with exercise have been 
investigated both within this thesis and elsewhere, they can ultimately at best be speculated due 
to the lack of in situ molecular mechanistic data available. The previous caveat of animal and 
cell culture models comprising the predominance of molecular insight has been overcome in 
this thesis by the successful implementation of the endovascular biopsy technique in 
accordance with previous research (Colombo et al., 2002; Donato et al., 2007; Feng et al., 
1999). 
 This work determined that the endovascular biopsy technique provides an efficient 
method of EC extraction that can be implemented and applied to cross-sectional populations. 
Animal models and cell culture work have provided preliminary data, but this method allows 
harvesting of EC that have been subjected to the specific haemodynamic and humoral 
environment that cannot be fully matched in previously employed in vitro methods. Although 
conducted within a clinical setting in this thesis (chapter 6), this method  offers potential for 
further application in additional cohorts and, specifically, trained individuals.  
The endovascular biopsy technique has previously been identified as a potential method 
for the elucidation of the molecular events underlying various clinical pathologies, including 
coronary heart failure (Colombo et al., 2002), atherosclerosis (Onat et al., 2007) and obesity 
(Jelic et al., 2010; Silver et al., 2007). The development of this technique in the current thesis 
implemented several improvements compared with the original methods employed by the 
pioneering groups (Feng et al., 1999; Silver et al., 2010). Primarily, the comprehensive 
improvement of immunocytochemical methods (chapter 5) ensured the valid and reliable 
identification of eNOS, a key protein in relation to vascular status. Additionally, the 
improvement in cell yield (Colombo et al., 2002; Feng et al., 1999) allowed for sufficient 
extraction of RNA to allow for quantification of mRNA. Original work suggesting the 
requirement for single cell qPCR has been advanced and one-step  RT-qPCR is proposed as a 
successful method for gene expression analysis. This is comparably more accessible and time-
effective as compared to single cell analysis, whilst offering a relatively more reliable 
quantification method than immunocytochemistry.  
The improvement in techniques presented in this thesis suggests that the methodology 
utilised during the extraction protocol and post-harvest processing is of relatively greater 
suitability to future research compared to previous research, improving the plausibility of its 
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use. The endovascular biopsy technique subsequently has the potential to assist in the 
elucidation of the molecular mechanisms involved in vascular adaptation and moreover, the 
cell activity affected in states of vascular dysfunction and adaptation. Provided there is suitable 
access to medical expertise or those capable of obtaining arterial access given the lack of 
suitability of venous samples in providing reliable measures of all genes and proteins of interest 
(Colombo et al., 2002), the endovascular biopsy offers an accessible and relatively non-
invasive method of extracting EC. When used in conjunction with the already established in 
vivo methods of assessing vascular health (2D Doppler ultrasound), this may provide a direct 
and thorough measurement of endothelial health status (Fig. 7.2). Correlating results from this 
method with additional in vivo measurements of vascular function and structure may allow for 
improved biochemical elucidation of the mechanisms of dysfunction and adaptation with health 
status and exercise, respectively. 
 
 
Figure 7.1 Simultaneous use of EC biopises and 2D Doppler ultrasound to allow a 
comprehensive understanding of the cellular and molecular basis of clinical, pathological or 
physiological conditions. Diagram adapted from (Fadini and Avogaro, 2010); A 2D Doppler 
ultrasound; B EC biopsy; C immunocytochemistry; D RT-qPCR. 
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7.4 Limitations 
The limitations of this thesis are acknowledged. The use of 2D Doppler ultrasound has inherent 
limitations that require discussion. The original calculation of shear stress includes a measure 
of blood viscosity, which was assumed to be similar between subjects as standard and was 
consequently excluded from shear stress calculation (chapters 3, 4). However, athletes exhibit 
greater total RBC and haemoglobin and a concurrent enhancement in plasma volume compared 
with their untrained counterparts (Mairbäurl, 2013), hence may exhibit altered blood viscosity. 
Participants were young and of good health, thus it is unlikely that viscosity was different 
between groups, but it should nonetheless be stated that it may have contributed to variations 
in shear stress values. Additionally, the probe insonation angle was set at <69º between the 2D 
Doppler beam and the vessel orientation (chapters 2, 3, 4) as opposed to the suggested 60º to 
minimise measurement error (Thijssen et al., 2011).  Although it has been recommended that 
for clinical ultrasound an insonation angle of 60º should be selected, angles ranging between 
60 and 70º provide a valid velocity assessment (Thijssen et al, 2011; Thrush and Hartshorne, 
2004). A compromise between optimising the angle of insonation and maintaining the 
sensitivity of the B-mode image is an unavoidable factor when undertaking simultaneous B-
mode and 2D Doppler measurements. Thus, any reduction in insonation angle may negatively 
impact the sensitivity of measurements of artery characteristics, specifically diameter and FMD. 
In respect of the current thesis where the primary outcomes are predominantly related to 
brachial artery diameter (i.e. FMD and DC), it was preferential to avoid a sacrifice to the quality 
of B-mode images and hence validity of diameter measurements in order to increase the 
insonation angle and subsequently measure 2D Doppler shifts with a slightly lessened error. 
As is good practice the insonation angle was reported in the methods (chapter 2). There is also 
an inherent error associated with intrinsic spectral broadening when calculating TAMV such 
that there is an average overestimation of mean velocity of approximately 20-30%. However, 
this error is associated with each measurement thus when comparisons are made within and 
between groups, associated error is equal. 
When determining arterial structure, the maximum diameter following ischaemic 
exercise (DC) was implemented. Although this method has previously been validated against 
sublingual glyceryl trinitrate (GTN) administration (Naylor et al., 2005), the additional 
administration of a pharmacological vasodilator (GTN, Ach) may have provided a greater peak 
reactive hyperaemic diameter (Naylor et al., 2005) and hence diminished the effects of potential 
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functional confounders. However, the requirement for a relatively invasive arterial cannulation 
prevented its application in this work. 
Due to the specific properties of the 2D Doppler ultrasound equipment, shear profiles 
could not be fully quantified (absence of retrograde flow). This limitation should be noted given 
the previously discussed varying effects of shear patterns on EC phenotype (Laughlin et al., 
2008). It is plausible that greater oscillatory stress was bourne by the EC during IPC of greater 
durations, which may in part explain the return in arterial function after 8 weeks of intervention. 
The absence of full shear profile quantification prevented elucidation of this hypothesis. 
Participants recruited within the in vivo studies (chapters 3, 4) were healthy, 
recreationally active individuals and although the effects of an IPC intervention have been 
speculated to be transferrable to a clinical population, they cannot be certain in these groups. 
However, IPC has indeed been shown to be applicable to those with cardiac abnormalities 
(Hausenloy and Yellon, 2008). This research prolonged the previously established stimulus 
and merely speculated regarding the potential to apply chronic IPC in these clinical populations. 
In addition, endovascular biopsy proof of concept work was conducted in a clinical population 
lacking various anthropometrical and physiological measurements, which may have 
confounded observations.  
A limitation increasingly apparent with EC extractions was the lack of standardisation 
of the procedure of EC sampling in that although the same surgeon extracted each sample in 
accordance with a standardised protocol, differences in wire (coronary) and balloon type 
selection (measurements, brand), guidewire pressure applied and duration of catheterisation 
were unavoidable. This caveat was minimised where possible, ensuring brachial guidewires 
were consistently of the same brand and dimensions and were sampled when the PCI procedure 
was at completion. Further, a protocol was followed which demanded a specific number of 
advancements within the artery such that a forward and backwards motion was completed 
approximately 5 times (brachial). The latter standardisation technique was however, not 
possible within the coronary arteries due to the complexities of the PCI procedure. Further, the 
inflation duration of pre-stent balloons before extraction could not be matched between 
participants, implicating various lengths of contact time between the balloon and the 
endothelial lining of the coronary arteries and possibly affecting the EC yield. 
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7.5 Directions for future research 
The findings of this research have highlighted the possibilities of manipulating the contributing 
stimuli that potentially contribute to vascular adaptations whilst simultaneously demonstrating 
the applicability of the endovascular biopsy technique to provide a comprehensive evaluation 
of EC in cohorts of varying vascular status. This work has generated questions that require 
addressing in future research and has crucially developed a novel methodology to do so. 
Implementation of endovascular biopsy: Comprehensive research has aimed to determine the 
vascular adaptations with exercise and the potential contributing factors (Green et al., 2010; 
Laughlin et al., 2008) but as yet, no studies have implemented a technique to provide an 
inclusive evaluation of the in vivo cellular and molecular mechanisms underpinning these 
changes. A combination of functional and structural measures (2D Doppler ultrasound) and 
determination of the molecular pathways (endovascular biopsy) would provide a 
comprehensive picture of the mechanisms involved in vascular health and adaptation. This 
cellular and molecular analysis as adjunctive to the in vivo vascular assessment in both diseased 
and adapted vasculature would provide novel insight in to potential therapeutic targets. 
Investigations could utilise this methodology and investigate the variations in gene expression 
following an acute bout of exercise or IPC. This could be enhanced by obtaining multiple 
extractions across a training period similar to that in chapter 4 and determining the chronic 
changes in gene and protein expression with repeated exposure to the key stimuli suggested to 
be responsible for the observed adaptations. 
Improvement of the endovascular biopsy: Standardisation of the endovascular biopsy technique 
is required to ensure comparisons both within and between research groups. If arterial access 
is obtained for the sole purpose of EC extraction, this would offer increased potential for 
standardisation without the requirement for prior coronary procedures. Further, if access can 
be obtained within a research setting as opposed to during surgical interventions, this would 
minimise sample transportation time, allowing for further post-harvest standardisation. In order 
to determine the applicability and success of endovascular biopsy methodologies, improvement 
was focussed primarily on the quantification of eNOS expression. Future research should focus 
on the quantification of additional proteins of interest to vascular health (VEGFR-2; MMPs; 
AMPK) and the applicability of this technique to distinguish differences within a wider range 
of target proteins between additional cohorts. Further, improvement of post-extraction analysis 
techniques (immunocytochemistry utilising light microscopy of greater magnification and 
confocal microscopy) should aid in observing potential differences between cohorts. 
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Therapeutic application of IPC: IPC offers a unique training stimulus that may be utilised in 
those intolerant to the high load of regular exercise such as elderly, clinical or injured 
populations. Currently, remote IPC is utilised in cardiac patients to render the myocardium 
resistant to subsequent ischaemia-reperfusion injury induced by pathological events, or prior 
to planned ischaemic events (cardiovascular surgery) (Davies et al., 2013). Findings in this 
thesis suggest that employing IPC in clincal populations in the weeks preceding these events 
may improve endothelial function for up to 6 weeks, which may have implications for surgery 
success and recovery, whilst offering a method of improving vascular health in those 
contraindicated to traditional exercise.  
Manipulation of confounding stimuli: Future studies should directly investigate the 
contributory roles of metabolic/chemical stimuli to conduit vessel adaptation with exercise in 
order to fully decipher their relative importance. In addition to previous research, this would 
determine not only the crucial roles of the predominant stimuli (shear stress) but also the 
possible prevailing compensatory mechanisms. This could be implemented via the reduction 
of shear stress (via occlusion) and addition of hypoxia and / or muscle contraction, 
manipulating the previously established BFR protocols (Hunt et al., 2012; Takarada et al., 
2000). Although initially attempted within this thesis, due to technical difficulties in obtaining 
accurate measurements throughout alternate protocols, this could not be successfully 
implemented.  
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7.6 Conclusions 
The studies contained in this thesis demonstrate the potential stimuli for conduit artery 
adaptation with exercise and have developed an efficient method to further elucidate these 
mechanisms at a cellular level. These findings support the theory that conduit artery adaptations 
to exercise-induced shear stress occur in a time-dependent manner and transient functional 
enhancements are superseded by structural adaptation with prolonged exercise training, the 
latter of which is dependent on additional confounders associated with exercise. For the first 
time it has shown that IPC induces a trend for a transient functional enhancement in both the 
intervention and contralateral conduit arteries, indicating a local and systemic effect of IPC 
which is significant when controlled for baseline artery diameter. Further, this thesis has 
developed, improved and implemented an endovascular biopsy technique and highlights the 
potential of this technique to elucidate the biomolecular mechanisms underlying adaptation to 
provide a greater understanding of the responsible stimuli. Future research should combine 
measures of endothelial function (2D Doppler ultrasound) and biochemical pathways 
(endovascular biopsy) to provide a comprehensive understanding of vascular adaptation to 
exercise and disease, consequently providing considerable therapeutic potential. 
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Appendix A: Participant Information 
  
The effect of exposure to ischaemic preconditioning on vascular function and structure 
in recreationally active males 
 
Name, address, email and contact number of Main Investigator 
Dr Richard Ferguson  R.Ferguson@lboro.ac.uk    01509 226333 
Loughborough University 
Clyde Williams Building 
Ashby Road 
Loughborough 
 
Name, address, email and contact number of all other investigators/supervisors 
Miss Emilia Thompson E.B.Thompson@lboro.ac.uk   01509 226352 
(see address details above) 
 
Study Overview 
The aim of this study is to examine the effect of 8 weeks ischaemic preconditioning on brachial 
artery adaptations. The investigation will also compare the responses between the intervention 
and non-intervention limb. 
 
Who is doing this research? 
Dr Richard Ferguson is the senior investigator leading the project. Emilia Thompson is a PhD 
student and will be responsible for the day-to-day running of the research project.  
 
Are there any exclusion criteria? 
You will be one of 12 male participants aged 18-40. You will be recreationally active. 
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Prior to any experiments you will complete a pre-participation consent form and health and 
physical activity questionnaire to ensure you are eligible to take part. If you have a history of 
cardiovascular, metabolic or blood disorders you will be excluded from this study. If you report 
a sedentary lifestyle of less than three 30-min physical activity sessions per week you will be 
excluded. If you have done any resistance type training for the previous 2 years you will also 
be excluded. 
 
Once I take part, can I change my mind? 
It should be noted that you will be free to withdraw from the study at any time without giving 
a reason. 
If you are a student of Loughborough University your decision to participate / not participate / 
withdraw will not have any bearing on your academic progress. 
 
Will I be required to attend any sessions and where will these be? 
You will be asked to attend the laboratory on 5 occasions for data collection. The location is 
the Cardiovascular Laboratory (room HE2.42) in the Clyde Williams building (location no. 
105 on the University Campus map) on the Loughborough University campus. You will also 
have to attend one familiarisation trial, and following the initial testing session you will be 
required to attend the laboratory for training sessions 3 times per week for 8 weeks. 
 
How long will it take? 
The familiarisation session will take approximately 20 minutes, whilst the total duration of 
each main testing session will be approximately 1.5 hours. Each training session will last 
approximately 30 minutes. 
 
Is there anything I need to do before the sessions? 
Although it is necessary that you maintained your weekly routine of physical activity, for the 
24 hour before the testing visits you will be asked to refrain from strenuous physical activity 
and avoid the consumption of alcohol, smoking, caffeine for 12 hours prior to testing. We will 
also ask you to attend the laboratory in the morning following an overnight fast and not having 
consumed any breakfast. 
 
Is there anything I need to bring with me? 
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No 
 
What type of clothing should I wear? 
On each visit you should bring comfortable loose fitting clothing and a t-shirt, or preferably a 
sleeveless top. There will be a private changing room made available for you.  
 
What will I be asked to do? 
Experimental overview 
 
Testing and Data Collection Visits (x5) (Duration: 1.5 hours) 
Experimental measures will be performed on both arms (see below). 
 
Experimental Procedures 
Brachial Artery Flow Mediated Dilatation and Peak Vasodilator Capacity 
A pressure cuff will be placed around your forearm and you will be asked to lie still on your 
back for a period of twenty minutes. A Doppler Ultrasound probe will be used to locate the 
brachial artery in your upper arm.  
To measure flow mediated dilatation the cuff will then be inflated to a high pressure 
(200mmHg) for 5 minutes. During this time the blood flow to your forearm will be severely 
reduced and you may experience a feeling of ‘pins and needles’. Measurement of artery 
diameter and flow readings will be taken 15 seconds before the cuff is deflated and continue 
for 2 minutes thereafter. 
To measure peak vasodilator capacity the pneumatic cuff will be placed on the upper arm.  You 
will have another 20 min rest period and then the cuff will be inflated to 200 mmHg for 5 min. 
You will perform handgrip exercise during the middle 3 min of occlusion.  Doppler recordings 
will be measured 15 sec prior to cuff deflation and will continue for 2 min thereafter. 
 
Training Visits (x12) (Duration: 6 hours) 
Training will be performed 3 times per week for a total of 8 weeks. You will be lying supine 
throughout training. On one arm, a pressure cuff will be placed around your forearm or upper 
arm and inflated to 200mmHg for 5 minutes. The cuff will then be deflated and will remain so 
for 5 minutes. This will be repeated a further 2 times. Inflation duration will be increased by 1 
minute every 2 weeks until a final time of 8 minutes is reached with an equivocal rest period. 
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Possible benefits of taking part 
You will hopefully find the experience of being a participant for a research study extremely 
interesting. If you are Sport and Exercise Science student you will gain valuable experience 
and information about experimental methodologies and the science related to the project. If 
you are involved in sport and exercise participation some of the tests will provide you with 
information about your physical potential for performance. You will also be playing your own 
part in contributing to the existing body of scientific knowledge. 
 
What personal information will be required from me? 
All personal information required will be found in the health screen questionnaire. 
 
Are there any risks in participating? 
All physiological measurements are non-invasive. The measurement of blood flow requires 
very high cuff inflation pressure and the performance of muscle contractions during total blood 
flow occlusion. This will result in severe local muscle fatigue. All responses are transient and 
the investigators involved are vigilant in ensuring the participants comfort and safety at all 
times. 
 
Will my taking part in this study be kept confidential? 
All data will be dealt with under the strictest of guidelines and according to the Data Protection 
Act. Participants will be numerically coded and data will be discussed only amongst the lead 
investigators. 
 
What will happen to the results of the study? 
The results of the study will be used to formulate relevant conclusions. After completion it may 
be used in further publication, however confidentiality will be preserved. 
 
What do I get for participating? 
Information on the study can be sent to participants if they require. Unfortunately no financial 
incentives are offered. 
 
I have some more questions who should I contact? 
Dr Richard Ferguson  
Miss Emilia Thompson 
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What if I am not happy with how the research was conducted? 
The University has a policy relating to Research Misconduct and Whistle Blowing which is 
available online at http://www.lboro.ac.uk/admin/committees/ethical/Whistleblowing(2).htm. 
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Appendix B: Informed Consent Form 
(to be completed after Participant Information Sheet has been read) 
 
The effect of exposure to ischaemic preconditioning on vascular function and structure 
in recreationally active males 
 
 The purpose and details of this study have been explained to me.  I understand that this 
study is designed to further scientific knowledge and that all procedures have been 
approved by the Loughborough University Ethical Advisory Committee. 
 I understand that a duplicate copy of this form will be kept by the University.  
 I have read and understood the information sheet and this consent form. 
 I have had an opportunity to ask questions about my participation. 
 I understand that I am under no obligation to take part in the study. 
 I understand that I have the right to withdraw from this study at any stage for any reason, 
and that I will not be required to explain my reasons for withdrawing. 
 I understand that all the information I provide will be treated in strict confidence and will 
be kept anonymous and confidential to the researchers unless (under the statutory 
obligations of the agencies which the researchers are working with), it is judged that 
confidentiality will have to be breached for the safety of the participant or others.  
 I agree to participate in this study. 
 
Your name 
              
Your signature 
 
Signature of investigator 
 
Date 
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Appendix C: Health Screen Questionnaire 
 
Note to Investigators:  This HSQ can be used in its entirety but you can also remove some 
of the questions if you know they are not relevant to your study. 
 
As a volunteer participating in a research study, it is important that you are currently in good 
health and have had no significant medical problems in the past.  This is (i) to ensure your 
own continuing well-being and (ii) to avoid the possibility of individual health issues 
confounding study outcomes. 
 
If you have a blood-borne virus, or think that you may have one, please do not take part in 
this research. 
 
Please complete this brief questionnaire to confirm your fitness to participate: 
 
1. At present, do you have any health problem for which you are: 
(a) on medication, prescribed or otherwise ............. Yes  No  
(b) attending your general practitioner .................... Yes  No  
(c) on a hospital waiting list .................................... Yes  No  
 
2. In the past two years, have you had any illness which required you to: 
(a) consult your GP ................................................. Yes  No  
(b) attend a hospital outpatient department ............. Yes  No  
(c) be admitted to hospital  ...................................... Yes  No  
 
3. Have you ever had any of the following: 
(a) Convulsions/epilepsy  ........................................  Yes  No  
(b) Asthma  ..............................................................  Yes  No  
(c) Eczema  ..............................................................  Yes  No  
(d) Diabetes  ............................................................  Yes  No  
(e) A blood disorder  ...............................................  Yes  No  
(f) Head injury  .......................................................  Yes  No  
(g) Digestive problems  ...........................................  Yes  No  
(h) Heart problems  ..................................................  Yes  No  
(i) Problems with bones or joints    ........................  Yes  No  
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(j) Disturbance of balance/coordination  ................  Yes  No  
(k) Numbness in hands or feet  ................................  Yes  No  
(l) Disturbance of vision  ........................................  Yes  No  
(m) Ear / hearing problems  ......................................  Yes  No  
(n) Thyroid problems  ..............................................  Yes  No  
(o) Kidney or liver problems  ..................................  Yes  No  
(p) Allergy to nuts  ..................................................  Yes  No  
 
 
 
4. Has any, otherwise healthy, member of your family under the 
age of 35 died suddenly during or soon after 
exercise?  ..................................................................... 
Yes  No  
 
If YES to any question, please describe briefly if you wish (eg to confirm problem was/is 
short-lived, insignificant or well controlled.) 
......................................................................................................................................................
......................................................................................................................................................
.......... 
 
5. Allergy Information 
(a) are you allergic to any food products? Yes  No  
(b) are you allergic to any medicines? Yes  No  
(c) are you allergic to plasters? Yes  No  
 
If YES to any of the above, please provide additional information on the allergy 
…………………………………………………………………………………………………
…………………………….. 
 
6. Additional questions for female participants 
(a) are your periods normal/regular?  .......................  Yes  No  
(b) are you on “the pill”?  .........................................  Yes  No  
(c) could you be pregnant?    ....................................  Yes  No  
(d) are you taking hormone replacement therapy 
(HRT)? 
Yes  No  
 
Please provide contact details of a suitable person for us to contact in the event of any 
incident or emergency. 
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Name:  
………………………………………………………………………………………………
………………. 
 
Telephone Number:  
………………………………………………………………………………………………
………………. 
 
 Work  Home  Mobile  
 
Relationship to 
Participant:…………………………………………………………………………………
………............ 
 
7. Are you currently involved in any other research studies at the University or 
elsewhere? 
 Yes  No  
 
If yes, please provide details of the study 
……………………………………………………………………………………………
………………………………………………………………………………………………
………………………………… 
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Appendix D: Melt curve produced during eNOS RT-qPCR 
 
 
 
 
